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The immune system provides protection against pathogens such as bacteria, 
viruses, parasites and fungi. It comprises a cellular and humoral compartment. 
The former is a complicated network of immune cells in lymphoid organs, tissues 
and the circulation and is classically divided into the innate and adaptive immune 
compartment. Innate immunity provides a crucial first line of defense mediated by 
a swift, general and non-specific response to the invader. The innate compartment 
consists of various types of phagocytic granulocytes, myeloid cells, such as 
macrophages and dendritic cells (DCs), and innate lymphoid cells (ILCs) including 
cytolytic natural killer (NK) cells and CD127+ ILCs. Simultaneously, the adaptive 
immune system will mount a more tailored and specific response through antigen-
specific receptors-expressing B and T lymphocytes, the latter including helper 
CD4+ T cells and cytotoxic CD8+ T cells. Ultimately, the combined innate and 
adaptive will lead to suppression or elimination of the invading pathogen and the 
generation of immunological memory that provides long-lasting immunity to the 
pathogen. Typically, adaptive immune responses will be initiated in the lymph 
nodes by dendritic cells that have moved into the lymph node upon encounter 
with and internalization of pathogens in peripheral tissues or fluids, upon which 
the activated immune cells will leave the lymph node and attack the invading 
pathogen in the body. Lymphoid organs include primary organs (thymus and bone 
marrow) and secondary tissues such as spleen and mucosal-associated lymphoid 
tissue, in which the immune process takes place. 
The immune system develops in the fetus during pregnancy. The developing fetus 
expresses the polymorphic major histocompatibility complex (MHC) molecules, 
half of which are inherited from the mother and half from the father. This implies 
that the paternal MHC antigens are potential allogeneic targets for the maternal 
immune system. Similarly, the non-inherited maternal MHC antigens can potentially 
be recognized by the fetal immune system. For a successful pregnancy it is thus 
crucial that both the fetal and maternal immune system remain tolerant to the 
semi-allogeneic environment, but it is at present unclear how this is achieved. 
On the other hand, the fetus has to be prepared for the massive colonization 
of mucosal and epithelial surfaces with commensals and exposure to pathogens 
directly upon birth. In this respect, it is intriguing that in utero the fetus is 
thought to be protected from exposure to foreign antigens. In agreement, the 
vast majority of cord blood T cells exhibit a naive phenotype. Yet, it is unclear 
how such a naive immune compartment would be able to adequately deal with 
the rapid microbial colonization upon birth. Thus, the developing immune system 
should be poised for environmental attack while remaining tolerant to the semi-
allogeneic environment, a seemingly conflicting and impossible task. 
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Hematopoiesis
In human fetus, the first occurrence of hematopoietic stem cells (HSCs) is in 
the dorsal aorta of the aorta-gonad-mesonephros (AGM) region at week 5 of 
gestation and before their appearance in the yolk sac1. The HSCs then migrate 
into the fetal liver, which becomes the main hematopoietic site at the 5-6 weeks 
of gestation. Hematopoiesis in the fetal liver reaches the peak in the second 
trimester and terminates soon upon birth. In the second trimester, the HSCs 
are mainly produced by the bone marrow, which remains the primary organ of 
hematopoiesis throughout whole life. The HSCs from fetal liver are the first to 
colonize the thymus and spleen2, 3, 4. 
Development of the fetal immune system
T cells
The early prothymocytes can be detected in the fetal liver at week 7 of gestation and 
are characterized by the expression of CD45, CD7 and cytoplasmic CD3 but lacking 
expression of membrane CD3, TCR β chain and TdT (terminal deoxynucleotidyl 
transferase) a DNA polymerase, which can insert random N-nucleotides into 
the DJ region of the T-cell receptor (TCR), contributing to the diversity of TCR 
repertoire5. T cells first appear in the perithymic mesenchyme at around week 7 
of gestation and become mature between week 7 to 12 of gestation as indicated 
by the expression of P80, a marker for mature thymocytes6. These cells begin to 
migrate to the periphery at approximately week 14 of gestation7. The expression 
of TdT enzyme is not readily detectable before week 19 of gestation in the thymus, 
however, TdT mRNA can be amplified in the thymus as early as week 8 of gestation 
at a minimal quantity8.
Compared with a predominant memory T cells (CD45RO+) in the adult tissue, the 
fetal cord blood T cells mainly display a naive phenotype (CD45RA+) at birth9. 
However, a recent study has identified a minor population of effector memory T 
cells in cord blood, which expresses the tissue resident and activation marker CD69 
and displays both Th1- and Th2-type functional profiles in the absence of known 
infections during pregnancy10. In addition, Byrne et al. have provided evidence 
for the existence of abundant CD45RO+ memory T cells (including both CD4+ and 
CD8+ T populations) in the human fetal spleen from 14-22 weeks of gestation, 
which were able to proliferate in response to IL-211. Between week 16 and 18 of 
gestation the frequencies of these cells can reach levels comparable to those in 
the adult spleen but they are dramatically decreased in the neonatal spleen11. In 
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addition, memory T cells have also been identified in the human fetal skin12 and 
intestine13. Although scarce, T cells are first detectable in the epithelial and lamina 
propria of the human fetal intestine from week 12 of gestation onwards, and 
the number of T cells increases along with the gestational age14. Bunders et al. 
demonstrated that in the human fetal mucosa, there is a dominance of CD45RO+ 
memory T cells with Th1- and Th17-phenotype. These cells express the activation 
marker HLA-DR and are polyclonal and highly susceptible to HIV infection13. The 
observations of memory T cells in fetal tissues suggest the occurrence of complete 
T cell maturation in utero but it is unclear how this is induced or regulated. 
Interestingly, almost 50% of CD8+ T cells in the fetal intestinal lamina propria 
express CD8aa homodimers, as opposed to CD8αβ heterodimers, commonly 
found on peripheral CD8+ T cells, which indicates that these CD8aa cells may be 
thymus-independent and develop in the mucosal tissue niche15. As it has been well 
documented in human studies that from 18 to 24 weeks of gestation, the fetal 
mesenteric lymph nodes (mLNs) are dominated by CD45RA+ T cells, which can 
proliferate upon addition of exogenous of IL-2 but not in response to PHA or CD3 
specific monoclonal antibodies16, fetal intestinal memory T cells exhibit unique 
properties. Finally, mucosal associated invariant T (MAIT) cells have also been 
identified in the human fetal intestine at the second trimester but their functional 
properties remain to be further explored17.
Thus, many issues regarding the nature and development of T cells in the fetal 
intestine remain unresolved. 
Regulatory T cells
Regulatory T cells (Tregs), characterized as CD3+CD4+CD25highFoxP3+, play a 
crucial role in modulating the immune system to maintain immune tolerance and 
prevent autoimmunity. They are classified into two types: “natural” Tregs, which 
differentiate from T cell precursors in the thymus18 and “induced” Tregs, which are 
generated from the conventional Foxp3-CD4+ T cells outsize the thymus19. It has 
been reported that Tregs are more abundant in the developing fetus compared 
with newborns and adult9, 20 and are present in the human fetal thymus, spleen, 
lymph nodes (LNs) during the second trimester20, 21 as well as in cord blood20. 
Moreover, Mold et al. reported that after stimulation with foreign APCs in vitro, 
human fetal CD4+ T cells derived from fetal LNs and spleens preferentially gave rise 
to Tregs, which were specific for the non-inherited maternal antigens (NIMAs)22. 
Moreover, HSCs derived from fetal liver and fetal bone marrow were found to 
generate a significant higher frequency of Foxp3+ Tregs compared to adult derived 
bone marrow HSCs, indicating that fetal HSCs are prone to Treg differentiation23. 
13
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Finally, the absence of Foxp3+ Tregs in utero has been linked with diseases like 
type 1 diabetes and dermatitis24, which further highlights the value to study the 
Tregs in fetal tissues in detail.
Innate lymphoid cells
Innate lymphoid cells (ILCs) lack the expression of antigen-specific receptors and 
the major immune lineage markers but otherwise they are the innate counterparts 
of T cells. NK cells, group 1 ILCs (ILC1s), group 2 ILCs (ILC2s) and group 3 ILCs 
(ILC3s) mirror CD8+ cytotoxic T cells, CD4+ Th1, Th2 and Th17 cells, respectively, 
with respect to their function and development25. It has been reported that fetal 
ILCs are found in the human liver, lymphoid tissue, lung and intestine26, 27, 28. In the 
fetal liver, NKp44- ILC3s are abundant and appear as early as week 6 of gestation 
whereas the other subsets are detectable only after week 1526. Compared to fetal 
liver, NKp44+ ILC3s are enriched in the human fetal intestine, where there are 
hardly any ILC1s, suggesting that the differentiation of ILC1s may be related to 
microbiota colonization29. Lymphoid tissue inducer (LTi) cells, a subtype of ILC3s 
expressing Neuropilin-127, play a crucial role in second lymphoid organs formation 
during the fetal development, and have been identified in the fetal LNs and spleen 
in the first and second trimester27, 30, 31. In addition, Mjösberg et al. has provided 
evidence for the existence of ILC2s in the mucosal tissue such as fetal intestine and 
lung during the second trimester32. Thus, tissue specific localization of particular 
subsets is already evident in the developing fetus. In recent years, substantial 
plasticity and heterogeneity within ILC compartment have been described in 
adults25, 33 but this is still unexplored in the human fetus. 
The knowledge on ILC development is mainly based on studies in mice, where the 
common lymphoid progenitors (CLPs) give rise to the common innate lymphoid 
progenitors (CILPs), which further differentiate into NK cell precursors (NKP) 
and common helper innate lymphoid progenitors (CHILPs). CHILPs give rise to 
lymphoid tissue inducer progenitors and innate lymphoid cell precursors (ILCPs), 
which generate LTi and ILC1s, ILC2s, and ILC3s, respectively25. In humans, 
multipotent CLP-like CD34+ progenitor and CD34+CD117+ CILPs have been 
identified in human lymphoid tissues, such as tonsil34, 35. Additionally, a subset 
of CD34-CD127+CD117+ ILCPs has been described in different tissues, including 
fetal liver36. Recently, Chen et al. demonstrated that human CD56+ ILCPs can give 
rise to NK cells and ILC3s whereas CD56- ILCPs generate ILC2s, pointing towards 
differences in the developmental pathways of ILC in human and mice37. Finally, as 
only the NKP and ILC3 precursor have been identified in humans38, several other 
precursors and intermediates of the ILC developmental pathways still need to be 
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identified. 
B cells and dendritic cells 
B cells appear in the fetal liver as early as week 8 of gestation39 and in the spleen 
by week 1340 and B cells with a diverse B cell receptor repertoire are detectable 
in cord blood already at week 12 of gestation41. The presence of DCs has been 
demonstrated in different fetal tissues, such as spleen, skin and intestine, where 
the DCs suppress the T-cell immunity by promoting the induction of Tregs and 
inhibiting the production of tumor-necrosis factor (TNF)42. In addition, follicular 
DCs co-localized with B cells in the fetal spleen, indicating antigen presentation to 
B cells43. Although different types of subsets in both innate and adaptive immunity 
have been identified in utero, most of the knowledge is based on studies with cord 
blood collected at birth due to scarcity of human fetal tissues. In addition, the recent 
discoveries of effector T cells and mature DCs in the developing fetus suggest that 
the fetal immune system is more complex than previously appreciated. Therefore, 
further investigations into the development of early-life immunity with a global 
and detailed view across fetal tissues such as the intestine are needed.
Intestinal mucosal immune system
The intestine harbors the largest immune compartment in our body and is a main 
interface for direct interaction between the immune system and a large array 
of environmental antigens. It is continuously exposed to both antigens derived 
from harmless dietary constituents and potential harmful (commensal) bacteria, 
separated from each other by only a single layer of epithelial cells. For this, an 
elaborate intestinal immune system has evolved to distinguish the harmful from 
beneficial antigens. T cells are scattered throughout the epithelium and the 
underlying lamina propria harbors both adaptive and innate immune cells as well as 
a variety of antigen presenting cells. In addition, there are gut-associated lymphoid 
tissues, such as mesenteric lymph nodes and Peyer’s patches44, the latter of which 
are first detectable in the fetal intestine between week 16-19 of gestation45. While 
there is extensive literature on the organization and composition of the immune 
system in the intestine in children and adults, relatively little is known about this 
issue in the developing fetal intestine. In the current study, we have approached 
this issue by making use of recently introduced single cell technologies, including 
(imaging) mass cytometry and single-cell RNA-sequencing. 
Mass cytometry
15
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Mass cytometry or cytometry by time-of-flight (CyTOF) is a new platform that 
couples flow cytometry with mass spectrometry. This technique uses rare earth 
metals as reporters instead of fluorophores, which removes the limitation on the 
number of antibodies that can simultaneously be used due to the spectral overlap 
of the fluorochromes, and eliminates the problem of autofluorescence. Through 
mass cytometry up to 42 markers can now be used simultaneously at single-
cell resolution with minimal overlap between channels46, 47. Theoretically, with 
the availability of additional metal reporters, over 100 markers can be measured 
simultaneously in the future. The schematic overview of the mass cytometry 
workflow is described in Figure 1. Therefore, mass cytometry now provides the 
opportunity to study the diversity and heterogeneity of the immune system with an 
unprecedent high-resolution. Although mass cytometry has many advantages over 
traditional flow cytometry, there are still some challenges with mass cytometry46. 
First, the sensitivity of the metal reporters used in mass cytometry is lower than 
the brightest fluorophores in flow cytometry. Second, the acquisition speed can 
reach thousands of events per second with around 95% recovery in flow cytometry, 
compared to only 300 events per second with around 60% recovery (Helios) in 
mass cytometry. Third, as the cells are destroyed during the data acquisition, 
mass cytometry cannot be used to sort cells for further functional analysis. Finally, 
in mass cytometry the classical forward and size scatter parameters are lacking. 
Chapter 1
16
Figure 1.Workflow of CyTOF. A single-cell suspension is labeled with metal-conjugated antibodies 
(A) and injected into the nebulizer (B). After aerosolizing into a single-cell droplet, it is directed into the 
inductively coupled plasma (ICP) torch, in which it is vaporized, atomized and ionized (C). The low mass 
ions are removed by the high pass optic (D), resulting in an ion cloud enriched with heavy metal isotypes, 
which then enters the time of flight (TOF) chamber (E). The ions are then separated based on the their 
mass as they accelerate to the detector, where the intensity of each metal for each individual cells will be 
measured (F). Finally, data is generated in the FSC format (G) and analyzed using third-party software 
(H). Adapted from Fluidigm. 
Data analysis in mass cytometry
In flow cytometry, cell populations are manually identified by using sequential 
gating based on bimodal expression patterns within one- or two-dimensional plots. 
With the substantial increase in the number of parameters in mass cytometry, the 
complexity of the data interpretation has challenged this manual “gating strategy” 
and inspired the development of new computational tools. t-distributed Stochastic 
Neighbor Embedding (t-SNE) is a non-linear dimensionality reduction algorithm 
and currently widely used for the analysis of mass cytometry data. t-SNE takes 
all the marker expression patterns into account simultaneously and projects the 
high dimensional data onto two dimensional plots48. Nevertheless, conventional 
t-SNE has several limitations like a restriction of the size of the dataset and long 
computing time. Hierarchical Stochastic Neighbor Embedding (HSNE), an in-
house developed software, removes the scalability limitation of the conventional 
t-SNE analysis and allows the rapid exploration of millions of cells simultaneously. 
Furthermore, the implementation of HSNE in Cytosplore49, named Cytosplore+HSNE 
50, allows the user to analyze the entire dataset at several levels of hierarchy, 
going from a global overview of the data structure to full single cell resolution.
Imaging-mass cytometry
Recently, imaging-mass cytometry has been developed as a new technology to 
gain spatial information in situ, which couples a laser ablation system with a 
mass cytometer. In this way, it enables the visualization of dozens of markers on 
the same tissue section simultaneously with a sub-cellular resolution of 1 μm51. 
A schematic overview of the imaging-mass cytometry workflow is described in 
Figure 2. In addition, the traditional imaging analysis can be performed at the 
cell level by applying cell segmentation, cell neighborhood analysis and distance 
measurement. Up till now, imaging-mass cytometry has been mainly applied for 
biomarker identification in pharmaceutical research52 and analysis of the tumor 
environment in cancer research51, 53, 54. However, imaging-mass cytometry can be 
of great value in many other studies as well as it offers an opportunity to gain 
unprecedented insight into the organization of the immune system in situ.
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antibodies, and amplification is achieved 
by a polymeric metal-chelating reagent 
or metal nanoparticles23,24. Because of 
these features, mass cytometry could 
be adapted to meet the sensitivity and 
multiplexing needs for tissue analysis 
at subcellular resolution23. Previously, 
mass cytometry has been used only to 
analyze cells in suspension, and informa-
tion on cell-cell interactions within tissue 
or tumor microenvironments has therefore 
been lost25–30. Here we describe imaging 
mass cytometry—an approach that 
combines CyTOF mass cytometry with 
immunocytochemistry (ICC) and IHC techniques, a high- 
resolution laser ablation system and a low-dispersion laser 
ablation chamber—to image 32 proteins and their modifications 
simultaneously at a cellular resolution of 1 µm (ref. 31).
Applying this approach, we analyzed human formalin-fixed, 
paraffin-embedded (FFPE) breast cancer samples and human 
mammary epithelial (HMLE) cells32. Analysis across cell states 
revealed substantial tumor microenvironment heterogeneity. 
Imaging mass cytometry can be combined with other imaging 
techniques and has the potential to influence both biological 
research and clinical management.
results
imaging mass cytometry
We introduce here an imaging technique that extends the 
multiplexed analysis capabilities of CyTOF-based mass 
cytometry23,27,30 to make spatially resolved measurements. We 
developed a workflow to couple mass cytometry, ICC and IHC 
analyses with a high-resolution laser ablation system to allow anal-
ysis of adherent cells and tissue sections with cellular resolution 
of 1 µm (Fig. 1). In the first step, the cell sample or tissue section 
was prepared for antibody labeling using routine ICC and IHC 
protocols (Online Methods). Antibodies were selected to target 
proteins and protein modifications relevant to breast cancer. Before 
staining, antibodies were tagged with a unique rare-earth-metal 
isotope of defined atomic mass. Currently, 32 rare-earth-metal 
isotopes are available as reporters. After air drying, the sample 
was positioned in a laser ablation chamber recently developed to 
minimize aerosol dispersion for high-resolution, high-throughput 
and highly sensitive analyses31. The tissue was then ablated 
spot by spot and line by line, and the ablated material was then 
transported by a mixed argon and helium stream to the CyTOF 
mass cytometer.
As determined from the data sets presented in this study, 
the signals of individual laser shots at 20 Hz were fully separated 
(Supplementary Fig. 1), and the limit of detection was approxi-
mately six ion counts (corresponding to ~500 molecules), assuming 
Poisson statistics (Online Methods). After data preprocessing, 
the 32 transient, single isotope signals were plotted using the 
coordinates of each single laser shot, and a high-dimensional 
image of the sample was generated by overlaying all analyzed 
measurement channels. Next, single-cell features were computa-
tionally segmented using a watershed algorithm, and the single-
cell marker expression data were extracted (Online Methods). 
These single-cell data were used for all downstream data analyses 
and to investigate cell subpopulations within a set of 21 tumor and 
normal samples in total from 20 breast cancer patients.
Validity of the approach
To evaluate the validity of imaging mass cytometry for IHC, we 
first performed experiments using FFPE breast cancer samples 
to ensure that metal labeling of the antibodies did not interfere 
with their target specificity. We compared unlabeled and metal-
labeled antibodies using IFM analysis on serial sections of tissues 
no. 210 and no. 37, which are from tumors of the same type (Fig. 
2a and Supplementary Fig. 2). We observed no apparent change 
in antibody specificity due to the metal labeling. Quantitative 
CyTOF mass
cytometer
UV
laser
Signal extraction of
32 measured  markers
Tissue or cell-line
preprocessing
Marker staining with
metal-labeled antibodies
Laser ablation coupled 
to mass cytometry
Downstream data analysis Single-cell segmentation Data preprocessing
and image assembly
× 4
Figure 1 | Workflow of imaging mass cytometry.
Unlabeled
antibody, IFM
HER2 (r)
Metal-labeled
antibody, IFM
CK8/18 (r)
Vim (y)
CyTOF imaging
mass cytometry
Metal-labeled
antibody, IFM
H3 (c)
E-Cad (r)
ba
Figure 2 | Validation of imaging mass cytometry. (a) IFM on serial breast 
cancer tissue sections of the luminal HER2+ subtype (case no. 37) using 
unlabeled and metal-labeled antibodies recognizing the indicated markers. 
(b) IFM and CyTOF imaging mass cytometry on breast cancer tissue 
sections of the luminal HER2+ subtype (case nos. 210, 23 and 37) using 
metal-labeled antibodies recognizing the indicated markers. E-cadherin 
(E-Cad) and vimentin (Vim) were not analyzed on serial sections.  
Both Hoechst 33258 in IFM images and H3 in all images are shown in  
cyan (c). r, red; y, yellow; CK8/18, cytokeratin 8/18. Scale bars, 25 µm.
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Figure 2. Work flow of imaging-mass cyto etry. Adapted from Giesen et al. (2014) 
Single-cell RNA-sequencing
As a complementary approach to mass cytome ry, single-cell RNA sequencing 
dissects the gene expression profiles on tens of thousands of individual cells at 
the single-cell level. In recent years, a varieties of single-cell RNA-sequencing 
techniques have been developed such as microfluidic-, plate- and droplet-based 
approaches55. As each of them has its own advantages and drawbacks56, the users 
can choose the best approach based on their research goals. As such, single-cell 
RNA-sequencing provides an opportunity to determine the cell transcriptomic 
heterogeneity, allows the discovery of rare cell populations, can be used to 
determine cellular differentia ion trajectories and to reveal regulatory networks 
among cells at the gene level57.
Outline of the sis
In recent years, several studies have highlighted the uniqueness of the human 
immune system in early life. Due to the scarceness of human fetal tissues and 
technical limitations, a system-wide and detailed phenotypical characterization of 
the composition and development of the human fetal immune system was lacking. 
In this thesis, I describe my work to gain further insight in the composition and 
d velopment of the human fetal immune system using an array of advanced high-
throughput technologies. 
The immune system comprises both the innate and adaptive immune 
compartments. With respect to the innate compartment, I was the first to apply 
mass cytometry to delineate the innate lymp oid cells (ILCs) in the human fetal 
intestine (Chapter 2). This revealed extensive heterogeneity of ILCs. Beside 
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the known ILC subsets, a previously unrecognized subset was identified, named 
int-ILCs, with a cell surface phenotype that combined CD127+ ILC and NK cell 
properties. In line with this, visualization of the t-SNE computation demonstrated 
that this cell positioned itself in between the CD127+ ILC and NK clusters, giving 
rise to the hypothesis that these cells might be precursors that could give rise to 
both NK cells and CD127+ ILCs. In functional in vitro studies I demonstrated that 
this was indeed the case. This study was one of the first to generate a data-driven 
hypothesis by exploring the heterogeneity of the immune system using mass 
cytometry, followed by functional validation.
With respect to the adaptive immune compartment, I used an array of advanced 
single-cell techniques, including high-throughput mass cytometry and imaging-
mass cytometry, single-cell RNA-sequencing and TCR sequencing, to characterize 
the CD4+ T cell compartment in the human fetal intestine (Chapter 3). By 
combining the acquired datasets with advanced computational analysis tools 
and functional analysis this revealed that memory-like CD4+ T cells with pro-
inflammatory properties were already generated in the developing human fetal 
intestinal immune system, indicative of in utero exposure to foreign antigens.
To further extend the understating of the fetal immune system, I applied mass 
cytometry and imaging-mass cytometry to both the innate and adaptive immune 
compartments in the fetal intestine, spleen and liver (Chapter 4). This revealed 
an early-life immune compartmentalization in these different fetal tissues.
Also, I was involved in a study in which we analyzed the composition of the 
mucosal immune system of patients with inflammatory intestinal diseases and 
controls using mass cytometry (Chapter 5). This first in its kind study revealed 
previously unrecognized heterogeneity in the mucosal immune system and tissue- 
and disease-specific immune subsets.
Finally, in chapter 6, I discuss the major findings described in Chapter 2-5 and 
their implications for shaping the prenatal immune system. In addition, potential 
directions for future research are discussed.
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Li et al. apply mass cytometry to delineate the fetal gut innate lymphoid cell (ILC) population 
and use a t-SNE-based approach to predict potential differentiation trajectories. This image 
represents the composition of the ILC compartment in the individual fetal intestines. The image 
was taken from the original manuscript and modified by the JEM editorial office. See page 77
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Abstract
Innate lymphoid cells (ILCs) are abundant in mucosal tissues and involved in 
tissue homeostasis and barrier function. While several ILC subsets have been 
identified, it is unknown if additional heterogeneity exists and their differentiation 
pathways remain largely unclear. We applied mass cytometry to analyze ILCs in 
the human fetal intestine and distinguished 34 distinct clusters through a t-SNE-
based analysis. A lineage (Lin)-CD7+CD127-CD45RO+CD56+ population clustered 
between the CD127+ ILC and natural killer (NK) cell subsets, and expressed diverse 
levels of Eomes, T-bet, GATA3 and RORγt. By visualizing the dynamics of the 
t-SNE computation, we identified smooth phenotypic transitions from cells within 
the Lin-CD7+CD127-CD45RO+CD56+ cluster to both the NK cells and CD127+ ILCs, 
revealing potential differentiation trajectories. In functional differentiation assays 
the Lin-CD7+CD127-CD45RO+CD56+CD8a- cells could develop into CD45RA+ NK 
cells and CD127+RORγt+ ILC3-like cells. Thus, we identified a previously unknown 
intermediate innate subset that can differentiate into ILC3 and NK cells.
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Introduction
Innate lymphoid cells (ILCs) lack expression of T cell receptors but otherwise are 
a functional counterpart of cytotoxic and helper T cell subsets. Helper ILCs are 
classified into 3 groups: ILC1, ILC2 and ILC3 1. ILC1s are mainly characterized 
as Lineage (Lin)-CD161+CD127+CRTH2-CD117-, express the transcription factor 
T-bet and produce T helper 1 (TH1) cell-associated cytokines. ILC2s are Lin-
CD161+CD127+CRTH2+, express GATA3, and produce T helper 2 (TH2) cell-
associated cytokines. ILC3s, including fetal lymphoid tissue-inducer (LTi) cells, are 
Lin-CD161+CD127+CRTH2-CD117+, RORγt+, and secrete TH17/TH22 helper T cell-
associated cytokines 1,2. A fraction of human ILC3s expresses natural cytotoxicity 
receptors such as NKp44, NKp46 and NKp30, and neural cell adhesion molecule 
CD56, similar to natural killer (NK) cells 3,4. NK cells are a cytotoxic subset of 
ILCs that express the transcription factor T-bet and/or Eomes and produce IFN-γ, 
granzymes and perforin 1. Also, ILCs are most abundant and reside in (mucosal) 
tissues such as the tonsil, lung and intestine, where they can expand locally 5.
Several studies have reported the differentiation pathways of ILCs in a variety of 
tissues in both mice and humans 6,7. For example, in murine fetal liver and adult 
intestine, a CXCR6+RORγt+α4β7+ subset has been identified that can differentiate 
into ILC3s and NK cells 8. As this subset was not found in adult bone marrow, it 
might migrate to the intestine during fetal development. In humans, RORγt+CD34+ 
progenitor cells were identified in the tonsil and intestine, but these were absent in 
peripheral blood, umbilical cord blood, bone marrow and thymus 9,10. Since these 
progenitors could differentiate into helper ILCs and NK cells, mucosal organs might 
be the preferential sites for ILC differentiation. In addition, a CD127+CD117+ ILC 
precursor (ILCP) has been identified in cord blood, peripheral blood and tissues, 
including fetal liver, adult lung and tonsil, which can generate all ILC subsets in 
situ and could represent an intermediate between precursor cells and mature 
ILCs 11. Also, previous studies have observed ILC plasticity mainly in mucosal 
tissues, such as the small intestine 12–15, suggesting that environmental cues may 
play an important role in cell-fate decision. So far, most of the studies on human 
ILC differentiation used CD34+ progenitors and mature types of ILCs 6, while the 
intermediates or transitional stages connecting the CD34+ populations to mature 
types of ILCs have not been fully identified. 
High-dimensional mass cytometry provides an opportunity to analyze the 
heterogeneity and potential differentiation pathways of human ILCs in an 
unbiased and data-driven fashion based on the simultaneous measurement of 
over 30 cellular markers at single-cell resolution 16. Although the sensitivity of 
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metal reporters in mass cytometry is not as sensitive as some of the brightest 
fluorochromes in flow cytometry, the advantage of including many more markers 
in a single antibody panel offers unique opportunities to evaluate the composition 
of the immune system with unprecedented resolution. Up to recently, analysis 
of flow cytometry data was mainly performed with gating strategies based on 
(primarily) bimodal expression patterns. The incorporation of over 30 markers 
in mass cytometry antibody panels is not well compatible with such an analysis 
approach. Instead, t-Distributed Stochastic Neighbor Embedding (t-SNE)-based 
approaches are currently becoming the standard in the field as they allow the 
simultaneous analysis of all marker expression profiles in an unbiased fashion. 
Hierarchical SNE, for example, allows efficient analysis of mass cytometry data 
sets on tens of millions of cells at the single-cell level 17. Here, we applied mass 
cytometry to analyze the ILC compartment in the human fetal intestine and provide 
evidence for previously unrecognized heterogeneity within this compartment. 
Moreover, we utilized a t-SNE-based computational approach to predict potential 
differentiation trajectories in silico, and provide evidence for the existence of a 
previously unrecognized innate cell subset that can differentiate into both NK cells 
and ILC3 in vitro.
Results
High-dimensional analysis reveals previously unrecognized heterogeneity 
in the ILC compartment
We developed a 35 metal isotope-tagged monoclonal antibody panel (Table S1) 
to identify the 6 major immune lineages (B cells, myeloid cells, CD4+, CD8+, γδ T 
cells, and Lin-CD7+ cells; the latter hereafter referred to as ILCs) and heterogeneity 
within those lineages. For this purpose the panel included lineage markers and 
markers linked to cell differentiation, activation, trafficking and responsiveness 
to humoral factors. With this panel, single-cell suspensions prepared from 7 fetal 
intestines were analyzed individually. Single, live CD45+ cells were discriminated 
by event length, DNA stainings and CD45 antibody staining (Fig. S1 A). All 
antibodies showed clear discrimination between antibody-positive and -negative 
cells (Fig. S1 B). Similar to our previous study 18, we applied a combined t-SNE 
19-ACCENSE 20 data analysis approach to the 6 major cell lineages (Fig. S1 C) 
which revealed a large degree of heterogeneity within these lineages.
We next focused on the ILC compartment (Fig. S2 A) which comprised 20.4% ± 
7.8% of the CD45+ cells. We pooled the data from the 7 samples and performed a 
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Fig. 1.  High-dimensional mass cytometry analysis reveals previously unrecognized heterogeneity 
in the fetal intestinal ILC compartment (A) A t-SNE embedding showing the collective ILCs (4.5x104 
cells) derived from 7 fetal intestines, each black dot represents a single cell. (B) A t-SNE embedding 
as shown in panel A. Colors represent the different samples. (C) A density map describing the local 
probability density of t-SNE-embedded cells where black dots represent centroids of identified clusters 
using Gaussian Mean Shift clustering. (D) A t-SNE plot showing cluster partitions in different colors. (E) 
Heatmap showing the median ArcSinh5-transformed marker expression values (black-to-yellow scale) 
of the clusters identified in panel A with description of ten annotated categories based on pre-existing 
literature, and hierarchical clustering thereof. (F) Composition of the ILC compartment in the individual 
fetal intestines (N=7) represented in vertical bars where the size of the colored segments represents the 
proportion of cells as % of total ILC in the sample. Colors as in panel A. 
t-SNE analysis in Cytosplore 21. This provided a two-dimensional map where cellsare 
positioned based on the similarity in expression of all marker simultaneously (Fig. 
1 A and B). Based on the density features of the t-SNE-embedded cells, we 
identified 34 phenotypically distinct clusters (Fig. 1, C and D) using the Gaussian 
Mean Shift clustering and generated a heatmap showing the distinct marker 
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expression profiles for each cluster (Fig. 1 E). Unbiased hierarchical clustering 
revealed distinct clusters including a group of CD34+ cells expressing CD45RA and 
CD117, a larger cluster of several types of NK cells, and a CD127+ ILC cluster with 
cells expressing markers corresponding to ILC1, ILC2, CD45RAhigh ILC3, subsets of 
several types of CD56+ and CD56- ILC3 2,22 and a CD161- ILC3-like population 23. In 
addition, several unrecognized cell clusters with a Lin-CD7+CD127-CD45RO+CD56+ 
phenotype [referred to as intermediate ILC (int-ILC) hereafter] were identified 
which clustered between the NK cells and CD127+ ILCs (Fig. 1, C-E). While the 
majority of these int-ILCs (6.6% of ILCs ± 2.3%) were CD8a-, a smaller related 
population (3.0% ± 1.6%) was CD8a+ (Fig. 1 F). Importantly, analysis of the 
composition of the cluster frequencies in the individual fetal samples demonstrated 
that even though quantitative differences exist, most of the identified clusters, 
including the int-ILCs were present in all 7 samples (Fig. 1 F).
Together, these data indicate that all known NK and CD127+ ILC cell clusters 
could be identified simultaneously while evidence for the existence of previously 
unrecognized clusters was obtained as well. 
Visualization of the t-SNE computation dynamics predicts potential 
differentiation trajectories in the ILC compartment
The cell surface phenotype of int-ILC (i.e. CD127-CD45RO+) places them in between 
the CD127+ ILCs and the NK cells (Fig. 1, C-E), suggesting potential relationships 
with both. To investigate this in more detail, we sought to visualize potential 
relationships between cell populations without prior designation of a user-defined 
starting cell type in silico. To this end, we exploited the ability of Cytosplore 
to visualize the evolution of the t-SNE map 21. Separating the computational 
modelling into 6 stages revealed how distinct cell clusters were formed, while 
their high-dimensional similarities were projected onto a two-dimensional map, 
Fig. 2.  Monitoring t-SNE computation dynamics predicts potential differentiation trajectories 
of ILCs (A) t-SNE embeddings of the collective ILC single-cell data derived from 7 fetal intestines 
showing density features (upper row) and single cells (bottom row) at 6 stages over the course 
of the t-SNE computation. Colors represent the local probability density of t-SNE-embedded cells 
(upper row), or cluster partitions (bottom row), as described in Fig. 1 A. (B) t-SNE embeddings at 
stage 4 of the optimization phase as described in panel A. Colors of the cells represent ArcSinh5-
transformed expression values of indicated markers. (C) Left panel: t-SNE embedding at stage 4 as 
in panel A. Colors represent density features and black encirclement indicates the trajectory of cells 
along the CD56 expression continuum shown in panel B. Right panel: Wanderlust graph (trajectory 
0-1.0) of the CD56 positive cells in the left panel showing median ArcSinh5-transformed expression 
of CD8a, CD45RO, CD45RA, CD7, CD3, CD56, CD117, CD127 and CRTH2 from the CD8a- int-ILCs 
(shaded red box) via the CD8a+ int-ILC (shaded yellow box) to NK cells (shaded blue box), and from 
the CD8a- int-ILCs to ILC3s (shaded green box). The rainbow color bar indicates relative cell density. 
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and linked to each other based on marker expression profiles (Fig. 2 A). Since the 
initial positions in the t-SNE map are assigned randomly, at the first stage of the 
t-SNE computation all cells were unordered around a single density peak. Shortly 
thereafter the CD34+ lymphoid precursor cells separated from the other cells (stage 
2) and the first formation of the NK and CD127+ ILC clusters became apparent 
(stage 2 and 3). These early events were based on relatively large and highly 
discriminatory differences in the expression profiles between cell clusters, like the 
unique combination of CD34 and HLA-DR expression by CD34+ cells. At stage 4 of 
the t-SNE computation the int-ILC cluster was positioned in the center with several 
distinct strands of cells forming trajectories towards the NK, CD27+ ILC1, KLRG-1+ 
ILC2 and CD103+ ILC3 clusters. In addition, a trajectory between the ILC2 and ILC3 
clusters was visible (stage 4). Furthermore, cells from the CD8a- int-ILC population 
connected via the CD8a+ int-ILC population with NK cells, further supporting the 
notion that these two CD8a- and CD8a+ int-ILC populations are highly related (Fig. 
2 A and Fig. S2 B). At the final stage of the t-SNE computation the 34 clusters 
were defined while the connections between the individual clusters were less clear 
as the t-SNE algorithm eventually assigns cells in between two clusters to either 
one of the two. Individual marker expression patterns at stage 4 of the t-SNE 
computation gave insight into the separations of and the connections between 
clusters (Fig. 2 B). Here, the NK cluster was characterized by the co-expression 
of CD45RA, CD56, CD122 and NKp46 while the CD127+ ILC cluster expressed 
CD45RO, CD117, CD127, CD25 and to a lesser extent CCR6 and CD103. Similarly, 
connections between int-ILC to ILC1, ILC2, ILC3 and NK cells were marked by 
(gradients of) expression of CD27, KLRG-1, CD103 and CD56, respectively. The 
absence of CD45RA, CD127, and CCR6 in combination with the presence of CD45RO 
and CD56, and divergent expression of CD117, CD122 and CD25, positioned the 
int-ILC in between the NK cell and ILC clusters. Interestingly, CD56 expression 
linked the ILC3 to the CD8a- int-ILC, and the CD8a+ int-ILC to the NK cells.
We next applied Wanderlust 24 to determine changes in marker expression along 
this CD56 continuum (Fig. 2 C), which demonstrated that the expression of 
CD127, CD117 and CD45RO gradually decreased while that of CD45RA and CD8a 
increased moving from CD8a- int-ILC to NK cells, via CD8a+ int-ILC; and the 
expression of CD127 and CD117 gradually increased from CD8a- int-ILC to ILC3. 
Altogether, these results suggest that these t-SNE-based trajectories may reflect 
potential differentiation pathways.
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Expression of cytokines, transcription factors and CD94 distinguish int-
ILCs from mature CD127+ ILCs and NK Cells
To further characterize the int-ILC population, we used the mass cytometry data 
(Fig. S3 A) to design a minimal antibody panel to distinguish the CD127-CD45RO+ 
int-ILCs from CD45RA+ NK cells, and to identify the mature CD127+ ILC types 
through differential expression of CD117 and CRTH2 (Fig. 3 A). Subsequently, 
we analyzed the proliferative state and examined the capacity of the subsets to 
Fig. 3.  Cytokine production profiles of fetal intestinal ILCs ex vivo. (A) Representative biaxial plots 
depicting the gating strategy for ILC1, ILC2, ILC3, NK and int-ILC subsets derived from a human fetal 
intestine analyzed by flow cytometry. The antibody cocktail contains lineage (Lin) markers (CD3, CD19, 
CD11c and CD14), and CD7, CD127, CD56, CRTH2, CD117, CD45RA, CD45RO and CD8a to allow 
distinction of the ILC subsets. (B and C) Expression of cytotoxic molecules (Perforin + Granzyme B) 
and cytokines (IFN-γ and TNF-α) by the indicated subsets defined in panel A after stimulation with PMA 
and ionomycin for 6 h. The biaxial plots (B) depict one representative experiment and the bar graphs 
(C) depict quantification of data obtained from 3 different human fetal intestines.Three independent 
experiments). FMO, fluorescence-minus-one control. Error bar shows mean ± SEM. (D) Bar plots depict 
the secretion of TNF-α, IL-17A and IL-22 by CD8a- int-ILC and ILC3, after stimulation with IL-2, IL-1β and 
IL-23 for 4 days, using Luminex bead-based assay of an experiment with 3 intestines and duplicate wells. 
(Two independent experiments). Error bar shows mean ± SD. 
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Fig. 4.  Transcription factors and CD94 expression profiles of fetal intestinal ILCs ex vivo. (A and 
B) Flow cytometric determination of the expression of the transcription factors Eomes, T-bet, GATA3 and 
RORγt by the indicated ILC subsets as defined in Fig. 3 A. Histograms (A) depict the results with one 
representative human fetal intestine and the graphs (B) depict quantification of data obtained from 3 
different human fetal intestines. (Three independent experiments). FMO, fluorescence-minus-one control. 
Error bar shows mean ± SD. (C) Biaxial plots showing the expression of CD94 and CD117 by the indicated 
subsets. Results on 3 human fetal intestines are shown. (Three independent experiments).
produce cytokines and express markers linked to cytolytic potential by flow 
cytometry. For the former we stained the cells with the proliferation marker Ki-67 
ex vivo. The highest percentage of Ki-67 positive cells was present in the CD8a+ 
int-ILC population (43.9%) while on average 20% of cells in the other subsets 
were Ki-67 positive (Fig. S3 B). Upon stimulation with PMA and ionomycin 
Perforin/Granzyme B was detectable in all subsets, but more profoundly in the 
NK cells and CD8a+ int-ILCs compared with the CD8a- int-ILCs and ILC3s (Fig. 3, 
B and C). Moreover, all subsets expressed high levels of TNF-α, while IFN-γ was 
detected mainly in the NK cells and CD8a+ int-ILCs but hardly in the CD8a- int-ILCs 
and ILC3s (Fig. 3, B and C). ILC2s expressed IL-4, IL-5 and IL-13, but ILC1s very 
little IFN-γ (not shown). In contrast, IL-4, IL-5 and IL-13 was undetectable in any 
of the other subsets (not shown) while IL-17A and IL-22 expression was higher by 
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ILC3s than CD8a- int-ILCs (Fig. 3 D).
Next we determined the expression of key transcription factors associated with 
ILC development and phenotype. The expression of ID2, TCF7, AHR, NFIL3, 
ZBTB16 and TOX did not discriminate between the subsets (Fig. S3 C). In line 
with previous work 25, the ILC2 subset was strongly GATA3 positive and RORγt 
negative, while ILC3s were GATA3 and RORγt positive (Fig. 4, A and B and Fig. 
S3 D). However, we found only low levels of T-bet expression by ILC1 (Fig. 4, A 
and B). Notably, both mature NK cells and CD8a+ int-ILCs expressed high levels 
of Eomes (Fig. 4, A and B and Fig. S3, E and F). In contrast, the CD8a- int-
ILCs were heterogeneous with respect to the expression of the 4 transcription 
factors which were all expressed by a proportion of the cells (Fig. 4, A and B), 
an expression profile that does not correspond to those found in mature CD127+ 
ILCs. Furthermore, multiple lineage transcription factors could be simultaneously 
expressed by CD8a- int-ILCs, such as T-bet and GATA3 (26.1% of CD8a- int-ILCs) 
(Fig. S3, G-I). Finally, the frequency of cells expressing Eomes decreased along 
the potential differentiation trajectory linking the NK cells to CD8a+ int-ILCs, CD8a- 
int-ILCs and ILC3s, while that of RORγt increased (Fig. 4, A and B).
To investigate the relationship between the int-ILCs, NK cells and ILC3s further, 
we evaluated the expression of CD62L, CD57, CD5 and the NK cell-associated 
C-type lectin receptor CD94. Here, expression of CD62L, CD57 and CD5 was 
almost lacking and did not discriminate between the subsets (not shown) while 
CD94 expression was high on NK cells but virtually absent from ILC3s (Fig. 4 C), 
in agreement with previous studies 2,10. In contrast, only part of the int-ILCs were 
CD94 positive with a higher expression level of CD94 on CD8a+ int-ILCs compared 
to CD8a- int-ILCs (Fig. 4 C), a result in line with the lower expression of Eomes 
in the latter. Furthermore, in contrast with CD94- cells, CD94+ cells lacked the 
expression of CD117, similar to mature NK cells (Fig. 4 C).
Together, these data indicate that the int-ILC subset is distinct from mature ILCs, 
where the expression pattern of the cytokines, CD94 and transcription factors link 
the CD8a+ int-ILCs to NK cells and the CD8a- int-ILCs to ILC3s.
int-ILC can differentiate into CD45RA+ NK cells
To test the hypothesis that the int-ILC subset may differentiate into CD127+ ILCs 
and/or NK cells, we first purified the CD8a- int-ILCs by flow cytometry (Fig. 5 
A) and performed functional differentiation assays by co-culturing these with 
OP9 stromal cells expressing the Notch ligand Delta-like 1 (OP9-DL1). After 7 
days of culture in medium containing stem cell factor (SCF), IL-7, IL-2 and IL-15 
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(hereafter referred to as NK cytokine mix), the majority of the int-ILCs acquired a 
CD45RA+ phenotype (Fig. 5 B) and expanded substantially (Fig. 5 C). Also, these 
cells upregulated CD94 (42% positive) (Fig. S4 A) and displayed expression of 
Eomes and/or T-bet, but no RORγt or GATA3 (Fig. 5 D), all similar to mature 
NK cells. Furthermore, part of these cells expressed CD8a (Fig. 5 B), a marker 
expressed by most fetal NK cells ex vivo (Fig. 2 B), where most of the CD8a+ 
cells displayed the highest expression of Eomes (Fig. S4 B). Moreover, a small 
fraction of generated cells maintained the CD45RA-CD45RO+ int-ILC phenotype 
and a fraction of them also acquired CD8a (Fig. 5 B). In line with the suggested 
differentiation trajectory (Fig. 2 C), the expression of ILC3-associated RORγt 
decreased from the CD8a- int-ILCs to CD8a+ int-ILCs to CD45RA+ NK cells while all 
populations expressed high levels of NK cell-associated Eomes and/or T-bet (Fig. 
5 D). Also, the cells became uniformly Ki-67 positive (Fig. 5 F), consistent with 
the observed increase in cell numbers (Fig. 5 C). As similar results were obtained 
when purified CD8a- int-ILCs were co-cultured with OP9 stromal cells without 
Delta-like 1, Notch signalling appears not to be involved (Fig. S4 C). In addition, 
upon culture on OP9-DL1 purified CD8a+ int-ILCs also acquired the CD45RA+ NK cell 
phenotype, maintained CD8a expression and expressed high levels of CD94 (84% 
positive) (Fig. S4 D). Finally, purified CD8a- int-ILCs co-cultured with OP9-DL1 
Fig. 5.  int-ILC can differentiate into CD45RA+ NK cells and ILC3. (A) Representative histograms 
depicting the expression of CD127, CD117, CD45RA, CD45RO, CD56 by flow cytometry-purified 
CD8a- int-ILCs (black line) and ILC3s (grey line) from human fetal intestines. Data are representative 
of six independent experiments. (B-G) Purified CD8a- int-ILCs and ILC3s were co-cultured in 96 well 
plates at 500 cells/well with irradiated OP9-DL1 stromal cells for 7 days with culture medium alone 
or supplemented with SCF, IL-7, IL-2, IL-15 (referred to as NK cytokine mix). Generated cells were 
analyzed by flow cytometry. Duplicated wells were included for each condition. Representative plots 
show a single duplicate. (B) Representative biaxial plots depict the phenotypes of generated Lin-CD7+ 
cells based on the gating strategy for ILC1, ILC2, ILC3, NK and int-ILC subsets as shown in Fig. 3 
A, for three different combinations of sorted cell populations (int-ILC in black contours, ILC3 in grey 
contours) and culture conditions as indicated. (Three to five independent experiments). (C) Quantification 
of the generated Lin-CD7+ cells in panel B in absolute cell number (left axis) and fold change (right axis) 
compared to the number of initially sorted cells (dashed line). (Two to four independent experiments). 
Error bar shows mean ± SD. (D and E) Histograms depict the expression of transcription factors Eomes, 
T-bet, GATA3 and RORγt by the indicated subsets generated from (D) sorted CD8a- int-ILCs with 
NK cytokine mix and (E) sorted CD8a- int-ILCs or ILC3s with culture medium. Numbers indicate the 
percentage of positive cells. FMO, fluorescence-minus-one control. Combined data on 5 human fetal 
intestines. (F and G) Biaxial plots depict the expression of Ki-67 by indicated subsets generated from 
the combinations of sorted cell populations (int-ILC in black contours, ILC3 in grey contours) and culture 
conditions as in panel D and E. Combined data on 5 human fetal intestines. (H-I) Purified CD8a- int-
ILCs were co-cultured at 500 cells/well with irradiated OP9-DL1 stromal cells in culture medium and 
harvested at the time points indicated in hours. Duplicated wells were included in each experiment. (Two 
independent experiments). (H) Quantification of the generated Lin-CD7+ cells in absolute cell number 
(left axis) and fold change (right axis) compared to the number of initially sorted cells (dashed line). (I) 
Representative biaxial plots show the expression of CD127 and CD117 by the generated Lin-CD7+ cells.
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and IL-15 cytokine only similarly expanded (not shown), acquired CD45RA, 
upregulated CD94 (41% positive), and became in part CD8a positive (Fig. S4 
E). However, under these conditions approximately 60% of these generated cells 
remained CD117+ (Fig. S4 E), suggesting an incomplete conversion to the mature 
NK cell phenotype 26. Together these data indicate that in the presence of NK 
cytokines, proliferative CD45RA+ NK cells are generated from int-ILC.
CD8a- int-ILC can differentiate into ILC3
In marked contrast, when purified CD8a- int-ILCs and ILC3s (Fig. 5 A) were 
individually co-cultured with OP9-DL1 in cytokine-free culture medium, the ILC3s 
retained their phenotype while the CD8a- int-ILCs acquired an ILC3 phenotype as 
they became CD127+CD117+ (Fig. 5 B), remained CD45RA-CD45RO+ (Fig. 5 B) 
and CD8a- (not shown), in the absence of cell expansion and proliferation (Fig. 
5, C and G). This phenotype was also stable during prolonged culture (Fig. S4 
F). In addition, these cells homogeneously expressed RORγt, but no Eomes or 
T-bet (Fig. 5 E), suggesting an established ILC3 population 2. As similar results 
were observed when we co-cultured the CD8a- int-ILCs with OP9 stromal cells that 
lacked Notch ligand Delta-like 1, Notch signalling appears not to be involved (Fig. 
S4, G and H). Unlike CD8a- int-ILCs and ILC3s, both purified CD45RA+ NK cells 
and CD8a+ int-ILCs did not survive under these conditions. To exclude that the 
generation of ILC3 by int-ILCs was due to outgrowth of contaminating ILC3s, we 
determined cell numbers and the acquisition of CD127 and CD117 at various time 
points during culture. After 24 and 72 h of culture, 38% and 88% of purified CD8a- 
int-ILCs had acquired both CD127 and CD117, respectively, while no increase in 
cell numbers was observed (Fig. 5, H and I). Together with the observation that 
only a very small proportion of both the purified mature ILC3s and differentiated 
ILC3s from int-ILCs were Ki-67+ (Fig. 5 G), this indicates that it is highly unlikely 
that selective outgrowth of contaminating ILC3s could explain the appearance of 
cells with an ILC3 phenotype in the CD8a- int-ILC/OP9 co-cultures. Thus, these 
results indicate that the CD8a- int-ILC population can differentiate into ILC3 in 
vitro.
Differentiation properties of CD8a- int-ILC subpopulations
By the differential expression of CD94 and CD117 three distinct CD8a- int-ILC 
subpopulations could be distinguished: CD94+CD117-, CD94-CD117- and CD94-
CD117+ (Fig. 4 C). We therefore investigated whether these subsets could 
differentiate into either NK cells or ILC3s in vitro. For this purpose, we first 
examined the expression of transcription factors (Fig. 6, A and B). This revealed 
that Eomes was primarily present in the CD94+CD117- subset while RORγt 
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Fig. 6. Distinct differentiation properties of CD8a- int-ILC subpopulations. (A and B) Expression 
of the transcription factors Eomes, T-bet, GATA3 and RORγt by the indicated subpopulations of CD8a- 
int-ILC ex vivo. Histograms (A) depict the results with one fetal intestine and the graphs (B) depict 
quantification of data obtained from 3 intestines. (Two independent experiments). Error bar shows mean ± 
SD. (C and D) Purified CD94+CD117-CD8a- int-ILC, CD94-CD117-CD8a- int-ILC and CD94-CD117+CD8a- 
int-ILC populations were co-cultured in 96 well plates at 500 cells/well with irradiated OP9-DL1 stromal 
cells for 7 days with (C) culture medium supplemented with NK cytokine mix or (D) culture medium alone. 
Generated cells were analyzed by flow cytometry. Representative biaxial plots depict the phenotypes of 
the generated Lin-CD7+ cells based on the gating strategy for ILC1, ILC2, ILC3, NK and int-ILC subsets 
as shown in Fig. 3 A, for the five combinations of cell populations and culture conditions indicated. 
Duplicated wells were included in each condition. Representative plots show a single duplicate. (Three to 
four independent experiments).
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expression was most pronounced in the CD94-CD117+ subset. In addition, all 
subsets expressed GATA3 and T-bet, where T-bet expression was most pronounced 
by the CD117- subsets. Together, these results explain the heterogeneity in the 
expression of transcription factors by CD8a- int-ILCs and position the CD94-CD117- 
subset in between the CD94+CD117- and CD94-CD117+ subsets.
Next, we purified CD94+CD117-, CD94-CD117-, and CD94-CD117+ subsets 
individually and co-cultured them with OP9-DL1 stromal cells with either NK 
cytokine mix or cytokine-free medium. In the presence of NK cytokine mix 
(Fig. 6 C), virtually all of the CD94+CD117- cells acquired the CD45RA+ NK cell 
phenotype, maintained expression of high levels of CD94 (76%), acquired CD8a 
expression (43%) and expanded substantially (12-fold; not shown). Similarly, 
most of the CD94-CD117- cells and the majority of the CD94-CD117+ cells also 
acquired the CD45RA+ NK cell phenotype, acquired expression of CD94 (17% and 
25%, respectively) and CD8a (24% and 16%, respectively), and expanded (9-fold 
and 7-fold, respectively; not shown). In contrast, in cytokine-free medium (Fig. 6 
D) both the CD94-CD117- and CD94-CD117+ int-ILCs acquired an ILC3 phenotype 
as they became CD127+, remained CD45RO+CD45RA-CD94-CD8a- and acquired 
or increased the levels of CD117 expression, respectively (Fig. 6 D). Similar to 
CD8a+ int-ILCs and CD45RA+ NK cells the CD94+CD117- int-ILCs did not survive 
under these conditions.
Taken together, in these in vitro experiments all three subpopulations of the CD8a- 
int-ILCs can differentiate into NK cells, whereas the CD94-CD117- and CD94-
CD117+ cells, but not the CD94+CD117- cells can differentiate into ILC3s.
Discussion
Numerous studies have reported substantial heterogeneity in the ILC compartment 
2,22. In our mass cytometry-based approach the NK, ILC1, ILC2 and ILC3 subsets 
could be readily identified in the human fetal intestine as well as substantial 
variability within those subsets, results that were highly consistent in several samples 
analyzed. Based on the marker expression profiles, we identified a large number 
of distinct NK cell clusters, whose biological significance needs to be investigated 
in the future studies. In addition, we found a small CD27+ ILC cluster that matches 
ILC1 criteria 1,27. However, in contrast to findings from Bernink et al. (2013), but in 
line with other studies 22,23, only few of these ILC1s expressed T-bet. Furthermore, 
two additional CD127+ ILC1-like clusters were identified which clustered with the 
NK cells due to the expression of several NK cell-associated markers, including 
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CD45RA, CD56, CD8a and NKp46. Consistent with previous reports 2,13,22 the ILC3 
compartment was most frequent and heterogeneous, including CD45RO+ ILC3, 
CD45RA+ ILC3, HLA-DR+ ILC3 and CD56+/- ILC3 clusters. Further studies will be 
required to clarify the potential functional significance of observed heterogeneity 
in the ILC3 lineage. We could not distinguish LTi cells from ILC3s as no specific 
cell surface marker for human LTi cells was available at the time we performed our 
analysis. Moreover, while most of the human ILCs described express CD161 1,2, we 
also detected a recently described CD161-CD117+ ILC3-like cluster that clustered 
with the CD127+ ILCs 23. In addition, we identified two previously unknown CD8a+ 
counterparts of ILC3s that warrants further investigation. We also observed a rare 
CD34+CD45RA+CD117+ population that resembles the CD34+ precursors recently 
described in human tonsils and intestines after birth 9,10.
Finally, we identified a Lin-CD7+CD127-CD45RO+CD56+ group of cells which by 
unbiased clustering were positioned between the CD45RA+ NK cells and CD127+ 
ILCs, and were termed int-ILC. While in previous studies 1,2 such CD56+CD127- 
cells were classified as NK cells, the simultaneous use of CD45RA and CD45RO 
allowed us to distinguish these CD45RO+ cells from the CD45RA+ NK cells. It is 
important to note that these int-ILCs display variable expression of several surface 
markers, including CD8a, CD94, CD117, CD122, CD25, CD27, KLRG-1 and CD103, 
indicating that they are not a homogenous group of cells. Their unique position 
in between the NK cells and CD127+ ILCs, however, prompted us to investigate 
potential relationships between these cell clusters.
In recent years, several studies have explored developmental pathways by 
applying computational approaches on mass cytometry datasets. Wanderlust, 
accurately predicted B cell lymphopoiesis 24 and Wishbone was found to recover 
the T cell developmental pathway 28 at single-cell resolution. However, Wanderlust 
is not suitable to predict multi-lineage differentiation trajectories. While Wishbone 
can be used to identify bifurcating developmental trajectories, it needs the 
designation of a user-defined precursor cell type. As we wished to investigate 
potential developmental relationships without pre-assumptions we developed a 
novel computational approach to visualize the evolution of the t-SNE map over 
the course of the optimization. t-SNE is a non-linear dimensionality reduction 
algorithm which projects the high-dimensional similarities onto a two-dimensional 
map based on the concurrent marker expression profiles 19. Here t-SNE not 
only employs bimodal distribution patterns but also incorporates gradients 
of the expression of cellular markers and therefore offers superior resolution. 
Importantly, the Cytosplore framework 21 can visualize every iteration by making 
use of the A-tSNE 29. This allowed us to analyze potential relationships between 
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the int-ILC, ILC1, ILC2, ILC3 and NK clusters through visualization of gradients 
along putative differentiation trajectories. Such gradients are clearly visible in our 
Cytosplore analysis (Fig. 2) and contribute to the generation of cell clusters. Our 
current results indicate that at least some of those gradual changes in marker 
expression profiles correlate with differentiation pathways of immune subsets. 
Consistent with the observed plasticity among ILCs 13,15, the analysis revealed 
a clear trajectory between the ILC2 and ILC3 clusters. This may imply that the 
CD103- ILC2 can differentiate into CD103+ ILC3 locally depending on physiological 
or pathological conditions. Alternatively, the fetal ILC2s may leave the intestine, in 
line with previous reports that ILC2s can be found in the peripheral blood 30 but are 
virtually absent in the human intestine after birth 13. In addition, a trajectory within 
the CD56+ cell compartment was revealed, where the CD8a- int-ILC was connected 
with the CD56+ ILC3 on one side and with the CD8a+ int-ILC and the NK cells on 
the other. Importantly, while the above analysis was performed on the innate 
cell population present in the 7 fetal intestines collectively, similar relationships 
between cell populations were revealed when the innate cell compartment of each 
fetal sample was analyzed individually, attesting to the robustness of the approach 
(Fig. S2 B).
The putative link between the int-ILC and the mature ILC and NK cells is further 
strengthened by several other observations. First, both the cytokine production 
profiles and CD94 expression profile ex vivo link the CD8a+ int-ILCs to NK cells and 
the CD8a- int-ILCs to the ILC3s. Second, the expression pattern of the transcription 
factors by int-ILCs is heterogeneous with features of both NK cells (Eomes and 
T-bet) and ILC3s (GATA3 and RORγt) where the CD8a+ int-ILCs resemble the NK 
cells while the CD8a- int-ILCs are closer to CD127+ ILCs. Finally, in the OP9-based 
co-culture system, in the presence of NK cytokines purified int-ILC expanded and 
displayed a CD45RA+Eomes+/T-bet+ NK cell phenotype while in the absence of 
cytokines the cells did not expand but acquired a stable CD127+CD117+RORγt+ 
ILC3 phenotype.
Further dissection of the CD8a- int-ILC compartment demonstrated the existence of 
three distinct subpopulations based on differential expression of CD94 and CD117: 
CD94+CD117-, CD94-CD117- and CD94-CD117+. In our in vitro experiments both 
the Eomes-expressing CD94+CD117- and non-Eomes-expressing CD94-CD117- 
and CD94-CD117+ subpopulations could differentiate into CD45RA+ NK cells when 
cultured with NK cytokine mix. Furthermore, the differentiation into CD45RA+ NK 
cells was most efficient in the case of the CD94+CD117- cells and least for the 
CD94-CD117+ cells, compatible with a model where the CD94+CD117- cells are 
positioned close to NK cells, the CD94-CD117+ cells most distant and the CD94-
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CD117- cells in between. The acquisition of CD8a by the CD94-CD8a- int-ILCs 
in these cultures indicates that the CD8a+ int-ILC may also be an intermediate 
stage towards NK cell differentiation. In the absence of cytokines CD117+CD127+ 
ILC3-like cells could be generated from both CD94-CD117+ and CD94-CD117- cells 
but not from CD94+CD117- cells. Together this indicates that CD94+CD117- cells 
can exclusively differentiate into NK cells while the other two populations can 
differentiate into both NK cells and ILC3s, at least under the in vitro conditions 
employed.
In the absence of cytokines the int-ILC changed into ILC3-like cells without signs 
of cell expansion, cell division or cell death, arguing that the generation of ILC3 
from the int-ILC is not due to selective outgrowth of contaminating ILC3s. In 
agreement, we did not observe any proliferative response of flow cytometry-
purified ILC3 under the same experimental conditions.         
In mice, it has been shown that developmental hierarchy of ILCs goes from the 
common lymphoid progenitor (CLP) to mature ILCs via α4β7-expressing lymphoid 
progenitor (αLP), early innate lymphoid progenitor (EILP), common helper ILC 
progenitor (CHILP), and the ILC precursor (ILCP) 7. Here EILP has been distinguished 
from other progenitors by the lack of CD127 and ILC lineage-specific transcription 
factors 31, while the ILCP exhibits co-expression of transcription factors associated 
with ILC1, ILC2 and ILC3 subsets 32. Finally, a murine fetal transitional CD127+ 
ILCP (ftILCP) has been identified in the intestine which expresses varying amount 
of T-bet, GATA3 and RORγt 33. In humans, two studies have shown that ILC3s 
can be generated from RORγt+CD34+ progenitors from tonsils and intestines 9,10 
but little is known about the intermediate stages. Interestingly, Scoville et al. 
(2016) generated both NK cells and the three types of helper ILCs from these 
CD34+ progenitors in vitro, however, the generated cells did not express CD127 
but rather CD161 and intracellular ILC-related cytokine profiles. Also, a NK cell 
lineage-restricted CD34+ progenitor was identified in the human fetal liver and 
bone marrow 34. In contrast, CD127- int-ILC in our study express CD45RO and 
variable levels of Eomes, T-bet, GATA3 and RORγt, but no CD34 and CD45RA, 
markers expressed by most human progenitors. Also, with our mass cytometry 
approach we have been unable to identify cells with an int-ILC phenotype in the 
human fetal liver and fetal spleen (not shown), indicating that the int-ILC may 
specifically reside in mucosal tissues. Together, the cell surface phenotype, tissue 
distribution and transcription factor profiles of CD127- int-ILC suggests that these 
cells are distinct from previously identified ILC progenitors and may be in an 
intermediate differentiation stage among ILC lineages. Finally, we observed that 
the ILC3s and NK cells derived from the CD8a- int-ILC could partly revert their 
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phenotype upon prolonged culture indicating that the int-ILC may represent an 
intermediate between two plastic lineages (not shown).
It has been shown that environmental cues including OP9/OP9-DL1 stromal 
cells and cytokines such as IL-7 and SCF play an important role in driving ILC3 
differentiation 9,10,35. While the addition of SCF and IL-7 did promote significant 
expansion of the CD8a- int-ILCs, they did not differentiate into other types of 
cells (not shown). Instead, the differentiation of CD8a- int-ILCs toward ILC3s 
occurred in cytokine-free medium. In mice, Notch signalling for ILC3 development 
is necessary in adults but not in fetuses 8, while in humans, the differentiation of 
CD34+ progenitors to ILC3s can occur without Notch signalling 9,10. Consistent with 
these observations the generation of ILC3s from the CD8a- int-ILCs was Notch 
independent.
In conclusion, we delineated the heterogeneity of ILCs in the human fetal 
intestine and developed a computational model to predict potential differentiation 
trajectories based on mass cytometry data. This allowed the identification of a 
previously unidentified innate cell cluster that harbors cells that can differentiate 
into NK cells and ILC3-like cells in vitro. This may provide plasticity in the human 
fetal intestine in response to (external) stimuli. 
Material and methods
Human fetal intestine and cell isolation 
Human fetal intestines from elective abortions were collected after informed 
consent. Approval by the medical ethical commission of the LUMC (protocol 
P08.087) was obtained in accordance with the local ethical guidelines and the 
declaration of Helsinki. The gestational age ranged from 16 to 22 weeks. Single 
cell suspensions from fetal intestines were prepared as previously described. 
Briefly, the mesentery, colon part and meconium were removed from the fetal 
intestine. The intestines were then cut into small fragments and treated with 1 
mM 1,4-Dithiothreitol (Fluka) in 15 mL of HBSS (Sigma-Aldrich) for 2 x 10 min 
(replacing buffer) at room temperature (rT) to dissolve the mucus and subsequently 
with 1 mM EDTA (Merck) in 15 mL of HBSS under rotation for 2 x 1 h (replacing 
buffer) at 37 °C to separate the epithelium from the lamina propria fraction. To 
obtain single-cell suspensions from the lamina propria, the intestines were rinsed 
with HBSS and incubated with 15 mL Iscove’s Modified Dulbecco’s Medium (IMDM; 
Lonza) supplemented with 10% FCS, 10 U/mL collagenase IV (Worthington), 200 
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µg/mL DNAse I grade II (Roche Diagnostics), at 37 °C overnight, after which cell 
suspensions were filtered through a 70 µm nylon cell strainer. Finally, the immune 
cells were isolated with a Percoll (GE Healthcare) gradient and stored in liquid 
nitrogen. 
Mass cytometry antibody staining and data acquisition
Details on antibodies used are listed in Table S1. Conjugation of the purified 
antibodies with metal reporters was performed with the MaxPar X8 antibody 
labeling kit (Fluidigm Sciences) according to the manufacturer’s instruction. 
Procedures for mass cytometry antibody staining and data acquisition were carried 
out as previously described 18. Briefly, cells from fetal intestinal lamina propria 
were thawed and incubated with 1 mL 500x diluted 500 µM Cell-ID intercalator-
103Rh (Fluidigm Sciences) for 15 min at rT to identify dead cells. Cells were then 
stained with metal-conjugated antibodies for 45 min at rT. After staining, cells 
were labeled with 1 mL 1,000x diluted 125 µM Cell-ID intercalator-Ir (Fluidigm 
Sciences) to stain all cells in MaxPar Fix and Perm Buffer (Fluidigm Sciences) 
overnight at 4 °C. Finally, cells were acquired by CyTOF 2TM mass cytometer 
(Fluidigm Sciences). Data were normalized by using EQ Four Element Calibration 
Beads (Fluidigm Sciences) with the reference EQ passport P13H2302 during the 
course of each experiment.
Mass cytometry data analysis
The biaxial plots showing antibody staining patterns in Fig. S1 were generated 
in Cytobank 36. Data for single, live CD45+ cells gated from each fetal intestine 
individually using Cytobank 36 as shown in Fig. S1 A, were sample tagged and 
hyperbolic arcsinh transformed with a cofactor of 5 prior to t-SNE analysis. The 907 
clusters shown in Fig. S1 C were identified by analyzing the entire immune system 
(CD45+ cells) using the t-SNE-ACCENSE analysis pipeline as described before 18. 
Next, t-SNE was performed for the ILC dataset using A-tSNE 29 in Cytosplore 
21. t-SNE was carried out with default parameters (perplexity: 30; iterations: 
1000). All t-SNE plots were generated in Cytosplore. Hierarchical clustering of 
the heatmap was created with Pearson Correlation and average linkage clustering 
in MultiExperiment Viewer (http://www.tm4.org). Wanderlust analysis was 
performed on cells that were selected along the linear CD56 expression continuum 
at stage 4 of the t-SNE computation with the CD56+CD8a+ ILC3 cluster as starting 
point (as this cluster is located at the outer end of the CD56 trajectory), using Cyt 
in Matlab 24.
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Antibodies and flow cytometry 
FITC-conjugated anti-CD11c (3.9), PerCP-Cy5.5-conjugated anti-CD45RO 
(UCHL1), PE/Dazzle 594-conjugated anti-CD45RA (HI100), PE-Cy7-conjugated 
anti-CD127 (A019D5), Brilliant Violet 605-conjugated anti-CRTH2 (BM16), anti-
T-bet (4B10), PE-conjugated anti-T-bet (4B10), anti-IFN-γ (4S.B3), anti-IL-5 
(TRFK5), anti-IL-13 (JES10-5A2), anti-IL-17A (BL168) and anti-TNF-α (Mab11) 
were purchased from Biolegend. The following monoclonal antibodies were 
purchased from BD: FITC-conjugated anti-CD3 (SK7), anti-CD19 (4G7) and 
anti-CD14 (MφP9), APC-conjugated anti-CD117 (YB5.B8), APC-R700-conjugated 
anti-CD56 (NCAM16.2), V450-conjugated anti-CD7 (M-T701), Brilliant Violet 
605-conjugated anti-CD94 (HP-3D9), PE-conjugated anti-CD94 (HP-3D9), anti-
RORγt (Q21-559), anti-Ki-67 (B56), anti-Perforin (δG9), anti-IL-4 (3010.211). PE-
conjugated anti-Eomes (WD1928), anti-GATA3 (TWAJ), anti-Granzyme B (GB11), 
and eFluor 660-conjugated anti-GATA3 (TWAJ) were purchased from eBioscience. 
PE-conjugated anti-IL-22 (IC7821P) was purchased from R&D systems. Pacific 
Orange-conjugated anti-CD8a (3B5) was purchased from Life technologies.
For the cell surface staining, cells were incubated with fluorochrome-conjugated 
antibodies and human FC block (Biolegend) for 30-45 min at 4 °C. The transcription 
factor staining was performed by using Foxp3 Staining Buffer Set (eBioscience) 
according to the manufacturer’s instruction. For the intracellular cytokine staining/
cytotoxic molecule, cells were stimulated with 0.1 mg/mL PMA (Sigma-Aldrich) 
and 1 µg/mL Ionomycin (Sigma-Aldrich) for 6 h at 37 °C and GolgiPlug (BD 
Biosciences) was added for the final 4 h after which cells were stained by using 
Fixation Buffer and Intracellular Staining Perm Wash Buffer (Biolegend). Cells 
were acquired on an LSR II cytometer (BD Biosciences) or sorted on a FACSAria™ 
III sorter (BD Biosciences) based on the gating strategy as shown in Fig. 3 A. 
Data were analyzed with FlowJo V10 software.
Quantitative Real-Time PCR (RT-PCR)
RNA extraction was performed with the NucleoSpin® RNA XS kit (Macherey-Nagel). 
cDNA was synthesized with the High Capacity cDNA Reverse Transcription kit (Applied 
Biosystems). RT-PCR was performed in a StepOnePlus™ Real-Time PCR Systems 
(Applied Biosystems) with FastStart Universal SYBR Green Master Mix (Roche). ΔCt 
values were calculated using GAPDH as reference gene. The sequences of RT-PCR 
primers are as follows: GAPDH, forward primer: 5’-GTCTCCTCTGACTTCAACAGCG-3’; 
reverse primer, 5’-ACCACCCTGTTGCTGTAGCCAA-3’; AHR, forward primer: 
5’-CTTAGGCTCAGCGTCAGTTA-3’; reverse primer, 5’-GTAAGTTCAGGCCTTCTCTG-3’; 
ID2, forward primer: 5’-TTGTCAGCCTGCATCACCAGAG-3’; 
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reverse primer, 5’-AGCCACACAGTGCTTTGCTGTC-3’; NFIL3, 
forward primer: 5’-TGGAGAAGACGAGCAACAGGTC-3’; reverse 
primer, 5’-CTTGTGTGGCAAGGCAGAGGAA-3’; ZBTB16, 
forward primer: 5’-GAGCTTCCTGATAACGAGGCTG-3’; reverse 
primer, 5’-AGCCGCAAACTATCCAGGAACC-3’; TOX, forward 
primer: 5’-AGCATACAGAGCCAGCCTTG-3’; reverse primer, 
5’-TGCATGGCAGTTAGGTGAGG-3’; and TCF1, forward primer: 
5’-TGCAGCTATACCCAGGCTGG-3’; reverse primer, 5’-CCTCGACCGCCTCTTCTTC-3’.
Cell culture and differentiation assays
OP9-DL1 or OP9 stromal cells were maintained in Minimum Essential Medium 
α (Lonza) supplemented with 10% FCS. Flow cytometry-purified CD8a- int-ILCs 
or CD94+CD117-, CD94-CD117- and CD94-CD117+ subpopulations (500 cells/well) 
or CD8a+ int-ILCs (100 cells/well) were co-cultured with irradiated OP9 or OP9-
DL1 stromal cells (1,500 RAD, 5,000 cells/well) in a 96 well plate (Corning) and 
maintained in culture medium (IMDM supplemented with 10% human serum or 
in culture medium containing 25 ng/mL SCF (Miltenyi Biotec), 25 ng/mL IL-7 
(Peprotech), 10 U/mL IL-2 (Novartis) and 10 ng/mL IL-15 (R&D Systems) or only 
IL-15. The phenotype of generated progeny was determined by flow cytometry.
Cytokine secretion
CD8a- int-ILCs and ILC3 (2,000 cells/well) were stimulated with 10 U/mL IL-2 
(Novartis), 50 ng/mL IL-1β (Peprotech) and 50 ng/mL IL-23 (Peprotech) for 4 
days. TNF-a, IL-17A and IL-22 were measured by using Bio-Plex ProTM human 
cytokine 17-plex panel kit and Bio-Plex ProTM human Treg cytokine panel 12-plex 
kit (Bio-Rad).
Online supplemental material
Fig. S1 shows the mass cytometry-based analysis of the entire immune system 
in the human fetal intestine. Fig. S2. Top panel: t-SNE plots revealing the major 
lineage subsets, Bottom panel: t-SNE analysis of the innate cell compartment 
in the individual fetal samples. Fig. S3 shows Ki-67 and transcription factor 
expression profiles of fetal intestinal ILCs ex vivo. Fig. S4 is related to Fig. 5, and 
shows that CD8a- int-ILC can differentiate into CD45RA+ NK Cells and ILC3. Table 
S1 lists the information of antibodies used in the mass cytometry data.
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Supplemental information
Table S1. CyTOF antibody panel
The conjugation, validation and titration of all the antibodies which were not bought from DVS were done 
in house.
Antigen Tag Clone Supplier Cat. Final  dilution
1 CD127 165Ho AO19D5 DVS 3165008B 1/800
2 CCR6 141Pr G034E3 DVS 3141003A 1/200
3 CD8a 146Nd RPA-T8 DVS 3146001B 1/200
4 CD11c 162Dy Bu15 DVS 3162005B 1/200
5 CD38 172Yb HIT2 DVS 3172007B 1/200
6 CD45 89Y HI30 DVS 3089003B 1/100
7 CD117 143Nd 104D2 DVS 3143001B 1/100
8 CD4 145Nd RPA-T4 DVS 3145001B 1/100
9 CD16 148Nd 3G8 DVS 3148004B 1/100
10 CD25 149Sm 2A3 DVS 3149010B 1/100
11 CD123 151Eu 6H6 DVS 3151001B 1/100
12 CD7 153Eu CD7-6B7 DVS 3153014B 1/100
13 CD163 154Sm GHI/61 DVS 3154007B 1/100
14 CCR7 159Tb G043H7 DVS 3159003A 1/100
15 CD14 160Gd M5E2 DVS 3160001B 1/100
16 CD161 164Dy HP-3G10 DVS 3164009B 1/100
17 CD27 167Er O323 DVS 3167002B 1/100
18 CD45RA 169Tm HI100 DVS 3169008B 1/100
19 CD3 170Er UCHT1 DVS 3170001B 1/100
20 PD-1 175Lu EH 12.2H7 DVS 3175008B 1/100
21 CD56 176Yb NCAM16.2 DVS 3176008B 1/100
22 CD11b 144Nd ICRF44 DVS 3144001B 1/100
23 TCRgd 152Sm 11F2 DVS 3152008B 1/50
24 HLA-DR 168Er L243 BioL 307651 1/200
25 CD20 163Dy 2H7 BioL 302343 1/200
26 CD34 142Nd HIB19 BioL 343531 1/100
27 IgM 150Nd MHM88 BioL 314527 1/100
28 CD103 155Gd Ber-ACT8 BioL 350202 1/100
29 CRTH2 156Gd BM16 BioL 350102 1/100
30 CD28 171Yb CD28.2 BioL 302902 1/100
31 CD45RO 173Yb UCHL1 BioL 304239 1/100
32 CD122 158Gd TU27 BioL 339002 1/50
33 KLRG-1 161Dy REA261 MACS 120-014-229 1/50
34 CD8b 166Er SIDI8BEE ebio 14-5273 1/50
35 NKp46 174Yb 9E2 BioL 331902 1/40
DVS Sciences (DVS), eBioscience (eBio) and Biolegend (BioL).
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Fig. S1. Analysis of the entire immune system in the human fetal intestine using mass cytometry.
(A) Representative biaxial density dot plots from one fetal intestine showing the gating strategy for single, 
live CD45+ cells with percentages analysed by mass cytometry (N=7). Event length is a mass cytometry 
parameter defined as signal duration for the number of scans taken to acquire a given ion cloud. (B) 
Representative biaxial density dot plots from one fetal intestine showing the typical cell staining profiles of 
the antibodies used in mass cytometry after gating as shown in panel A (N=7). Gated cell populations are 
annotated above the plots. (C) A heatmap showing the median ArcSinh5-transformed marker expression 
values of the total 907 clusters identified by analyzing the entire immune system (CD45+ cells) from 7 
fetal intestines using the t-SNE-ACCENSE analysis pipeline (clustering per individual sample) for each of 
the 6 major immune lineages individually, as described before18, and hierarchical clustering thereof. four 
independent experiments).
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Fig. S2. t-SNE-based analysis of the Lin-CD7+ innate immune compartment in the human fetal 
intestine. (A) Gating strategy of the Lin-CD7+ innate cell population in the human fetal intestine. t-SNE 
embeddings of the collective CD45+ cells (2.2x105 cells) from 7 fetal intestines at single-cell resolution. 
Colors of cells represent ArcSinh5-transformed expression values of indicated markers. (B) Monitoring 
t-SNE computation dynamics for each individual fetal intestine. t-SNE embeddings of the ILC mass 
cytometry data showing single cells at stage 4 of the optimization course of the t-SNE computation for 
each individual fetal intestine (N=7). Colors represent the cluster partitions.
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ON THE COVER
Koning and colleagues used mass cytometry, single-cell RNA-seq and high-throughput TCR 
sequencing to characterize the CD4+ T cell compartment in the human fetal intestine
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Abstract
The fetus is thought to be protected from exposure to foreign antigens, yet 
CD45RO+ T cells reside in the fetal intestine. Here we combined functional assays 
with mass cytometry, single-cell RNA-sequencing and high-throughput T cell 
antigen receptor (TCR) sequencing to characterize the CD4+ T cell compartment 
in the human fetal intestine. We identified 22 CD4+ T cell clusters, including naive-
like, regulatory-like and memory-like subpopulations, which were confirmed and 
further characterized at the transcriptional level. Memory-like CD4+ T cells had high 
expression of Ki-67, indicative of cell division, and CD5, a surrogate marker of TCR 
avidity, and produced the cytokines IFN-γ and IL-2. Pathway analysis revealed a 
differentiation trajectory associated with cellular activation and proinflammatory 
effector functions, and TCR repertoire analysis indicated clonal expansions, 
distinct repertoire characteristics and interconnections between subpopulations of 
memory-like CD4+ T cells. Imaging-mass cytometry indicated that memory-like 
CD4+ T cells colocalized with antigen-presenting cells. Collectively, these results 
provide evidence for the generation of memory-like CD4+ T cells in the human 
fetal intestine that is consistent with exposure to foreign antigens.
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Introduction
Adaptive immunity is founded on the selection and expansion of antigen-specific 
T cells from a clonally diverse pool of naive precursors1. Naive T cells recirculate 
among lymph nodes to survey the array of peptide epitopes bound to major 
histocompatibility complex (MHC) proteins on the surface of antigen-presenting 
cells (APCs), and functional recognition of a given peptide-MHC molecule is 
governed by various danger signals and specific engagement via the clonotypically 
expressed T cell antigen receptor (TCR). This triggers a program of differentiation 
and proliferation that results in the generation of effector T cells, which home 
to the site of the primary infection and contribute to pathogen clearance, and 
memory T cells, which remain in the circulation and mediate anamnestic responses 
to secondary infection. In the last decade, it has also become clear that tissue-
resident T cells are commonly present at barrier sites, including the intestine2.
Fundamental knowledge of adaptive immunity during early life remains sparse. The 
infantile intestine is known to harbor clonally expanded T cells3, which were also 
identified in the human fetal intestine, but rarely in fetal mesenteric lymph nodes, 
fetal thymus or fetal spleen, suggesting compartmentalization4. In addition, a rare 
population of CD4+ T cells displaying a memory and proinflammatory phenotype 
has been identified in umbilical cord blood5. Although the dogma of a sterile womb 
has been challenged by reports of bacteria colonization in the placenta6,7, amniotic 
fluid8,9 and meconium10, others have questioned these results11. Here we have 
combined functional studies with mass cytometry, RNA-sequencing (RNA-seq) 
and high-throughput TCR-sequencing to perform an in-depth analysis of the fetal 
intestinal CD4+ T cell compartment. Our results provide evidence for memory 
formation in the human fetal intestine, consistent with in utero exposure to foreign 
antigens. 
Results
Human fetal intestinal CD4+ T cells are phenotypically diverse
To explore the CD4+ T cell compartment in the human fetal intestine, we applied 
a mass cytometry panel comprising 35 antibodies (Supplementary Table 1) 
that was designed to capture the heterogeneity of the immune system to seven 
lamina propria samples aged 14-21 gestational weeks12. After data acquisition, we 
selected CD45+ immune cells (Supplementary Fig. 1a) and mined the dataset via 
hierarchical stochastic neighbor embedding (HSNE)13. At the overview level, HSNE 
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landmarks depicted the general composition of the immune system, with clear 
separation of the CD4+ T cell lineage (Supplementary Fig. 1b). We identified 
110,332 CD4+ T cells, with an average of 15,761 events per fetal intestine, 
comprising 47.9% ± 9.6% of all immune cells. We then subjected HSNE-defined 
CD4+ T cells (Supplementary Fig. 1b) to t-distributed stochastic neighbor 
embedding (t-SNE)14 in Cytosplore15 to project their marker expression profiles 
onto a two-dimensional graph (Fig. 1a and Supplementary Fig. 1c). CD4+ T 
cells were characterized as CD45+CD3+CD4+CD7+ (Fig. 1a). Moreover, all CD4+ T 
cells were positive for the tissue-resident marker CD38 and approximately 50% of 
cells expressed CD161. 24.1% of the CD4+ T cell population co-expressed CD27, 
CD28, CD45RA and CCR7, indicative of a naive T cell (TN) phenotype, whereas 
64.5% expressed CD45RO, indicative of a memory T cell (TM) phenotype (Fig. 
1a,b). While all CD45RO+ TM cells were CD28+, differential expression of CD25, 
CD27, CD103, CD117, CD127, CCR6 and CCR7 was observed on these cells (Fig. 
1a,b), reflecting substantial phenotypic diversity. 
We next applied Gaussian mean-shift clustering to the mass cytometry data using 
the t-SNE coordinates of the embedded CD4+ T cells (Fig. 1a). Based on cell 
density features (Fig. 1c), this identified 22 distinct CD4+ T cell clusters (Fig. 
1d), each defined by a unique marker expression profile. Hierarchical clustering 
of the heatmap revealed eight major groups (CD161+CCR6–CD117– TM cells, 
CD161+CCR6+CD117+ TM cells, DN TM cells, Treg cells, CD161–CCR7+ TM cells, CD161– 
TN cells, CD161lo TN/TM cells and CD161–CCR7– TM cells) (Fig. 1e). High expression 
of CD25 and a lack of CD127 distinguished two regulatory T (Treg) cell clusters, 
with either a CD45RA+ TN or a CD45RO+ TM phenotype (Fig. 1a,b,e). CD161+CD4+ 
T cells branched into a CCR6–CD117–CD45RO+ TM and a CCR6+CD117+CD45RO+ TM 
cluster (Fig. 1e). Moreover, CD45RA+ TN and CD45RO+ TM cells were detected in 
both the CD161– and the CD161lo subpopulations. Additional diversity was observed 
for the expression of several activation markers, including CRTH2, HLA-DR,
Fig. 1. Mass cytometric analysis of fetal intestinal CD4+ T cells. a, t-SNE embedding of all CD4+ 
T cells (n = 110,332) derived from human fetal intestines (n = 7). Colors represent the ArcSinh5-
transformed expression values of the indicated markers. b, t-SNE plot depicting the population cell 
border for TN cells (dashed yellow line), TM cells (dashed red line), and Treg cells (dashed green line). 
c, Density map describing the local probability density of cells, where black dots indicate the centroids 
of identified clusters using Gaussian mean-shift clustering. d, t-SNE plot showing cluster partitions 
in different colors. e, Heatmap showing median expression values and hierarchical clustering of 
markers for the identified subpopulations. f, Biaxial plots showing CD45RA and CCR7 expression on 
the indicated clusters analyzed by mass cytometry. The 22 clusters were merged into 6 phenotypic 
groups according to the heatmap shown in (e). g, Composition of the CD4+ T cell compartment 
in each fetal intestine represented by vertical bars, where the colored segment lengths represent 
the proportion of cells as a percentage of all CD4+ T cells in the sample. Colors as shown in (e) 
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KLRG-1 and PD-1, the latter especially within the CD45RO+ TM cell clusters 
(Supplementary Fig. 1c). Of note, a small population of CD4–CD8a–TCRγδ– (DN) 
TM cells clustered among CD4+ T cells in both the HSNE and t-SNE plots. Biaxial 
plots confirmed coexpression of CD45RA and CCR7 on TN cells (Fig. 1f), whereas 
the CD161lo/–CD45RO+ TM subpopulation contained both CCR7+ central memory T 
(TCM) cells and CCR7– effector memory T (TEM) cells (Fig. 1f). All other CD45RO+ TM 
subpopulations harboured primarily TEM cells. Quantification of cellular frequencies 
for the CD4+ T cell clusters per fetal intestine revealed highly similar compositions 
with all CD45RO+ TM clusters detectable in all samples (Fig. 1g). In contrast, 
parallel analyses of CD4+ T cells isolated from three fetal livers and three fetal 
spleens from one shared and two additional fetuses aged 16-21 gestational weeks 
revealed a predominance of CD45RA+ TN cells (Supplementary Fig. 2a,b). 
These results delineated a phenotypically diverse array of human fetal intestinal 
CD4+ T cells, most of which displayed features associated with antigen exposure.
Fetal CD4+ T cells display a memory gene expression profile 
We next performed single-cell RNA-seq on flow-sorted fetal intestinal CD4+ cells 
from a lamina propria sample that was also included in the mass cytometry 
analysis. This yielded data for 1,804 CD4+ T cells, identifying cell-specific variable 
expression of 2,174 genes (Methods), which were further analyzed using the Seurat 
computational pipeline16. Unsupervised clustering revealed nine transcriptionally 
distinct subpopulations, seven of which corresponded to CD3+ T cell subsets 
while two displayed a gene expression profile matching CD86+HLA-DR+ APCs. The 
corresponding gene expression profiles of the seven T cell subsets were projected 
onto a single graph using t-SNE (Fig. 2a), and the top 20 upregulated genes were 
displayed in a heatmap (Fig. 2b). Five of the seven RNA-seq-identified CD4+ T cell 
subpopulations corresponded to the mass cytometry-defined CD4+ T cell major 
groups: CCR7+ TN with CD45RA+ TN, KLRB1lo/–SELL– TM with CD161lo/–CD45RO+ 
TM, KLRB1+CCR6–SELL– TM with CD161+CCR6–CD45RO+ TM, KLRB1+CCR6+SELL– TM 
with CD161+CCR6+CD45RO+ TM and FOXP3+ Treg cells with CD25+CD127lo Treg cells. 
The mass cytometry defined CD161– and CD161lo subpopulations (Fig. 1e) could 
Fig. 2. Single-cell RNA-sequencing of fetal intestinal CD4+ T cells. a, t-SNE embedding of fetal 
intestinal CD4+ T cells (n = 1,804) showing seven transcriptionally distinct clusters, including CCR7+ TN (n 
= 358), KLRB1lo/–SELL– TM (n = 237), KLRB1
+CCR6–SELL– TM (n = 640), KLRB1
+CCR6+SELL– TM (n = 336), 
undefined TM (n = 101), FOXP3
+ Treg cells (n = 71), and proliferating cells (n =61). Colors indicate different 
cell clusters. b, Heatmap showing the normalized single-cell gene expression value (Z-Score, purple-to-
yellow scale) for the top 20 differentially upregulated genes in each identified cluster. Colors as shown in 
(a). c–e, Expression of the indicated genes in each identified cluster at (c) the RNA level (log-normalized) 
and (d,e) the protein level analyzed by (d) mass cytometry (CyTOF, ArcSinh5-transformed) or (e) flow 
cytometry, presented as violin plots. Dashed lines indicate background levels. Colors as shown in (a).
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not be discriminated in the RNA-seq dataset. One additional RNA-seq-identified 
subpopulation corresponded to proliferating cells, based on the expression 
of genes associated with cell division (CCNB2, CDK1 and MKI67) (Fig. 2a,b). 
As CD45RA and CD45RO were not detectable, we used other markers to distinguish 
TM from TN clusters. To compare gene or marker expression among cell clusters, 
we used violin plots, displaying the mode average as the thickest section (Fig. 
2c-e). Consistent with the mass cytometry data, RNA-seq-defined TN cells were 
KLRB1–CCR7+SELL+/– (Fig. 2c,d), the latter confirmed by flow cytometry (Fig. 2e 
and Supplementary Fig. 3a). In the absence of TM-associated markers, SELL– TM 
cell populations were identified on the basis of differential expression of KLRB1 
and CCR6 (Fig. 2c,d). Consistent with the mass cytometry data, expression of KIT 
(CD117) was restricted primarily to KLRB1+CCR6+SELL– TM cells (Supplementary 
Fig. 3b). Moreover, the gene expression profile of the IL2RA+IL7RloFOXP3+ Treg cell 
population (Fig. 2c) corresponded to the mass cytometry-defined CD25+CD127lo 
Treg cells (Fig. 2d). In addition, several RNA-transcripts including LAG3, TIGIT, 
CTLA4 and TNFRSF18 (GITR) ascertained the identity of FOXP3+ Treg cells (Fig. 
2b). Finally, the RNA-seq data revealed an undefined TM cluster that was not 
identified by mass cytometry, but expressed genes similar to those detected in 
the KLRB1+CCR6+SELL– TM subpopulation, such as CD69, CCL5 and JAML. Cell 
population frequencies identified by mass cytometry and RNA-seq were comparable 
with the exception of mass cytometry-defined CD25+CD127lo Treg cells and RNA-
seq-defined FOXP3+ Treg cells (Supplementary Fig. 3c). 
Compared with the CCR7+ TN population, KLRB1lo/–SELL– TM, KLRB1+CCR6–SELL– TM, 
KLRB1+CCR6+SELL– TM and undefined TM subpopulations had high expression of the 
tissue-resident and activation-associated gene CD69, the differentiation-promoting 
gene ANXA1 (Annexin A1), the chemokine-like factor CKLF, the cytokine IL32, 
the proliferation-associated gene JUN (C-Jun) and the adhesion molecule JAML 
(Fig. 3a). CD40LG (CD154), TNFSF14 and TGFB1 were specifically upregulated 
by KLRB1+CCR6–SELL– TM, KLRB1+CCR6+SELL– TM and undefined TM clusters, while 
CCL5 and MAP3K8 kinase upregulated by KLRB1+CCR6–SELL– TM and undefined TM 
subpopulations. Moreover, IL4I1 was specifically expressed by KLRB1+CCR6+SELL– 
TM and undefined TM cells. In addition, all fetal SELL– TM subpopulations had high 
expression of the tissue-resident genes ITGAE (CD103) and/or CD38 (Fig. 3a). 
In agreement with the RNA-seq data, flow cytometry indicated that the activation 
markers CXCR3, CCR4, CD69 and CD226 were highly expressed on CCR7– TEM 
cells (Fig. 3b). All CD4+ T cells expressed CD95, with the highest expression on 
CD161+ TEM cells (Fig. 3b). Expression of CD31, a marker associated with recent 
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Fig. 3. Targeted analysis 
of memory-like fetal 
intestinal CD4+ T 
cells. a, Expression 
(log-normalized) of the 
indicated genes in distinct 
CD4+ T cell clusters as 
determined by single-
cell RNA-seq analysis, 
presented as violin plots. 
Colors indicate different 
cell clusters. b, Biaxial 
plots showing expression 
of CXCR3, CCR4, CD69, 
CD226, CD95, and 
CD31 vs. CCR7 on the 
indicated CD4+ T cell 
clusters analyzed by flow 
cytometry. Data represent 
two to three independent 
experiments. 
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thymic emigrants17, was highest on CD45RA+ TN cells (Fig. 3b). 
Thus, RNA-seq confirmed the existence of distinct subpopulations of CD4+ 
T cells and indicate that many genes associated with inflammation and tissue 
residency were upregulated by fetal CD4+ TM cells, consistent with antigen-driven 
functionality and maturation.
Computational analysis reveals a differentiation pathway of CD4+ T cells
We next visualized the evolution of the t-SNE computation of the mass cytometry 
and RNA-seq data to reveal the ordering of single cells along putative differentiation 
trajectories12,15. At the onset of the mass cytometry data computation, where cells 
are grouped based on major shared features, CD25+CD127lo Treg cells clustered 
separate from the other cells, whereas the other cell clusters were ordered in a 
linear fashion with the CD45RA+ TN cells next to the CD161lo/–CD45RO+ TM cells, 
followed by the CD161+CCR6–CD45RO+ TM cells and the CD161+CCR6+CD45RO+ 
TM cells, consecutively (Fig. 4a). A similar phenotypic ordering was observed 
in parallel analyses of the RNA-seq data, although the KLRB1+CCR6+SELL– TM 
subpopulation aligned differently, but remained connected with the KLRB1+CCR6–
SELL– TM cluster (Fig. 4b). Individual marker expression patterns at the middle of 
the t-SNE computation validated the ordering of the clusters and the comparability 
of the mass cytometry and RNA-seq data (Supplementary Fig. 4a,b). Similar 
patterns were identified using Diffusion map18, VorteX19 and principal component 
analysis (PCA)20 (Supplementary Fig. 4c–f). Thus, this analysis reveals a 
putative differentiation pathway leading to TM formation.
To extend our analysis of the gene expression profiles underlying this putative 
differentiation trajectory, we used the pseudotime algorithm in the Monocle 
toolkit21,22, which calculates the ordering of individual cells based on single-cell 
expression profiles. Based on this analysis, CCR7+ TN cells were separated from 
SELL– TM cells (Fig. 4c). When we clustered genes according to expression patterns 
along the pseudotime trajectory, cell-to-cell transitioning could be explained by the 
kinetics of 1,376 variable genes, which formed three large modules (Fig. 4d). The 
first module contained 540 genes associated with CCR7+ TN cells, including SELL, 
CCR7, CD27 and CD28 (Fig. 4d). The second module contained 453 genes, many 
of which were associated with an ongoing transcriptional program, such as RPL21, 
RPS2 and RPLP1. The highest activity of this transcriptional gene expression profile 
coincided with the transition of cells with a CCR7+ TN phenotype into cells with a 
SELL– TM phenotype (Fig. 4c,d). The third module contained 383 genes (Fig. 
4d), 106 of which were associated with cellular activation and regulation of the 
immune system (Supplementary Fig. 5a), while 133 encoded proteins known 
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Fig. 4. Single-cell trajectory analysis of fetal intestinal CD4+ T cells. a–b, t-SNE embeddings of all 
fetal intestinal CD4+ T cells analyzed by (a) mass cytometry (n =10,436) and (b) single-cell RNA-seq (n 
= 1,743) at the onset and at the middle of the t-SNE computation. Colors indicate different cell clusters. 
c, A single-cell trajectory from the RNA-seq data (excluding Treg cells and proliferating cells) recovered by 
pseudotime analysis. Colors indicate different cell clusters as shown in (b). Grey arrows indicate three 
small branches. d, Three kinetic modules of pseudotime-dependent genes (n = 1,376) depicted in a log-
variance-stabilized expression heatmap, indicating gene-enriched biological processes. Genes confirmed 
by mass cytometry and flow cytometry are denoted by black labels, and genes involved in TCR signalling 
are denoted by gray labels. The dashed grey box indicates the coordinated expression profile of TNF, 
FASL, and FYN. Euclidean distance values comparing gene expression profiles for each ordered pair of 
neighboring cells along the pseudotime trajectory are shown in the graph (right).
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to interact physically with each other (Supplementary Fig. 5b). In addition, 23 
genes in module 3 could be assigned to cytokine or chemokine receptor pathways, 
including CCL20 and its receptor CCR6, the interferon receptor IFNGR1, TNF 
family members and IL-1 and IL-17 receptors (Supplementary Fig. 5b). Several 
signaling cascades were also represented in module 3, including the MAPK, TNF, 
IL-17 and TCR signaling pathways (FYN, LCP2, SOS1, MAP3K8 kinase, FASL and 
TNF) (Fig. 4d). The TH17-associated gene RORC was expressed in module 3 (Fig. 
4d). In addition, the dynamic expression profiles of FYN, FASL and TNF clustered 
tightly with KLRB1 (CD161) (Fig. 4d) at the point in the pseudotime trajectory 
where CCR7+ TN cells were aligned next to SELL– TM cells (Fig. 4d). Finally, we 
quantified the smoothness of cell-to-cell transitioning based on gene expression 
changes along the trajectory, which showed that the pseudotime trajectory was 
most uncertain at the beginning and toward the end, but quite robust in the 
middle, where CCR7+ TN cells were aligned next to SELL– TM cells (Fig. 4d). 
In sum, these results identified temporal patterns of gene expression along the 
single-cell trajectory that is compatible with the transition of cells displaying a TN 
phenotype into cells with a TM phenotype. 
TCR analysis reveals clonal expansion of fetal CD4+ T cells 
 Surface expression of CD5 correlates with TCR avidity23–26. Because CD5 gene 
expression was upregulated in TM cells compared to TN cells, we quantified CD5 
expression on all identified fetal intestinal CD4+ T cell subsets using flow cytometry 
and observed that all the CD4+ T cell subsets expressed CD5 (Fig. 5a), but that 
the median fluorescence intensity (MFI) was higher in CD161–, CD161+CD117– 
and CD161+CD117+ TM cells and lower in CD25+CD127lo Treg cells and CD45RA+ TN 
cells (Fig. 5a–c), suggesting that cells with a TM phenotype express TCR with a 
higher avidity compared to TN cells. 
Fig. 5. CD5 expression analysis and high-throughput TCR-sequencing of fetal intestinal CD4+ 
T cells. a–b, CD5 expression on the indicated CD4+ T cell clusters. (a) The biaxial plots depict one 
representative experiment, and (b) the bar graphs depict the median fluorescence intensity (MFI) of CD5 
expression for each cluster relative to the corresponding CD161+CD117– TM subpopulation in each fetal 
intestine (n = 7). Data represent six independent experiments. Error bars indicate mean ± SEM. *p < 
0.05, Two-tailed Wilcoxon matched-pairs signed-ranks test. c, Expression (log-normalized ) of CD5 gene 
transcripts in the indicated cell clusters, presented as violin plots. d, Dot plots showing the percentage of 
TCR cDNA molecules per unique TCRβ sequence in each cluster from each fetal intestine. Data are from 
two independent samples. A single duplicate is shown for samples with technical replicates. e, Dot plots 
showing the normalized Shannon-Wiener index for TCRα (TRA) and TCRβ (TRB) sequences in each 
cluster from each fetal intestine. Data are from two independent samples. f, Dot plots showing averaged 
TCR repertoire characteristics weighted per clonotype for each cluster. Data are from two independent 
samples. g, Dendrogram showing weighted clonal overlaps for TCRβ nucleotide sequences among 
clusters, analyzed using the F2 similarity metric in VDJtools. Colors indicate different fetal intestines.
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Next, we evaluated the TCR clonotypic architecture of flow-sorted fetal intestinal 
CD45RA+ TN, CD45RO+ TM and CD25+CD127lo Treg subpopulations. Analysis of the 
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TCRβ rearrangements in a single fetal intestine indicated limited overlap among 
the distinct subpopulations, most of which were highly polyclonal (not shown). 
Distinct clonotypes were expanded among CD45RO+ TM cells compared to CD45RA+ 
TN cells (Supplementary Fig. 6a). We then used a quantitative high-throughput 
approach for deep sequencing of TCRα and TCRβ rearrangements in all identified 
fetal intestinal CD4+ T cell subsets isolated from two additional fetal intestines 
(Supplementary Table 2). Post-analysis of the obtained repertoires was conducted 
using VDJtools27. As expected, all TM subpopulations showed greater clonality 
compared to the TN subpopulation (Fig. 5d,e). The averaged characteristics of 
CDR3 length, added N-nucleotides and physicochemical characteristics of the 5 
amino acid residues located in the middle of the CDR3 loop, which are most likely 
to contact the peptide-MHC complex28, also differed among all subpopulations 
(Fig. 5f). The latter analysis included the averaged statistical potential of the 
CDR3 loop with respect to epitope interactions, comprising the estimated “energy” 
of the interaction with a random epitope29, the “strength” of the interaction 
(derivative of “energy”, VDJtools27), hydrophobicity (Kidera factor 4)30,31 and 
“volume” (values from http://www.imgt.org/IMGTeducation/Aide-memoire/_UK/
aminoacids/IMGTclasses.html). These analyses provided no evidence for clonal 
expansion of CD4+ T cells as a function of intrinsically high TCR-avidities for self-
derived peptide-MHC complexes (Fig. 5d-f), suggesting indirectly that antigen-
specific interactions triggered clonal selection of CD4+ T cells from the TN cell 
pool. Analysis of V-J segment use (Jensen-Shannon divergence; Supplementary 
Fig. 6b) and overlaps among repertoires in terms of the weighted proportion of 
shared TCRβ clonotypes revealed tightly clustered technical replicates and clearly 
distinguished all subpopulations of CD4+ T cells (Fig. 5g). At the same time, 
the CD161–, CD161+CD117– and CD161+CD117+ TM cells clustered similarly in 
each fetus, with minimum overlap with the CD45RA+ TN and CD25+CD127lo Treg 
cells (Fig. 5g). Analysis of the clonal overlap of amino acid CDR3 repertoires 
between the same populations in the two fetal intestines revealed that the CD161–
, CD161+CD117– and CD161+CD117+ TM populations displayed much stronger 
overlap than the CD45RA+ TN and CD25+CD127lo Treg CD4+ T cells (Supplementary 
Fig. 6c), which could be explained by TCR selection due to exposure to similar 
foreign antigens. Finally, although the majority of the TCR repertoire was specific 
for each population, up to 20% of the T cell clones were shared between the 
CD45RA+ TN and the three CD45RO+ TM cell populations (Supplementary Fig. 
6d), suggesting a potential clonal relationship between CD45RA+ TN and CD45RO+ 
TM cells. These results indicate that avidity-based, clonotype-specific expansion of 
the TN pool is associated with TM formation and confirmed the close relationship 
between CD161–, CD161+CD117– and CD161+CD117+ TM cells.
Memory CD4+ T cells are generated in the human fetal intestine
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Fig. 6. Functional profiling of fetal intestinal CD4+ T cells. a–b, Purified fetal intestinal CD4+ T cells 
were treated with a control antibody or stimulated with anti-CD3 and anti-CD28 for 4 h. Intracellular 
expression of TNF, IL-2, IFN-γ, IL-4, granzyme B, and CD154 was determined for each subpopulation 
by flow cytometry. (a) The biaxial plots show data from one representative experiment after stimulation 
with anti-CD3 and anti-CD28, and (b) the bar charts show data for each subpopulation from each fetal 
intestine (TNF: n = 4 samples in two independent experiments; IL-2 and granzyme B: n = 3 samples in 
two independent experiments; IFN-γ, IL-4 and CD154: n = 7 samples in four independent experiments). 
Error bars indicate mean ± SEM. *p < 0.05, **p <0.01, Kruskal-Wallis test with Dunn’s test for multiple 
comparisons. 
Fetal CD4+ TM cells secrete proinflammatory cytokines 
To determine the functional profiles of fetal intestinal CD4+ T cells, we flow-sorted 
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CD3+CD4+ T cells and measured expression of TNF, IL-2, IFN-γ, IL-4, granzyme B 
and IL-17A in CD45RA+ TN cells and CD117– and CD117+ TM cells after cross-linking 
CD3 and CD28. The activation marker CD154 (CD40L) was upregulated on all cells 
analyzed (Fig. 6a,b), indicating efficient stimulation. All three subpopulations 
secreted large amounts of TNF (Fig. 6a,b), but CD117– TM cells and CD117+ TM 
cells displayed the highest MFIs (Supplementary Fig. 7a). Moreover, IL-2, IFN-γ, 
IL-4 and granzyme B were more commonly expressed in CD117– TM and CD117+ TM 
cells relative to CD45RA+ TN cells (Fig. 6a,b). The majority of cytokine-producing 
CD4+ T cells did not express Ki-67 (Supplementary Fig. 7b). Importantly, higher 
frequencies of IL-2+IFN-γ+ cells were detected in the CD117– TM and CD117+ TM 
cells compared with the CD45RA+ TN population (Supplementary Fig. 7c), 
suggesting greater polyfunctionality. Although the TH17-associated RORC gene 
was expressed by 1.3% of KLRB1+CCR6+SELL– TM cells (Fig. 4d), IL-17A production 
was undetectable by all TM cells. Thus, fetal intestinal CD117– TM and CD117+ TM 
cells deployed multiple effector functions reminiscent of classical CD4+ TM cells in 
response to TCR-mediated signal transduction and costimulation via CD28.
Fetal CD4+ T cells are co-localized with antigen presenting cells
The single-cell RNA-seq analysis revealed a MKI67+ cluster of proliferating cells, 
together with high expression of the TM cell-associated markers KLRB1 (CD161) 
and CD69 and low levels of the TN cell-associated markers CCR7 and SELL (CD62L) 
(Fig. 7a). Flow cytometry of fetal intestinal CD4+ T cells indicated the presence of 
Ki-67+ cells, predominantly within the CD45RO+ compartment (Fig. 7b). To assess 
the spatial distribution of CD4+ T cells in situ, we employed a panel of 15 antibodies 
(Supplementary Table 3) combined with a DNA stain to perform imaging-
mass cytometry on tissue sections of four human fetal intestinal samples. Stains 
for collagen I and smooth muscle actin were used to visualize the extracellular 
matrix of the basement membrane, and the epithelium and lamina propria 
Fig. 7. Characterization and spatial localization of fetal intestinal CD4+ T cells and APCs. a, 
Expression (log-normalized) of the indicated genes in proliferating fetal intestinal CD4+ T cells, presented 
as violin plot. b, Biaxial plots showing expression of Ki-67 vs. CD45RO in the fetal intestinal CD4+ T cell 
compartment analyzed by flow cytometry. Data represent two independent experiments. c, Representative 
mass cytometry image of a fetal intestine showing the overlay of CD3 (red), Ecadherin (green), and 
DNA (blue). Scale bar, 100 μm. d, Representative mass cytometry images of fetal intestines showing 
expression of the indicated stromal markers, immune markers, Ki-67 and DNA by the cells identified in (c). 
Scale bar, 200 μm (applies similarly to all the images in (d). Yellow arrows: CD4+CD45RA+ TN cells; white 
arrows: CD4+CD45RA– TM cells. e, Representative mass cytometry images of a fetal intestine showing the 
overlay of CD3 (red), CD4(green), CD163 (cyan), and HLA-DR (blue). Scale bar, 50 μm. Colors and scale 
bars are similar in all three panels. Data in (b-d) represent four independent samples in four independent 
experiments. f, Expression (log-normalized) of the indicated genes in two clusters of APCs, presented as 
violin plots. CCR7– APCs (n = 49), CCR7+ APCs (n = 17).
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were distinguished as vimentin–E-cadherin+ and vimentin+E-cadherin–, respectively 
(Fig. 7c,d). Most CD4+ T cells localized to the lamina propria (Fig. 7c,d). 
Differential expression of CD45RA further allowed discrimination of CD45RA+ TN 
(Fig. 7c,d) from CD45RA– TM cells in the lamina propria (Fig. 7c,d). In addition, 
all CD4+ T cells expressed CD38, whereas only some CD4+ T cells expressed 
CD69 (Fig. 7d). Using a second panel comprising 10 antibodies (Supplementary 
Table 3), we found that CD4+ T cells frequently colocalized with CD163+HLA-
DR+ APCs (Fig. 7e). Moreover, the single-cell RNA-seq analysis of fetal intestinal 
cells revealed two cluster of cells displaying high expression of gene transcripts 
encoding HLA-DR, CD74 (HLA-class II invariant chain), inhibitory molecule PD-L1 
(CD274), CD80 and CD86, typically found in APCs. Moreover, these APCs expressed 
gene transcripts encoding CD40, consistent with an activated phenotype (Fig. 
7f), whereas stimulated fetal intestinal CD4+ T cells expressed CD40L (CD154) 
(Fig. 6b). In addition, 25.8% of APCs had high expression of CCR7, potentially 
enabling migration to the mesenteric lymph nodes (Fig. 7f). Collectively, these 
results indicated the existence of CD4+ TM cells in the fetal intestine, many of 
which colocalized in the lamina propria with activated CD163+HLA-DR+ APCs.
Discussion
Here we used mass cytometry and single-cell RNA-seq to characterize CD4+ T cells 
in the human fetal intestine. Mass cytometry revealed three major populations of 
fetal intestinal CD4+ T cells (TN, TM and Treg cells), that could be further distinguished 
into eight distinct cells clusters that displayed additional heterogeneity. These cell 
clusters were present in seven human fetal intestines, suggesting a physiologically 
robust immune composition. Single-cell RNA-seq revealed the presence of seven 
CD4+ T cell subpopulations, five of which displayed phenotypic overlap with the 
mass cytometry-defined CD4+ T cell subpopulations. We used computational 
tools to construct putative CD4+ T cell differentiation trajectories. Using adapted 
t-SNE32, we obtained remarkably similar trajectories for the mass cytometry and 
RNA-seq data. We identified three distinct gene expression modules along the 
differentiation trajectory that correspond to an increase in gene translation and 
subsequent activation of immune related genes. In addition, high-throughput TCR 
sequencing indicated clonal expansions within the CD4+ TM cell pool, consistent with 
the evidence for cell proliferation within the CD45RO+ TM pool that was obtained 
at both the mRNA and protein level. Moreover, CD4+ TM cells secreted higher 
amounts of pro-inflammatory cytokines upon TCR triggering compared to CD4+ TN 
cells. Finally, fetal intestinal CD4+ TM cells displayed a tissue-resident profile and 
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were frequently found to colocalize with APCs in the lamina propria. Together, this 
suggested that clonotype-specific transcriptional programs regulated by antigen 
encounter underpinned the formation of CD4+ TM cells in the fetal intestine.
T cells in umbilical cord and peripheral blood obtained of infants aged 2 months 
were reported to display a typical CD45RA+ TN phenotype3. The observation herein 
that a large pool of CD45RO+ cells with a tissue-resident profile populated the 
fetal intestine suggests the compartmentalization of the immune system early 
in life. In conjunction with the earlier finding that clonally expanded T cells were 
present in the fetal intestine, but virtually absent in other fetal organs4, our results 
further suggest that memory formation was driven by local exposure to foreign 
antigens. The observation that there is a substantial overlap in the amino acid 
CDR3 repertoires of the memory CD4+ T cells compartment in the two fetuses 
analyzed may indicate exposure to similar foreign antigens. 
 Approximately 50% of all fetal intestinal CD4+ T cells were CD161+ and 
transcriptionally distinct from their CD161– counterparts, consistent with a recent 
study33. The kinetics of KLRB1 (CD161) expression was preceded by increased 
expression CD5 and coincided with increased expression of several TCR signaling 
genes, including FYN, FASL and TNF, suggesting a coordinated program of 
transcription. Of note, CD161 was identified as a costimulatory molecule in the 
context of TCR stimulation33.
Although the mass cytometry and RNA-seq data were largely compatible, there were 
exceptions. For example, coexpression of CCR6 and KIT among KLRB1+CCR6+SELL– 
TM cells was not reflected in the gene expression profiles. Conversely, expression 
of ITGAE (CD103) mRNA was not reflected by protein expression. These anomalies 
were likely attributable to discordant gene transcription and protein expression34 
and may also relate to differences in sensitivity of the employed techniques.
The presence of a large population of TN cells in the fetal intestine is in stark contrast 
to the predominace of TM cells in the adult intestine. As the TN cells expressed 
relatively high amounts of CD31, which demarcates recent thymic emigrants, our 
results indicate direct migration of recent thymic emigrants into the intestine35,36. 
We propose that antigen-specific priming of TN cells takes place in the mesenteric 
lymph nodes followed by migration of the resulting TM cells to the lamina propria 
leading to a progressive loss of TN cells. Similarly memory formation is taking 
place in the CD8+ T cell compartment (not shown). 
Distinct subpopulations of fetal intestinal Treg cells were distinguished by several 
markers, including high expression of CD25 and Foxp3, and a lack of CD127. In 
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line with previous results37, approximately 50% of these cells expressed CD45RO, 
while the remainder expressed CD45RA. The CD45RA+ Treg cells expressed TCRs 
with longer CDR3β loops, higher numbers of added N-nucleotides and distinct 
physicochemical characteristics, suggesting higher affinities for self-antigens 
compared to CD45RO+ Treg cells38. The presence of oligoclonal T cell expansions in 
fetuses with autoimmune conditions associated with a genetic absence of Treg cells 
indicate a key role for these cells in immune suppression in utero39. 
In conclusion, our study revealed a putative differentiation trajectory in the fetal 
intestinal CD4+ T cell compartment, consistent with the formation of TM cells in 
utero, presumably as a consequence of exposure to foreign antigens. These could 
include non-inherited maternal HLA-molecules40 and pathogen-derived ligands, 
which could be derived from amniotic fluid8,9. We propose that immune priming 
in the fetal intestine prepares the infant for the massive influx of bacteria that 
occurs immediately after birth, with anamnestic responses in situ facilitated by 
the colocalization of CD4+ TM cells with APCs.
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Methods
Sample processing and cell isolation 
Fetal tissues were obtained from elective abortions with informed consent. The 
gestational age ranged from 14 to 22 weeks. Intestines were separated from 
mesentery, cut into small pieces, embedded in optimal cutting temperature 
compound, and snap-frozen in isopentane. The remaining intestines were used for 
single-cell isolation as described previously12. Briefly, fetal intestines were cleared 
of meconium, cut into fine pieces, treated with 1 mM dithiothreitol (Fluka) for 2 
x 10 min (replacing buffer) at room temperature (rT), and then incubated with 1 
mM ethylenediaminetetraacetic acid (Merck) for 2 x 1 h (replacing buffer) at 37 
°C under rotation to separate the epithelium from the lamina propria. To obtain 
single-cell suspensions from the lamina propria, the intestines were rinsed with 
Hank’s balanced salt solution (Thermo Fisher Scientific), incubated with 10 U/mL 
collagenase IV (Worthington) and 200 µg/mL DNAse I grade II (Roche Diagnostics) 
overnight at 37 °C, and filtered through a 70 µm nylon mesh. Isolated cells were 
then further purified with a Percoll gradient (GE Healthcare). Fetal liver and spleen 
tissues were cut into small pieces and filtered through a 70 µm nylon cell strainer 
and the immune cells were isolated with Ficoll-PaqueTM density gradient. All the 
isolated cells were stored in liquid nitrogen. Study approval was granted by the 
Medical Ethics Commission of Leiden University Medical Centre (protocol P08.087). 
All experiments were conducted in accordance with local ethical guidelines and the 
principles of the Declaration of Helsinki. 
Cell suspension-mass cytometry
Antibodies used for cell suspension-mass cytometry are listed in Supplementary 
Table 1. Purified antibodies lacking carrier protein were conjugated with metal 
reporters by using a MaxPar X8 Antibody Labeling Kit (Fluidigm). Procedures 
for antibody staining and data acquisition were described previously41. Briefly, 
cells from fetal intestines were incubated with 5 µM Cell-ID Intercalator-103Rh 
(Fluidigm) for 15 min at rT and then stained with a cocktail of metal-conjugated 
antibodies for 45 min at rT. After washing, cells were incubated with 125 nM Cell-
ID Intercalator-Ir (Fluidigm) in MaxPar Fix and Perm Buffer (Fluidigm) overnight 
at 4 °C. Data were acquired using a CyTOF 2TM mass cytometer (Fluidigm) and 
normalized using EQ Four Element Calibration Beads with the reference EQ 
Passport P13H2302 (Fluidigm).
Imaging-mass cytometry
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Antibodies used for imaging-mass cytometry are listed in Supplementary Table 
3. Purified antibodies lacking carrier protein were conjugated with metal reporters 
by using a MaxPar X8 Antibody Labeling Kit (Fluidigm). Snap-frozen human fetal 
intestinal biopsies were sectioned at a thickness of 5 μm and fixed by incubating with 
1% paraformaldehyde for 5 min at rT followed by 100% methanol for 5 min at –20 
°C. After fixation, tissue sections were washed in Dulbecco’s phosphate-buffered 
saline (Thermo Fisher Scientific) containing 0.5% bovine serum albumin and 
0.05% Tween, rehydrated in additive-free Dulbecco’s phosphate-buffered saline, 
washed again, and blocked with Superblock Solution (Thermo Fisher Scientific). 
Tissue sections were then stained with a cocktail of metal-conjugated antibodies 
overnight at 4 °C, washed, and incubated with 125 nM Cell-ID Intercalator-Ir for 
30 min at rT. After a further wash, tissue sections were dipped in Milli-Q water 
(Merck Millipore) for 1 min and dried for 20 min at rT. Data were acquired using 
a HyperionTM imaging-mass cytometer (Fluidigm) at a resolution of 1 µm, with 
settings aligned to company guidelines. The ablation frequency was 200 Hz, and 
the energy was 6 dB. Regions of interest were acquired at a size of 1 by 1 mm2. 
All data were stored as MCD files and txt files.
Single-cell RNA-sequencing
Single, live, CD8a–TCRγδ–CD4+ cells from the intestines of fetus #6 were sorted 
using a FACSAria III flow cytometer (BD Biosciences). Post-sort purity was 
96.5%. Single-cell RNA-sequencing was performed as described previously42. 
Briefly, cells combined with oil, reagents, and beads were loaded on a Chromium 
Single Cell Controller (10x Genomics). Lysis and barcoded reverse transcription 
of polyadenylated mRNA from single cells were performed inside each gel bead 
emulsion. Next-generation sequencing libraries were prepared in a single bulk 
reaction, and transcripts were sequenced using a HiSeq4000 System (Illumina).
Integrated data analysis 
For cell suspension-mass cytometry, data from single, live, CD45+ cells, gated 
individually using Cytobank as shown in Supplementary Fig. 1a, were sample-
tagged and hyperbolic-arcsinh-transformed with a cofactor of 5 using Cytosplore+HSNE 
software13. The major immune lineages shown in Supplementary Fig. 1b were 
then identified at the overview level by performing a 3-level HSNE analysis 
carried out with default parameters (perplexity: 30; iterations: 1,000). All t-SNE 
plots and Gaussian Mean-Shift clustering-derived cell clusters were generated in 
Cytosplore15. Hierarchical clustering of the phenotype heatmap was created with 
Euclidean correction and average linkage clustering in Cytosplore+HSNE. Violin plots 
for cytometry data were generated in R. Diffusion map plots for mass cytometry 
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data were generated using the “density” package in R. Single-cell force-directed 
layouts for mass cytometry data were generated using “VorteX” software19. For 
imaging-mass cytometry, all images were generated using MCD Viewer software 
v1.0.560 (Fluidigm). For single-cell RNA-seq, single-cell transcriptome sequencing 
data were processed using the single-cell RNA-seq package “Seurat” in R16. 
The Seurat object was generated by following the criteria that each gene was 
expressed by at least 3 cells and that at least 200 genes were expressed per cell. 
Data were further filtered based on the parameters: (i) unique gene count per 
cell >200 and <2,000; and (ii) mitochondrial percentage of all genes <0.05. After 
log-normalization, a PCA-reduction analysis (pcs.compute = 20) was performed 
based on the 2,174 variable genes across single cells. Next, graph-based clustering 
detection and a t-SNE algorithm were applied to the top 13 PCA-dimensions. 
The resolution for cluster detection was 0.8. Heatmaps, PCA plots, diffusion map 
plots, and violin plots of the RNA-seq data were generated using the “Seurat” 
package. The t-SNE plots for RNA-seq data shown in Fig. 4b were generated 
in Cytosplore+HSNE. Only genes with local standardization (>0.5) across all cells 
were taken into account. Bar graphs and dot plots (showing mean and SD) were 
generated in Prism (GraphPad). The pseudotime analysis shown in Fig. 4c,d was 
performed using the Monocle 2 toolkit in R as described previously22, excluding 
unrelated Treg cells. Briefly, the single-cell trajectory was inferred using the 
dpFeature unsupervised procedure to identify variable genes, and the dimensions 
were reduced using t-SNE on the top high-loading principal components. The 
top 1,000 significant genes were selected as the ordering genes and reduced 
with the DDRTree method for the single-cell graph shown in Fig. 4c. Variable 
genes were selected at a significant false discovery rate of <10%, clustered by 
pseudo-temporal expression patterns, and visualized in a heatmap in Fig. 4d. 
Gene list enrichment analysis was performed using ToppGene43, gene interaction 
network analysis was performed using the BioGrid interaction database44, and 
gene pathway analysis was performed using the Kyoto Encyclopedia of Genes and 
Genomes45.
Flow cytometry
For surface staining, cells were incubated with fluorochrome-conjugated antibodies 
and human Fc block (BioLegend) for 30–45 min at 4 °C. For intracellular cytokine/
CD154 staining, cells were stimulated with CD3/CD28-specific (2.5 µg/mL 
each, BioLegend) or control antibodies (5 µg/mL, BioLegend) for 4 h at 37 °C. 
Brefeldin A (10 µg/mL, Sigma) was added for the final 3 h. Cells were then fixed/
permeabilized using Fixation Buffer and Intracellular Staining Perm Wash Buffer 
(BioLegend). For intracellular Foxp3/Ki-67 staining, cells were prepared using a 
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Foxp3 Staining Buffer Set (eBioscience). Electronic compensation was performed 
using individually stained CompBeads (BD Biosciences). Cells were acquired using 
an LSR II cytometer (BD Biosciences) or sorted using a FACSAria III flow cytometer 
(BD Biosciences) as shown in Supplementary Fig. 3a. Data were analyzed with 
FlowJo software v10 (Tree Star Inc.). The antibodies used in this study are listed 
in Supplementary Table 4.
TCR repertoire analysis
CD4+ T cell subsets were sorted according to the gating strategy shown in 
Supplementary Fig. 3a. For conventional sequencing, a total of 5,000 cells per 
subset was sorted directly into RNAlater (Applied Biosystems) using a FACSAria 
III flow cytometer (BD Biosciences). All expressed TCRβ rearrangements were 
amplified using a template-switch anchored RT-PCR, sequenced, and analyzed as 
described previously46. Gene use was determined according to the ImMunoGeneTics 
(IMGT) nomenclature47. 
For high-throughput sequencing, an average of 6,700 ± 2,000 cells per subset 
was sorted directly into RLT buffer (Qiagen) using a FACSAria III flow cytometer 
(BD Biosciences). Four volumes of TRIzol (Invitrogen) were then added to the 
RLT cell lysate. RNA was extracted according to the TRIzol Reagent User Guide. 
Unique molecular identifier (UMI)-labelled 5’RACE TCRα and TCRβ cDNA libraries 
were prepared using a Human TCR Profiling Kit (MiLaboratory LLC). All extracted 
RNA was used for cDNA synthesis, and all synthesized cDNA was used for PCR 
amplification. Libraries were prepared in parallel using the same number of PCR 
cycles and sequenced in parallel using a 150 + 150 bp MiSeq System (Illumina). 
This approach generated a total of 11,310,000 TCRα and TCRβ sequencing reads 
(250,000 ± 150,000 reads per library), from which 625,000 unique unique 
UMI-labelled TCR cDNA molecules (13,500 ± 7,000 molecules per library) were 
extracted using MIGEC48 and MiXCR49 software with a threshold of at least 2 
sequencing reads per UMI. Each library contained an average of 3,500 ± 1,300 
functional (in-frame, without stop-codons) CDR3 nucleotide sequences. Averaged 
TCR repertoire characteristics weighted by clonotype size were analyzed using 
VDJtools software27. Gene use was determined according to the ImMunoGeneTics 
(IMGT) nomenclature47.
Statistics
Results are shown as mean ± SEM. The statistics test used were two-tailed 
Wilcoxon matched-pairs signed-ranks test and Kruskal-Wallis test with Dunn’s test 
for multiple group comparisons, as appropriate (after normality test). P ≤ 0.05 
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was considered to be statistically significant. All statistics were analysed using 
GraphPad Prism 7 software.
Reporting Summary
Further information on research design is available in the Nature Research Life 
Sciences Reporting Summary linked to this article.
Data availability
Mass cytometry data are available via Flow Repository (https://flowrepository.org/
id/FR-FCM-ZYRD). scRNA-seq data are available via Gene Expression Omnibus 
accession code GSE122846. The remaining data that support the findings of this 
study are available from the corresponding author upon reasonable request.
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Supplemental information 
Supplementary Fig. 1. Mass cytometric analysis of fetal intestinal immune cells. (a) Biaxial plots 
from one fetal intestine showing the gating strategy for single, live, CD45+ cells analyzed by mass 
cytometry (n = 7). (b) First-level HSNE embedding of CD45+ immune cells (n = 224,286) derived from 
fetal intestines (n = 7). Each dot represents a landmark. The size of each landmark is proportional to the 
number of cells that the landmark represents. Colors indicate ArcSinh5-transformed expression values. 
(c) t-SNE embedding showing all CD4+ T cells (n = 110,332) derived from fetal intestines (n = 7). Colors 
indicate the ArcSinh5-transformed expression values. 
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Supplementary Fig. 2. Mass cytometric analysis of the fetal CD4+ T cell compartment across 
tissues. (a) t-SNE embedding of all CD4+ T cells (n = 9.7 x 104) derived from fetal intestines (n = 6.6 x 
104 cells from 7 samples), fetal livers (n = 1,530 cells from 3 samples), and fetal spleens (n = 3.0 x 104 
cells from 3 samples). Colors indicate tissue origin. Downsampling was performed for samples with more 
than 10,000 CD4+ T cells. (b) Bar graphs showing the quantification of Treg cells and TN cells, TCM cells, 
and TEM cells among fetal CD4
+ T cells across tissues. TN cells: CD45RA
+CCR7+; TCM cells: CD45RA
-
CCR7+; TEM cells: CD45RA
-CCR7-. Fetal liver and spleen, n = 3 independent samples; fetal intestine, n = 
7 independent samples. Error bars indicate mean ± SEM. **p <0.01, Kruskal-Wallis test with Dunn’s test 
for multiple comparisons.
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Supplementary Fig. 3. Identification of CD4+ T cell clusters in fetal intestines. (a) Representative 
biaxial plots showing the gating strategy for TN, CD161
- TM, CD161
+CD117- TM, CD161
+CD117+ TM and Treg 
cell clusters derived from one fetal intestine analyzed by flow cytometry for expression of CD3, CD4, CD8a, 
CD25, CD45RA, CD45RO, CD117, CD127, CD161 and TCRγδ (n = 10). (b) Expression (log-normalized) 
of KIT as determined by single-cell RNA-seq analysis, presented as violin plots. Colors indicate different 
cell clusters. (c) Bar plot depicting cell frequencies for clusters identified by mass cytometry and RNA-seq.
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Supplementary Fig. 4. Single-cell trajectories of fetal intestinal CD4+ T cells. (a-b) t-SNE embeddings 
of all fetal intestinal CD4+ T cells analyzed in (a) the mass cytometry dataset (n = 10,436 cells, 35 proteins) 
and (b) the RNA-seq dataset (n = 1,743 cells, 300 variable genes) at the middle of the t-SNE computation. 
Colors indicate marker expression. (c) Diffusion map and (d) VorteX analysis of all fetal intestinal CD4+ 
T cells analyzed in mass cytometry dataset (n = 10,436 cells, 35 proteins). Colors indicate different cell 
clusters. (e) Diffusion map and (f) PCA analysis of all fetal intestinal CD4+ T cells analyzed in the RNA-seq 
dataset (n = 1,743 cells, 2,174 variable genes). Colors indicate different cell clusters.
Supplementary Fig. 5. Immune-related genes in the pseudotime-dependent gene module. (a) Table 
listing 106 immune-related genes kinetically enriched in the pseudotime-dependent third gene module 
(Fig. 4d). (b) Interaction network of the pseudotime-dependent third gene module using Esyn. Orange 
lines indicate literature-described physical interactions of the gene-encoded proteins. Orange nodes 
indicate genes enriched in immunological processes.
CCR7CD127CD161 CD25 CD27 CD45RA CD45RO
Late stage
Single-cell 
RNA-seq
Single-cell 
CyTOF
a 
b
CCR7IL7RKLRB1 IL2RA CD27
Marker  expression
0 5
       t-SNE
Single-cell 
CyTOF
Single-cell 
RNA-seq
−10 −5 0 5 10
PC1
PC
2
−10 −5 0 5 10
PC1
PC
3
DC1
D
C
2
-0.01
-0.01
-0.03
0.00 0.01
0.01
DC1
D
C
3
-0.01
-0.01
-0.02
0.00 0.01
0.01
0.00
DC1
D
C
2
0.02
0.00
0.04
DC1
D
C
3
-0.00
-0.01
-0.02
0.02
0.01
-20
-30
0
-10
-5
-10
5
0
c d
e f
−0.05 -0.025 0.000 0.025 −0.05 -0.025 0.000 0.025
Diffusion map
Diffusion map
VorteX
PCA
KLRB1+CCR6-SELL- TM cells
KLRB1lo/- SELL- TM cells
CCR7+ TN cells
KLRB1+CCR6+SELL- TM cells
Undefined TM cells 
FOXP3+ Treg cells
CD45RA+ TN cells
CD161+CCR6-CD45RO+ TM cells
CD161lo/- CD45RO+ TM cells
CD161+CCR6+CD45RO+ TM cells
CD25+CD127lo Treg cells
DN TM cells 
Memory CD4+ T cells are generated in the human fetal intestine
87
3
a
Genes enriched in: regulation 
of immune system processes
& Leukocyte/cell/lymphocyte activation 
b
TCR 
signaling
Nr Gene 
Symbol
Gene Name Original Symbol Nr Gene Symbol Gene Name Original Symbol
1 5243 ABCB1 ATP binding cassette subfamily B member 1 54 4478 MSN moesin
2 101 ADAM8 ADAM metallopeptidase domain 8 55 4542 MYO1F myosin IF
3 132 ADK adenosine kinase 56 64005 MYO1G myosin IG
4 8943 AP3D1 adaptor related protein complex 3 delta 1 subunit 57 51237 MZB1 marginal zone B and B1 cell specif ic protein
5 51676 ASB2 ankyrin repeat and SOCS box containing 2 58 4681 NBL1 neuroblastoma 1, DAN family BMP antagonist
6 641 BLM Bloom syndrome RecQ like helicase 59 10787 NCKAP1 NCK associated protein 1
7 684 BST2 bone marrow  stromal cell antigen 2 60 114548 NLRP3 NLR family pyrin domain containing 3
8 760 CA2 carbonic anhydrase 2 61 114770 PGLYRP2 peptidoglycan recognition protein 2
9 784 CACNB3 calcium voltage-gated channel auxiliary subunit beta 3 62 118788 PIK3AP1 phosphoinositide-3-kinase adaptor protein 1
10 6364 CCL20 C-C motif chemokine ligand 20 63 84106 PRAM1 PML-RARA regulated adaptor molecule 1
11 6352 CCL5 C-C motif chemokine ligand 5 64 5573 PRKAR1A protein kinase cAMP-dependent type I regulatory subunit alpha
12 1235 CCR6 C-C motif chemokine receptor 6 65 5719 PSMD13 proteasome 26S subunit, non-ATPase 13
13 10803 CCR9 C-C motif chemokine receptor 9 66 26191 PTPN22 protein tyrosine phosphatase, non-receptor type 22
14 977 CD151 CD151 molecule (Raph blood group) 67 5814 PURB purine rich element binding protein B
15 952 CD38 CD38 molecule 68 5873 RAB27A RAB27A, member RAS oncogene family
16 966 CD59 CD59 molecule (CD59 blood group) 69 388 RHOB ras homolog family member B
17 10225 CD96 CD96 molecule 70 6095 RORA RAR related orphan receptor A
18 1021 CDK6 cyclin dependent kinase 6 71 6097 RORC RAR related orphan receptor C
19 1029 CDKN2A cyclin dependent kinase inhibitor 2A 72 860 RUNX2 runt related transcription factor 2
20 160364 CLEC12A C-type lectin domain family 12 member A 73 8935 SKAP2 src kinase associated phosphoprotein 2
21 64581 CLEC7A C-type lectin domain containing 7A 74 84174 SLA2 Src like adaptor 2
22 1192 CLIC1 chloride intracellular channel 1 75 6504 SLAMF1 signaling lymphocytic activation molecule family member 1
23 10695 CNPY3 canopy FGF signaling regulator 3 76 23657 SLC7A11 solute carrier family 7 member 11
24 10675 CSPG5 chondroitin sulfate proteoglycan 5 77 6654 SOS1 SOS Ras/Rac guanine nucleotide exchange factor 1
25 9646 CTR9 CTR9 homolog, Paf1/RNA polymerase II complex component 78 2040 STOM stomatin
26 2833 CXCR3 C-X-C motif chemokine receptor 3 79 8464 SUPT3H SPT3 homolog, SAGA and STAGA complex component
27 23604 DAPK2 death associated protein kinase 2 80 29110 TBK1 TANK binding kinase 1
28 1803 DPP4 dipeptidyl peptidase 4 81 55254 TMEM39A transmembrane protein 39A
29 2242 FES FES proto-oncogene, tyrosine kinase 82 7124 TNF tumor necrosis factor
30 10211 FLOT1 flotillin 1 83 8784 TNFRSF18 TNF receptor superfamily member 18
31 2534 FYN FYN proto-oncogene, Src family tyrosine kinase 84 8600 TNFSF11 TNF superfamily member 11
32 10912 GADD45G grow th arrest and DNA damage inducible gamma 85 10673 TNFSF13B TNF superfamily member 13b
33 10634 GAS2L1 grow th arrest specif ic 2 like 1 86 8740 TNFSF14 TNF superfamily member 14
34 2769 GNA15 G protein subunit alpha 15 87 50852 TRAT1 T cell receptor associated transmembrane adaptor 1
35 8111 GPR68 G protein-coupled receptor 68 88 28526 TRDC T cell receptor delta constant
36 3303 HSPA1A heat shock protein family A (Hsp70) member 1A 89 53347 UBASH3A ubiquitin associated and SH3 domain containing A
37 3304 HSPA1B heat shock protein family A (Hsp70) member 1B 90 6375 XCL1 X-C motif chemokine ligand 1
38 3398 ID2 inhibitor of DNA binding 2 91 7704 ZBTB16 zinc f inger and BTB domain containing 16
39 3459 IFNGR1 interferon gamma receptor 1 92 80149 ZC3H12A zinc f inger CCCH-type containing 12A
40 3601 IL15RA interleukin 15 receptor subunit alpha 93 3604 TNFRSF9 TNF receptor superfamily member 9
41 8809 IL18R1 interleukin 18 receptor 1 94 5167 ENPP1 ectonucleotide pyrophosphatase/phosphodiesterase 1
42 182 JAG1 jagged 1 95 1075 CTSC cathepsin C
43 120425 JAML junction adhesion molecule like 96 8807 IL18RAP interleukin 18 receptor accessory protein
44 3725 JUN Jun proto-oncogene, AP-1 transcription factor subunit 97 4217 MAP3K5 mitogen-activated protein kinase kinase kinase 5
45 3815 KIT KIT proto-oncogene receptor tyrosine kinase 98 115361 GBP4 guanylate binding protein 4
46 3820 KLRB1 killer cell lectin like receptor B1 99 6846 XCL2 X-C motif chemokine ligand 2
47 3937 LCP2 lymphocyte cytosolic protein 2 100 9934 P2RY14 purinergic receptor P2Y14
48 3956 LGALS1 galectin 1 101 27350 APOBEC3C apolipoprotein B mRNA editing enzyme catalytic subunit 3C
49 3958 LGALS3 galectin 3 102 6967 TRGC2 T cell receptor gamma constant 2
50 3976 LIF LIF, interleukin 6 family cytokine 103 4938 OAS1 2'-5'-oligoadenylate synthetase 1
51 3984 LIMK1 LIM domain kinase 1 104 8530 CST7 cystatin F
52 7940 LST1 leukocyte specif ic transcript 1 105 356 FASLG Fas ligand
53 1326 MAP3K8 mitogen-activated protein kinase kinase kinase 8 106 976 ADGRE5 adhesion G protein-coupled receptor E5
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Supplementary Fig. 6. TCR sequencing of distinct CD4+ T cell populations. (a) Dot plot showing the 
percentage of reads per unique TCRβ sequence in each cluster. Number of unique TCRβ sequences per 
cluster: TN cells, 59; CD161
- TM cells, 54; CD161
+CD117- TM cells, 37; CD161
+CD117+ TM cells, 51; 
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Supplementary Fig. 7. Cytokine production by fetal 
intestinal CD4+ T cells. (a-c) Purified fetal intestinal CD4+ T 
cells were treated with a control antibody or stimulated with 
anti-CD3 and anti-CD28 for 4 h. Intracellular expression of 
TNF, IFN-γ, IL-2, IL-4 and Ki-67 was determined for each 
subpopulation by flow cytometry. (a) Dot plot showing the 
median fluorescence intensity (MFI) of TNF for each cell 
cluster relative to corresponding CD117+ TM subpopulation in 
each fetal intestine (n = 4) after stimulation with anti-CD3 and 
anti-CD28. Data represent two independent experiments. (b) 
Representative biaxial plots showing coexpression of cytokines 
vs. Ki-67 for the indicated cell clusters after stimulation with 
anti-CD3 and anti-CD28. (c) Pie charts depicting coexpression 
profiles of IFN-γ and IL-2 for the indicated cell clusters from fetal 
intestines (n = 2) after stimulation with anti-CD3 and anti-CD28.
Data represent two independent experiments.
Naive Treg cells, 29; Memory Treg cells, 50. (b) Hierarchical clustering of CD4
+ T subpopulations based on 
individual V-J rearrangements in theTCRα (TRA) and TCRβ (TRB) datasets. Colors indicate different fetal 
intestines. (c) Dot plot showing weighted clonal overlaps for TCRβ amino acid sequences among clusters 
from two different fetal intestines analyzed using the F2 similarity metric in VDJtools. (d) Chord diagram 
showing clonal overlaps among different cell clusters. Numbers in the yellow circle indicate the total 
numbers and frequencies (parentheses) of private TCRβ clonotypes among TN cells. Numbers outside the 
plot border indicate the total numbers and frequencies (parentheses) of unique TCRβ clonotypes shared 
among TN cells and other CD4
+ T cell subpopulations. (a) Conventional sequencing, (b-d) high-throughput 
sequencing.
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Supplementary Table 1 CyTOF antibody panel
Table S1  CyTOF antibody panel 
Antigen Tag Clone Supplier Cat. Final  dilution
1 CD127 165Ho AO19D5 Flui 3165008B 1/800
2 CCR6 141Pr G034E3 Flui 3141003A 1/200
3 CD8a 146Nd RPA-T8 Flui 3146001B 1/200
4 CD11c 162Dy Bu15 Flui 3162005B 1/200
5 CD38 172Yb HIT2 Flui 3172007B 1/200
6 CD45 89Y HI30 Flui 3089003B 1/100
7 CD117 143Nd 104D2 Flui 3143001B 1/100
8 CD4 145Nd RPA-T4 Flui 3145001B 1/100
9 CD16 148Nd 3G8 Flui 3148004B 1/100
10 CD25 149Sm 2A3 Flui 3149010B 1/100
11 CD123 151Eu 6H6 Flui 3151001B 1/100
12 CD7 153Eu CD7-6B7 Flui 3153014B 1/100
13 CD163 154Sm GHI/61 Flui 3154007B 1/100
14 CCR7 159Tb G043H7 Flui 3159003A 1/100
15 CD14 160Gd M5E2 Flui 3160001B 1/100
16 CD161 164Dy HP-3G10 Flui 3164009B 1/100
17 CD27 167Er O323 Flui 3167002B 1/100
18 CD45RA 169Tm HI100 Flui 3169008B 1/100
19 CD3 170Er UCHT1 Flui 3170001B 1/100
20 PD-1 175Lu EH 12.2H7 Flui 3175008B 1/100
21 CD56 176Yb NCAM16.2 Flui 3176008B 1/100
22 CD11b 144Nd ICRF44 Flui 3144001B 1/100
23 TCRγδ 152Sm 11F2 Flui 3152008B 1/50
24 HLA-DR 168Er L243 BioL 307651 1/200
25 CD20 163Dy 2H7 BioL 302343 1/200
26 CD34 142Nd HIB19 BioL 343531 1/100
27 IgM 150Nd MHM88 BioL 314527 1/100
28 CD103 155Gd Ber-ACT8 BioL 350202 1/100
29 CRTH2 156Gd BM16 BioL 350102 1/100
30 CD28 171Yb CD28.2 BioL 302902 1/100
31 CD45RO 173Yb UCHL1 BioL 304239 1/100
32 CD122 158Gd TU27 BioL 339002 1/50
33 KLRG-1 161Dy REA261 MACS 120-014-229 1/50
34 CD8b 166Er SIDI8BEE ebio 14-5273 1/50
35 NKp46 174Yb 9E2 BioL 331902 1/40
Fluidigm (Flui), eBioscience (eBio) and Biolegend (BioL).
Memory CD4+ T cells are generated in the human fetal intestine
91
3
sam
ple_id
fetus
subset
chain
replicate
cells sorted
Total_reads
cD
N
A
_m
olecules_U
M
I
R
eads_per_U
M
I_threshold
cD
N
A
_m
olecules_U
M
I_after_filtering
C
lonotypes
Intestine 1_C
D
117T_TR
A
_1
Intestine 1
C
D
161+C
D
117+ Tm
TR
A
1
7140
175103
45659
2
11859
3724
Intestine 2_C
D
117T_TR
A
_1
Intestine 2
C
D
161+C
D
117+ Tm
TR
A
1
7507
556612
98407
2
18135
3970
Intestine 2_C
D
117T_TR
A
_2
Intestine 2
C
D
161+C
D
117+ Tm
TR
A
2
3124
281838
50527
2
7599
2026
Intestine 1_m
em
oryC
D
161neg_TR
A
_2
Intestine 1
C
D
161- Tm
TR
A
2
7888
333917
66317
2
14426
4915
Intestine 1_m
em
oryC
D
161neg_TR
A
_1
Intestine 1
C
D
161- Tm
TR
A
1
7731
254378
54054
2
13125
4713
Intestine 2_m
em
oryC
D
161neg_TR
A
_2
Intestine 2
C
D
161- Tm
TR
A
2
7714
554393
115584
2
16868
4541
Intestine 2_m
em
oryC
D
161neg_TR
A
_1
Intestine 2
C
D
161- Tm
TR
A
1
7617
197813
44832
2
6826
3073
Intestine 1_m
em
oryC
D
161pos_TR
A
_2
Intestine 1
C
D
161+C
D
117- Tm
TR
A
2
7600
528867
103916
2
13493
4093
Intestine 1_m
em
oryC
D
161pos_TR
A
_1
Intestine 1
C
D
161+C
D
117- Tm
TR
A
1
7556
219828
49602
2
10631
3671
Intestine 2_m
em
oryC
D
161pos_TR
A
_2
Intestine 2
C
D
161+C
D
117- Tm
TR
A
2
7481
741432
175332
2
21492
3714
Intestine 2_m
em
oryC
D
161pos_TR
A
_1
Intestine 2
C
D
161+C
D
117- Tm
TR
A
1
7581
360210
91069
2
17586
3600
Intestine 1_m
em
oryTreg_TR
A
_2
Intestine 1
M
em
ory Tregs
TR
A
2
2343
111156
23571
2
3957
1442
Intestine 1_m
em
oryTreg_TR
A
_1
Intestine 1
M
em
ory Tregs
TR
A
1
7536
119133
40023
2
8774
2757
Intestine 2_m
em
oryTreg_TR
A
_1
Intestine 2
M
em
ory Tregs
TR
A
1
7217
353446
93680
2
15382
2599
Intestine 1_N
aiveC
D
161neg_TR
A
_1
Intestine 1
Tn
TR
A
1
7697
246744
57601
2
9071
4182
Intestine 1_N
aiveC
D
161neg_TR
A
_2
Intestine 1
Tn
TR
A
2
7654
153032
42957
2
9550
4278
Intestine 2_N
aiveC
D
161neg_TR
A
_2
Intestine 2
Tn
TR
A
2
7672
298840
69436
2
11419
4289
Intestine 2_N
aiveC
D
161neg_TR
A
_1
Intestine 2
Tn
TR
A
1
7542
418501
82985
2
8439
3216
Intestine 1_nTreg_TR
A
_1
Intestine 1
N
aïve Tregs
TR
A
1
7140
66778
22677
2
5103
2916
Intestine 2_nTreg_TR
A
_1
Intestine 2
N
aïve Tregs
TR
A
1
716
31684
8182
2
1267
531
Intestine 1_C
D
117T_TR
B
_1
Intestine 1
C
D
161+C
D
117+ Tm
TR
B
1
7140
219407
53164
2
18482
4555
Intestine 2_C
D
117T_TR
B
_1
Intestine 2
C
D
161+C
D
117+ Tm
TR
B
1
7507
350183
83370
2
25446
4521
Intestine 2_C
D
117T_TR
B
_2
Intestine 2
C
D
161+C
D
117+ Tm
TR
B
2
3124
147361
37373
2
10450
2241
Intestine 1_m
em
oryC
D
161neg_TR
B
_2
Intestine 1
C
D
161- Tm
TR
B
2
7888
209909
60182
2
20581
5313
Intestine 1_m
em
oryC
D
161neg_TR
B
_1
Intestine 1
C
D
161- Tm
TR
B
1
7731
294147
74522
2
21375
5517
Intestine 2_m
em
oryC
D
161neg_TR
B
_2
Intestine 2
C
D
161- Tm
TR
B
2
7714
208020
66757
2
24319
5202
Intestine 2_m
em
oryC
D
161neg_TR
B
_1
Intestine 2
C
D
161- Tm
TR
B
1
7617
117422
37026
2
13320
4200
Intestine 1_m
em
oryC
D
161pos_TR
B
_2
Intestine 1
C
D
161+C
D
117- Tm
TR
B
2
7600
260491
64692
2
19719
4885
Intestine 1_m
em
oryC
D
161pos_TR
B
_1
Intestine 1
C
D
161+C
D
117- Tm
TR
B
1
7556
161120
46178
2
16619
4452
Intestine 2_m
em
oryC
D
161pos_TR
B
_2
Intestine 2
C
D
161+C
D
117- Tm
TR
B
2
7481
479970
129609
2
33397
4352
Intestine 2_m
em
oryC
D
161pos_TR
B
_1
Intestine 2
C
D
161+C
D
117- Tm
TR
B
1
7581
274782
79895
2
26100
4292
Intestine 1_m
em
oryTreg_TR
B
_2
Intestine 1
M
em
ory Tregs
TR
B
2
2343
69426
16249
2
5620
1444
Intestine 1_m
em
oryTreg_TR
B
_1
Intestine 1
M
em
ory Tregs
TR
B
1
7536
141814
38439
2
13827
3133
Intestine 2_m
em
oryTreg_TR
B
_1
Intestine 2
M
em
ory Tregs
TR
B
1
7217
237380
72338
2
22032
2870
Intestine 1_N
aiveC
D
161neg_TR
B
_1
Intestine 1
Tn
TR
B
1
7697
391216
77080
2
16174
5306
Intestine 1_N
aiveC
D
161neg_TR
B
_2
Intestine 1
Tn
TR
B
2
7654
128811
42777
2
15246
5040
Intestine 2_N
aiveC
D
161neg_TR
B
_2
Intestine 2
Tn
TR
B
2
7672
139563
53435
2
15449
4928
Intestine 2_N
aiveC
D
161neg_TR
B
_1
Intestine 2
Tn
TR
B
1
7542
226971
59369
2
15403
4017
Intestine 1_nTreg_TR
B
_1
Intestine 1
N
aïve Tregs
TR
B
1
7140
70846
30168
2
9278
3812
Intestine 2_nTreg_TR
B
_1
Intestine 2
N
aïve Tregs
TR
B
1
716
19528
7090
2
2010
585
B
asic_S
tatistics
M
etadata
Table S2
Inform
ation ofT
C
R
 repertoire analysisw
ith N
G
S
Supplementary Table 2 Information of TCR repertoire analysis with NGS
Chapter 3
92
Table S3 Imaging-mass cytometry antibody panel 
Antigen Tag Clone Supplier Cat. Final  dilution Panel
1 CD45 89Y HI30 Flui 3089003B 1/50 1 and 2
2 CD3 170Er UCHT1 Flui 3170001B 1/100 1 and 2
3 CD7 153Eu CD7-6B7 Flui 3153014B 1/100 1 and 2
4 CD4 145Nd RPA-T4 Flui 3145001B 1/50 1 and 2
5 CD38 172Yb HIT2 Flui 3172007B 1/50 1 and 2
6 CD8a 146Nd RPA-T8 Flui 3146001B 1/50 1 and 2
7 CD45RA 169Tm HI100 Flui 3169008B 1/100 1 and 2
8 Ki-67 166Er D3B5 CST CST9129BF 1/200 1
9 CD161 164Dy HP-3G10 Flui 3164009B 1/50 1 and 2
10 CD69 144Nd FN50 Flui 3149010B 1/50 1
11 CD163 154Sm GHI/61 Flui 3154007B 1/100 1 and 2
12 HLA-DR 168Er L243 BioL 307651 1/300 2
13 Collagen I 147Sm polyclonal Millipore AB758 1/100 1
14 Vimentin 175Lu D21H3 CST CST5741BF 1/200 1
15 SMA 148Nd 1A4 CST CST5685BF 1/200 1
16 E-Cadherin 150Nd 2.40E+11 CST CST3195BF 1/50 1
Fluidigm (Flui), Cell Signaling Technology (CST) and Biolegend (BioL)
Table S4 Flow cytometry antibody panel 
Antigen clone Flourchrome Supplier
1 CD3 SK7 Amcyan BD
2 CD4 RPA-T4 BV421 BioL
3 CD5 L17F12 PE BD
4 CD8a RPA-T8 BV650 BD
5 TCRγδ 11F2 BV650 BD
6 CD25 M-A251 PE-cy7 BD
7 CD31 WM59 PE BD
8 CD45RO UCHL1 PerCP/Cy5.5 BioL
9 CD45RA HI100 PE/Dazzle BioL
10 CD62L SK11 PE BD
11 CD69 FN50 PE BD
12 CD127 A019D5 PE BioL
13 CD127 A019D5 FITC BioL
14 CD127 A019D5 PE-cy7 BioL
15 CD117 YB5.B8 APC BD
16 CD154 24-31 BV605 BioL
17 CD161 DX12 BV605 BD
18 CXCR3 1C6 PE BD
19 CCR4 1G1 PE BD
20 DNAM-1 DX11 PE BD
21 TNF MAb11 PE-cy7 ebio
22 IFN-γ 4S.B3 PE BioL
23 IFN-γ 4S.B3 BV421 BioL
24 IL-4 MP4-25D2 FITC BD
25 IL-17A BL168 BV421 BioL
26 IL-2 MQ1-17H12 BV650 BioL
27 Ki-67 20Raj1 FITC eBio
28 Ki-67 20Raj1 PE eBio
29 Granzyme B GB11 PE eBio
30 Foxp3 PCH101 PE eBio
eBioscience (eBio), and Biolegend (BioL).
Supplementary Table 3 Imaging-mass cytometry antibody panel.
Supplementary Table 4 Flow cytometry antibody panel.
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Abstract
The human fetal immune system must protect the infant against the sudden 
exposure to a large variety of pathogens upon birth. While it is known that the 
fetal immune system develops in sequential waves, relatively little is known 
about the composition of the innate and adaptive immune system in the tissues. 
Here, we applied high-dimensional mass cytometry to profile the immune 
system in human fetal liver, spleen and intestine. With Hierarchical Stochastic 
Neighbour Embedding (HSNE) we distinguished 177 distinct immune cell clusters, 
including both previously identified and novel cell clusters. PCA analysis indicated 
substantial differences between the composition of the immune system in the 
different organs. Through dual t-SNE we identified tissue-specific cell clusters, 
which were found both in the innate and adaptive compartment. To determine 
the spatial location of tissue-specific subsets we developed a 31-antibody panel 
to reveal both the immune compartment and surrounding stromal elements 
through analysis of snap-frozen tissue samples with imaging mass cytometry. 
Imaging mass cytometry reconstructed the tissue architecture and allowed both 
the characterization and determination of the location of the various immune cell 
clusters within the tissue context. Moreover, it further underpinned the distinctness 
of the immune system in the tissues. Thus, our results provide evidence for early 
compartmentalization of the adaptive and innate immune compartment in fetal 
spleen, liver and intestine. Together, our data provide a unique and comprehensive 
overview of the composition and organization of the human fetal immune system 
in several tissues.
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Introduction
The notion of phenotypical and functional differences between the fetal and adult 
immune system has been widely accepted. The human fetal immune system has 
to maintain tolerance towards the semi-allogeneic environment in utero while 
being prepared for the massive exposure to massive foreign antigens directly after 
birth 1, 2. The ontogeny of the immune system occurs in sequential waves during 
gestation. Fetal hematopoiesis is initiated in the yolk sac around day 16 of the 
development, then transits to the fetal liver at 6 weeks until 22 weeks gestational 
age, where the progenitors give rise to both lymphoid and myeloid cells 3. T cells 
have been identified as early as 10 weeks of gestation while Foxp3+CD4+ regulatory 
T (Treg) cells, whose generation is mainly driven by maternal alloantigens, have 
also been observed in different fetal tissues 4. Furthermore, it has been shown 
that human fetal dendritic cells in spleen, skin, thymus and lung promote prenatal 
T-cell immune suppression 5. Interestingly, several studies have provided evidence 
for the existence of memory-like T (Tm) cells in fetal spleen 6, skin 7, intestine 
8, 9 and cord blood 10, which produce pro-inflammatory cytokines such as IFN-γ 
and TNF-α, suggesting functional maturation of T cells in utero. In line with the 
discovery of pro-inflammatory T cells, mucosa-associated invariant T cells as well 
as natural killer (NK) cells and innate lymphoid cells have also been found to be 
present in the fetal intestine 11, 12. A potential link between the composition of the 
prenatal immune system and disease later in life has been proposed 9, 13. Thus, 
the fetal immune system has both pro-inflammatory and immune suppressive 
capacity.
Most investigations of the human fetal immune system are based on umbilical cord 
blood collected at birth. However, the representation of cord blood has recently 
been questioned as cord blood samples were heterogeneous without clearly 
shared patterns in cell and plasma protein composition 14. Although in recent 
years several reports 5, 8 have studied the fetal immune system in tissues, due to 
the scarcity of human fetal tissues and technique limitations, a system-wide and 
detailed characterization of the human fetal immune system is currently lacking. 
Mass cytometry (cytometry by time-of-flight; CyTOF) now offers the opportunity 
to analyze the heterogeneity of the human immune system in an unbiased and 
data-driven fashion by the simultaneous measurement of over 40 unique cellular 
markers at the single-cell level with unprecedented resolution 15. As traditional 
analysis approaches for flow cytometry are not compatible with high-dimensional 
mass cytometry datasets, dimensionality reduction-based approaches such as 
t-stochastic neighbor embedding (t-SNE) 16 have been widely used as they allow 
users to analyze all the markers concurrently in an unbiased manner. Moreover, 
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hierarchical SNE (HSNE) has removed the scalability limitation of t-SNE, allowing 
the analysis of tens of millions of cells at single-cell resolution 17. 
Here, we applied suspension mass cytometry to study the complexity and 
heterogeneity of the immune system in the human fetal intestine, liver and 
spleen and confirmed the existence of previously identified subsets through the 
unsupervised HSNE analysis. In addition, we provide evidence for the existence 
of previously unrecognized distinct cell clusters. Besides the heterogeneity within 
each tissue, our data further reveals clear tissue-specific signatures in both the 
innate and adaptive immune compartment as early as week 16 of gestation. Finally, 
we employed imaging mass cytometry to reconstruct the tissue architecture and 
characterize and determine the location of the immune cell clusters within the 
tissue context, results that underpinned the compartmentalization of the immune 
system in the tissues. Together these data provide a comprehensive and valuable 
resource for understanding the fetal immune development and linking prenatal 
immunity with immunity after birth.
Results
Identification of major immune lineages across human fetal tissues
To explore the immune system in the human fetus, we employed a previously 
described CyTOF panel (Table S1) consisting of 35-metal isotope-tagged 
monoclonal antibodies 18 designed to identify the major immune lineages (B cells, 
CD4+ T, CD8+ T, γδ T cells, innate lymphoid cells (ILCs), and myeloid cells) and 
determine the heterogeneity within these lineages. For this purpose, the panel 
consisted of lineage markers, markers specific for cell differentiation, activation, 
trafficking and function. With this panel, single-cell suspensions from fetal 
Figure 1 HSNE analysis distinguishes major immune lineages across human fetal tissues. (A) 
HSNE embedding of 1.6 million immune cells derived from fetal intestines (N=7, 0.3 x 106 cells), fetal 
spleens (N=3, 1.1 x 106 cells), and fetal livers (N=3, 0.2 x 106 cells) at the overview level. Each dot 
represents an HSNE landmark and the size of the landmark is proportional to the number of cells that 
each landmark represents. Colors of the landmarks represent ArcSinh5-transformed expression values 
of the indicated markers. (B) A density map showing the local probability density of the embedded cells 
where black dots display the centroids of identified clusters using GMS clustering. (C) A HSNE plot 
showing main immune lineage cluster partitions in different colors. (D) HSNE embedding as shown in 
panel A. Colors represent different tissues. (E) The composition of major immune lineage clusters for 
CD45+ cells in the individual fetal tissues is represented in horizontal bars where the colored segment 
lengths represent the proportion of cells as a percentage of CD45+ cells in the sample. The dendrogram 
shows the hierarchical clustering of samples. Colors represent the different tissues as shown in panel D. 
Numbers indicate fetus ID. 
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intestines (N=7), fetal spleens (N=3) and fetal livers (N=3) (Table S2) were 
analyzed. Single, live CD45+ cells were distinguished by event length, DNA stains, 
and CD45 antibody stains (Figure S1). In the liver, but not in the spleen and 
intestine, three distinct subpopulations were observed based on different CD45 
and DNA stainings (Figure S1). Here, CD45hiDNAlow cells represent lymphoid 
cells, while CD45hiDNAhi and CD45lowDNAhi cells correspond to myeloid and CD34+ 
precursor cells, respectively (results not shown). All antibodies displayed a clear 
separation between antibody-negative and -positive cells as described previously 
18. 
To determine the major immune lineages, we pooled the data (1.6 x 106 CD45+ 
cells) derived from seven fetal intestines (39,357 cells per intestine), three 
fetal spleens (365,653 cells per spleen) and three fetal livers (69,928 cells per 
liver) and performed a 3-level HSNE analysis in Cytosplore+HSNE 17 from a global 
overview down to the single cell level. Here, HSNE landmarks depicted the global 
composition of the immune system (Figure 1). Based on the marker expression 
profiles (Figure 1A) and density features of the embedded cells (Figure 1B), we 
identified 6 phenotypically distinct major lineage clusters at the overview level, 
namely CD20+ B cells, CD3+CD4+ T cells, CD3+CD8+ T cells and CD3+TCRγδ+ T 
cells, CD3-CD20-CD11c-CD7+ ILCs, CD11c+ myeloid cells and a CD3-CD20-CD11c-
CD7+/- lineage-negative (Lin-) cell cluster (Figure 1C). In addition, the global 
differences in immune composition across tissues were revealed by visualizing the 
tissue-origin of the cells (Figure 1D). Next, we quantified the relative frequencies 
of major immune lineage clusters in each fetal tissue sample, showing that B cells 
were more abundant in the fetal spleen and fetal liver while Lin- cells were most 
profound in the fetal liver. CD4+ T, CD8+ T and γδ T cells together comprised more 
than 50% of immune cells in the fetal intestine but were typically lower in the fetal 
liver. There was no significant difference in the distribution of ILCs across fetal 
tissues. The frequencies of myeloid cells were low in all fetal tissues, however, 
these cells were relatively more abundant in fetal liver (Figure 1E). Importantly, 
unbiased hierarchical clustering of cell frequencies grouped the tissue samples in 
a tissue-specific manner (Figure 1E), indicating that despite differences between 
the samples the composition of the major immune lineage of each fetal tissue was 
relatively constant and tissue-specific.
Together, these global analyses revealed that the major immune lineages could be 
readily identified in each fetal tissue, and that the composition of these lineages 
differs between the examined human fetal tissues.
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Figure 2 Cellular signatures reveal the immune cell compartmentalization across human fetal 
tissues. (A) A collective t-SNE was performed on each major immune lineage individually and stratified 
for samples. The plots are showing in total 1.5 x 105 B cells, 2.3 x 105 CD4+ T cells, 6.9 x 104 CD8+ T 
cells, 3.6 x 104 γδ T cells, 2.6 x 105 ILCs, 6.4 x 104 myeloid cells and 8.7 x 104 Lin- cells. Colors represent 
different tissues. Numbers indicate fetus ID. (B) The similarity of a pair of t-SNE plots is shown by Jensen-
Shannon (JS) divergence within the major immune lineage. A higher JS divergence value indicates higher 
dissimilarity between pairwise t-SNE plots. 
Visualization of cellular signatures across human fetal tissues 
To compare immune cells between all samples and between the tissues, we 
next selected the major immune lineage clusters individually and embedded the 
clusters at the single-cell level to deduce the cellular signatures (Figure 2) 19. The 
results demonstrate that the intestine, spleen and liver displayed a distinct cellular 
signature for most of the seven major immune lineages. We observed especially 
highly distinct differences between the intestinal samples compared to the spleen 
and liver samples (Figure 2A). Also, the results underscore that samples from 
the same tissue type have a highly similar cellular signature (Figure 2A). We next 
applied the Jensen-Shannon (JS) divergence method to quantify the similarities 
and differences between pairs of t-SNE maps (Figure 2B). For all major immune 
lineages, the JS divergence was highest between the intestinal samples and 
the spleen and liver samples, while considerable differences in JS divergence 
were also found between the spleen and the liver samples, except for the ILC 
compartment. In general, the composition of the B cells, CD4+ T cells and ILCs 
was more similar within a tissue group while more variation was present among 
CD8+ T cells, γδ T cells, and myeloid cells (Figure 2B). Together, the visualization 
of cellular signatures provided further evidence for the distinct composition of 
immune system in the fetal tissues.
High-dimensional analysis reveals unprecedented immune heterogeneity 
in human fetal tissues 
To extend the analysis we next selected every main immune lineage individually 
and embedded them at the second level (B cells) or single-cell data level to 
identify the phenotypically distinct clusters, here illustrated for the CD8+ T cell 
compartment (Figure 3). First, the cluster including CD8+ T and γδ T cells 
(105,211 cells) were selected at the overview level and embedded in the second 
level of the HSNE analysis (Figure 3A, B), followed by selection of the CD8+ T 
cells (69,269 cells) to zoom-in further (Figure 3B), revealing more single-cell 
details (Figure 3C). Based on the density features of the t-SNE-embedded cells, 
we identified 20 distinct CD8+ T cell clusters (Figure 3C), each defined by a 
unique maker expression profile (Figure 3D). After hierarchical clustering of the 
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Figure 3 Identification of phenotypically distinct clusters in the CD8+ T cell compartment across 
human fetal tissues. (A) Global level of HSNE embedding of 1.6 million immune cells as shown in 
Figure 1C showing major immune lineage cluster partitions in different colors. (B) Second level of HSNE 
embedding of CD8+ T and γδ T cells (1.1 x 105 cells) derived from fetal intestines (N =7), fetal spleens 
(N=3) and fetal livers (N=3). Colors represent the ArcSinh5-transformed expression values of CD8a and 
TCR γδ. (C) A t-SNE embedding of collective CD8+ T cells (6.9 x 104 cells) derived from fetal intestines 
(N =7), fetal spleens (N=3) and fetal livers (N=3). Colors represent the ArcSinh5-transformed expression 
values of CD8a (left panel). A density map showing the local probability density of the embedded cells 
(middle panel). Colors represent cluster partitions (right panel). (D) Heatmap (blue-to-red scale) showing 
the median marker expression values of the clusters identified in panel C and hierarchical clustering 
thereof. (E) Heatmap (green-to-yellow scale) showing the corresponding cell frequencies of identified 
clusters of total CD8+ T cells in each sample. The dendrogram shows the hierarchical clustering of 
samples. Colors represent different fetal tissues. Tn = naive T cells, Tem = effector memory T cells and 
Temra = terminally differentiated T cells. 
heatmap, these clusters grouped into five main metaclusters (Figure 3D,E). 
CD45RA+CCR7+ naive T (Tn) cells were classified into two groups based on CD161 
expression while CD45RA-CCR7+ central memory T (Tcm) and CD45RA+CCR7- 
terminally differentiated T (Temra) cells were detected in the CD127dim/- 
compartment. In addition, a group of CD127+CD161highCCR6+KLRG-1+ Temra cells 
clustered separately from the other groups. We next quantified the cell frequencies 
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Figure 4 Immune system landscapes visualize cell cluster composition across human fetal tissues. 
(A and B) Heatmap showing the cell frequencies of 90 adaptive and 87 innate immune clusters identified 
in Figure S2 and S3 combined with hierarchical clustering of samples (Top) and phenotype of clusters 
(Left). Colors represent different fetal tissues as indicated. Tem = effector memory T cells, Tcm = central 
memory T cells, Temra = terminally differentiated T cells, and pDC = plasmacytoid dendritic cells.of each 
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of each cluster per sample and performed the hierarchical clustering of different 
samples based on the cell frequencies. In line with previous studies 20, several 
clusters including Tn cells (CD8_01-05, 15) and Tem cells (CD8_08, CD8_10) 
were present in all tissues (Figure 3E). CD127-CD161+/- Temra (CD8_07, CD8_11, 
CD8_13 and CD8_20) mainly existed in the spleen and liver whereas PD-1- Tem 
(CD8_09) were mainly abundant in the intestine. Hierarchical clustering revealed 
that all the intestinal samples clustered together whereas the spleen and liver 
samples clustered intermixed with each other.
By applying this approach to all 7 major immune lineage clusters, we identified 
177 phenotypically distinct clusters (8 B cell clusters, 24 CD4+ T cell clusters, 
20 CD8+ T cell cluster, 38 γδ T cell cluster (Figure S2A-C, Figure 4A), 39 ILC 
clusters, 26 myeloid cell clusters and 22 Lin- clusters (Figure S3A,B, Figure 4B). 
Consistent with previous reports 2, IgM+HLA-DR+ B cells were identified in all three 
tissues while the plasmacytoid dendritic cells (pDC)-like cells and monocytes were 
mainly identified in the intestine and non-intestine, respectively. In addition to Tn 
cells, we also identified several clusters of Tm cells, which were more prominent in 
the CD4+ T cell compartment in the fetal intestine, as reported 9. Strikingly, some 
of these Tm cells expressed a higher level of CD127, CD161, CCR6 and c-KIT, 
the latter a marker typically associated with progenitor cell types. Similarly, we 
identified a rare c-KIT+ (CD117+) CD8+ T cell population (CD8_16, < 1% of CD45+ 
cells) that is almost exclusively present in the intestine. As reported 21, helper-
ILCs were more dominant in the fetal intestine than the fetal spleen and liver, 
where the majority of ILCs were different types of NK cells such as CD27-CD11b+, 
CD27+CD11b+ NK clusters. Moreover, CD34+CD38+, CD34+CD38dim, CD34+CD38- 
precursor cell clusters and several previously unknown precursor-like cell clusters 
were mainly identified in the fetal liver (e.g., Lin-_02, Lin-_03, Lin-_15, Lin-_17) 
(Figure 4), an important organ for fetal hematopoiesis. Unbiased hierarchical 
clustering of cell frequencies for each sample revealed a clear distinction between 
the fetal intestine and the other two tissues in both the adaptive and innate 
immune compartment (Figure 4). The separation between fetal spleen and liver 
was readily observed in the innate immune compartment, due to the differential 
abundance of CD34+ cells and certain types of ILCs, such as ILC2 and CD7dim ILC3-
like cells (Figure 4B), but not in the adaptive immune compartment. 
Altogether, our data reveal that there is far greater heterogeneity of the immune 
system in human fetal tissues than previously appreciated and provide evidence 
for the existence of previously unknown immune cell types.
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An integrated system-wide analysis of the immune system reveals early 
immune compartmentation across fetal tissues
In order to investigate the entire immune profiles across fetal tissues, a principal 
component analysis (PCA) was performed on the samples based on the cluster 
frequency values of CD45+/dim cells. The samples were clearly separated from 
each other based on the tissue origin, especially the intestines and the other 
two organs by principal component 1 (explaining 39.1 % variance) (Figure 5A). 
In consistency with the cellular signatures (Figure 2), the variance of immune 
composition within spleens was higher than that within intestines and livers 
(Figure 5A). 
To reveal which cell clusters were most strongly associated with the tissue-
specificity, we performed a t-SNE analysis on 177 clusters based on the frequency 
values, visualizing networks of cell clusters, which determined the tissue-associated 
patterns (Figure 5B). Moreover, the dual-tSNE identified the top ten ranked 
clusters that contributed to the sample clustering patterns (Figure 5C). This 
analysis yielded three distinct networks of cell clusters corresponding to the three 
tissue types (Figure 5B). Several distinct hematopoietic progenitor clusters (Lin-
_16, ILC_38, Lin-_04, Lin-_18, Lin-_20 and Lin-_12) and four myeloid populations 
(Mye_13, Mye_14, Mye_15 and Mye_25) were specifically found in the fetal liver. For 
the fetal intestines, the main types of contributing cells were lymphoid precursors 
(Lin-_15 and Lin-_17) and CD4+ Tm clusters (CD4_01, CD4_08,CD4_09, CD4_06, 
CD4_04, CD4_05), including three previously unidentified c-KIT+ clusters, while 
for the spleen a diverse pool of CD8+ T cells, B cells and myeloid cells contributed 
to the tissue-specific signature (Figure 5C). Together, the integrated system-wide 
analysis of the immune system reveals a unique immune cell landscape and early-
life immune compartmentation across human fetal tissues, suggesting different 
immune responses in situ during human fetal development.
Imaging mass cytometry reveals the tissue-specific signatures in situ.
To extend the understanding of the fetal immune system, we applied an imaging 
mass cytometry panel comprising 31 antibodies to determine the spatial 
distribution of the immune and stromal cells in the tissues in situ. This panel 
contained markers for visualizing the tissue architecture such as E-cadherin 
(epithelium), CD31 (endothelial cells), D2-40 (lymphatic endothelium), vimentin 
(intermediate filament), smooth muscle actin (SMA) and collagen I (extracelluar 
matrix), as well as markers to identify various immune cell subsets such as T 
cells (CD3, CD8, CD4, CD45RA, CD45RO), NK cells (CD7 and CD56), myeloid 
cells (CD163) and antigen presenting cells (HLA-DR). In addition, the proliferation 
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Figure 5 Integrated analysis of immune cluster composition reveals highly discriminatory tissue-
specific signatures. (A) Principal component analysis (PCA) of 13 fetal samples. PCA was computed 
on the cell frequencies of 177 immune clusters per sample (as the percentage of CD45+ cells) and top 2 
principal components are shown describing 58% of total variance. One dot represents a single sample. 
Colors represent different fetal tissues. (B) t-SNE embedding of 177 immune clusters derived from 13 
samples showing the tissue-specific signatures. Every dot represents a single immune cluster. The size 
of the dot is proportional to the value of cell frequency, which is more similar across tissues when the 
clusters are together closer. (C) Table depicting top ten ranked clusters contributing to tissue-specific 
t-SNE sample signatures with biological annotation. Tem = effector memory T cells, Tcm = central memory 
T cells, Temra = terminally differentiated T cells, pDC = plasmacytoid dendritic cells and NK = natural killer 
cell.
marker Ki-67 was included (Table S3). With this panel, tissue sections derived 
from the fetal intestine, spleen and liver were analysed. All antibodies showed 
clear positive signals as illustrated in one of the regions of interest (ROIs) derived 
from the fetal intestine (Figure S4).
To obtain further information on the phenotype and localization of immune cell 
subsets within the tissue context, we visualized combinations of specific markers 
(Figure 6). Staining with E-cadherin, SMA and DNA were used to show the tissue 
structure, reflecting the overall morphological differences between the tissues and 
the distribution of the immune cells was revealed by CD45 staining. Most CD45+ 
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Figure 6 Spatial localization of immune and stromal cell subsets across tissues. (A-D) 
Representative mass cytometry images of a fetal intestine, spleen and liver, displaying the overlay of the 
indicated makers. Scale bar: 200 μm. Colors and scale bars are identical in panel A-C. (A) CD45 in red, 
E-cadherin in green, SMA in cyan and DNA in blue. (B) CD45 in red, Ki-67 in green and E-cadherin in 
blue. (C) CD3 in red, CD45RA in blue and CD161 in green. (D) CD3 in red, CD7 in green, CD127 in blue 
and DNA in white. White and purple arrows indicate the CD3-CD7+CD127+ ILCs. 
immune cells were in the E-cadherin- lamina propria in the intestine whereas these 
cells were scattered in the fetal spleen and liver (Figure 6A). While the majority 
of CD45+ immune cells lacked expression of Ki-67 in all three tissues, many non-
immune cells in the fetal liver and to a lesser extent in the fetal spleen were 
stained by the Ki-67-specific antibody, indicative of cell division and likely linked 
to the development of these organs at this stage (Figure 6B). In agreement 
with earlier work, Ki-67+ cells in the intestines resided in the crypt (Figure 6B), 
where stem cells and progenitor cells are enriched 22. Consistent with findings 
using suspension mass cytometry, both CD45RA+ Tn and CD45RA- Tm cells were 
identified in all three tissues. Compared with the spleen and liver, the CD45RA- 
Tm cells were most abundant in the intestine, especially CD161+CD45RA- T cells 
(Figure 6C). CD161-CD45RA- T cells and CD161+CD45RA+ T cells were more 
predominate in the spleen and liver as compared with the other two tissues, 
respectively (Figure 6C). Finally, simultaneous visualization of CD3, CD7 and 
CD127 reveals that CD3+ T cells and CD3-CD7+CD127+ ILCs (Figure 6D, white 
and purple arrows) were located in close proximity of each other in the lamina 
propria of the intestine.
Together, these data confirmed the existence of tissue-specific subsets in situ and 
underpinned the distinctness of the immune system in the tissues at the second 
trimester during pregnancy.
Discussion
While recent studies have investigated the heterogeneity and functionality of 
the developing immune system in prenatal life 5, 9, 10, knowledge of the immune 
system development remains sparse due to the relative scarcity of fetal tissues. 
In the current study, we applied high-dimensional mass cytometry to dissect 
both the innate and adaptive immune compartment in the human fetal intestine, 
spleen and liver in an unbiased and data-driven manner. For data analysis, we 
used HSNE 17, an in-house developed software, which allows the identification of 
phenotypically distinct clusters in datasets consisting of millions of cells. In line 
with previous work 5, 6, 9, 10, 21, we were able to readily define the major cell lineages 
Chapter 4
110
and substantial heterogeneity therein, and reveal the identity of previously 
unrecognized cell clusters. Moreover, our results provide evidence for tissue-specific 
compartmentalization of both the innate and adaptive immune compartment early 
in the second trimester of pregnancy. Altogether, our results confirm and extend 
previous studies that have analyzed the immune subsets in mucosal and lymphoid 
tissues from human fetus with immunohistochemical analysis 8, 23 or traditional 
multi-color flow cytometry 5, 24. Our comprehensive analysis provides a valuable 
resource that may aid future studies into the development of the human immune 
system during gestation.
Consistent with previous reports, our analysis confirmed the distinctness of the 
human fetal liver, with enrichment of myeloid and CD34+ precursor cell clusters. 
Six out of the top ten ranked clusters contributing to liver-specific signatures were 
CD34+ precursor cells. Also, we observed extensive diversity within the CD34+ cell 
population due to differential expression of several markers including c-KIT and 
HLA-DR, possibly reflecting differentiation pathways and linked to the crucial role 
of the fetal liver in haematopoiesis in prenatal life.
In addition, several other features distinguished the immune systems found in 
the tissues examined. Here, CD27-CD11b- NK cells exhibiting dominant inhibitory 
signals 25 were found primarily in the intestine while CD27-CD11b+ NK and 
CD27+CD11b+ NK cells with dominant activating signals 25 predominate in the 
spleen and liver and contribute to the tissue partitions and demarcate different 
functions in the tissues examined. Also, helper-ILCs were mainly present in 
the fetal intestine, as reported 21. Moreover, we have previously reported that 
memory-like T cells are located in the fetal intestine 9 but to a much lower degree 
in fetal spleen and liver indicative of in situ immune priming and maturation of 
T cells in the developing intestine. Intriguingly, previously unidentified CCR6+c-
KIT+CD45RO+ subpopulations of T cells were identified in all lineages in the fetal 
intestine, but not in other organs. Expression of c-KIT, a receptor for stem cell 
factor, has been shown to demarcate a subset of human CD8+ Tm cells with self-
renewal properties 26. Moreover, flow-sorted c-KIT+ Tm cells cocultured with OP9 
stromal cells in the presence of stem cell factor and IL-7 proliferated in vitro (data 
not shown). These observations suggest a potential role for CCR6+c-KIT+ Tm cells 
in the conservation of mucosal T cell memory.
CD161 has previously been shown to define a transcriptional and functional 
phenotype across human T cell lineages with an innate-like ability to respond 
to cytokines 27 while another study has described that CD161 mediates prenatal 
immune suppression 28. In our study, CD161-expressing T cells are more 
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pronounced in the human fetal intestine as compared to fetal spleen and liver, 
consistent with a unique function of CD161+ cells within the fetal intestine. HLA-
DR+ myeloid cells and B cells were found in all three organs, however, all B cells 
lacked expression of CD27, a classical memory B cell marker.
We have used imaging mass cytometry to gain insight into the localization of 
specific immune subsets within the tissue context. The results reiterate the highly 
distinct organization of the immune compartment in the three tissues investigated 
and allow the simultaneous analysis of cellular activity, i.e. cell proliferation. We 
demonstrate that this can be used to confirm results obtained by single-cell 
suspension mass cytometry while simultaneously obtaining information on the 
co-localization of specific immune subsets. For example, we obtained evidence 
that in the intestinal lamina propria CD3+ T cells are found in close proximity of 
CD3-CD7+CD127+ ILC, possibly pointing towards “crosstalk” between these cell 
subsets. This will be the topic of future studies. 
While this study is one of the first to study the immune landscape in human 
fetal tissues with high-dimensional analysis at the single-cell level, our study has 
limitations. First, we did not observe much heterogeneity in the B population as 
our antibody panel lacked several markers required for this. It would thus be 
important to include other antibodies such as IgD, CD10 and CD5 to dissect the 
B compartment further. Second, we had only access to fetal material from the 
second trimester (16-21 gestational weeks). In future studies, it would thus be 
valuable also to include samples from the first and third trimester. Third, while we 
identified 177 known and unknown cell clusters, the functional properties of these 
subsets need to be clarified. 
Nevertheless, our mass cytometric analysis provides the first global, comprehensive 
and detailed description of the immune landscape in the developing fetus in several 
tissues, reveals tissue-specific signatures and demonstrates a clear immune 
compartmentalization in the tissues in prenatal life. Recent studies have indicated 
that events shaping the immune system in utero and in early life can have a 
significant impact on the development of diseases in adult life 29, 30, 31. Detailed 
understanding of the early development of the immune system is crucial for the 
development of strategies to prevent such diseases and our study may help to 
achieve that goal. 
Materials and methods
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Human fetal tissues and cell isolation 
Human fetal tissues from elective abortions were obtained after informed consent. 
The gestational age ranged from 16 to 21 weeks. Single-cell suspensions from 
different tissues were prepared as previously described 18. Briefly, the mesentery 
and meconium were removed from the fetal intestine. The intestines were then 
cut into small fragments and treated with 1 mM dithiothreitol (Fluka) in 15 mL 
of HBSS (Sigma-Aldrich) for 2 x 10 min (replacing buffer) at room temperature 
to dissolve the mucus and subsequently with 1 mM ethylenediaminetetraacetic 
acid (Merck) in 15 mL of Hank’s balanced salt solution (ThermoFisher Scientific), 
under rotation for 2 x 1 h (replacing buffer) at 37 °C to separate the epithelium 
from the lamina propria fraction. To obtain single-cell suspensions from the lamina 
propria, the intestines were rinsed with HBSS and incubated with 15 mL Iscove’s 
Modified Dulbecco’s Medium (IMDM; Lonza) supplemented with 10% fetal calf 
serum (FCS), 10 U/mL collagenase IV (Worthington), 200 µg/mL DNAse I grade II 
(Roche Diagnostics), at 37 °C overnight, after which cell suspensions were filtered 
through a 70 µm nylon cell strainer. Finally, the immune cells were isolated with a 
Percoll (GE Healthcare) gradient. Fetal liver and spleen tissues were cut into small 
pieces then filtered through a 70 µm nylon cell strainer and the immune cells were 
isolated with Ficoll-PaqueTM density gradient (provided by the pharmacy of Leiden 
University Medical Center). All isolated cells were stored in liquid nitrogen. Study 
approval was granted by the Medical Ethics Commission of Leiden University 
Medical Centre (protocol P08.087). All experiments were conducted in accordance 
with local ethical guidelines and the principles of the Declaration of Helsinki. 
Mass antibodies and antibody conjugation
Antibodies used for suspension and imaging mass cytometry are listed in Table 
S1 and Table S3, separately. Conjugation of the purified antibodies lacking carrier 
protein with metal reporters was performed with the MaxPar X8 antibody labeling 
kit (Fluidigm Sciences) according to the manufacturer’s instruction.
Suspension mass cytometry staining and data acquisition
Procedures for suspension mass cytometry antibody staining and data acquisition 
were carried out as previously described 18. Briefly, cells from different fetal 
tissues were incubated with 1 mL 500x diluted 500 µM Cell-ID intercalator-
103Rh (Fluidigm Sciences) for 15 min at room temperature to identify dead cells. 
Cells were then stained with metal-conjugated antibodies for 45 min at room 
temperatur. After staining, cells were labeled with 1 mL 1,000x diluted 125 µM 
Cell-ID intercalator-Ir (Fluidigm Sciences) to stain all cells in MaxPar Fix and Perm 
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Buffer (Fluidigm Sciences) overnight at 4 °C. Finally, cells were acquired by CyTOF 
2TM mass cytometer (Fluidigm Sciences). Data were normalized by using EQ Four 
Element Calibration Beads (Fluidigm Sciences) with the reference EQ passport 
P13H2302 during the course of each experiment.
Imaging mass cytometry staining and data acquisition
Snap-frozen human fetal splenic, intestinal and liver biopsies were sectioned at a 
thickness of 5 μm. All sections were fixed by incubating with 1% paraformaldehyde 
for 5 min at room temperature followed by 100% methanol for 5 min at –20 °C. 
After fixation, tissue sections were washed in Dulbecco’s phosphate-buffered 
saline (ThermoFisher Scientific) containing 0.5% bovine serum albumin and 
0.05% Tween, rehydrated in additive-free Dulbecco’s phosphate-buffered saline. 
After washing again, tissue sections were blocked with Superblock Solution 
(ThermoFisher Scientific) for 30 min in a humid chamber. Tissue sections were then 
stained with a metal-conjugated antibody master mix overnight at 4 °C, washed 
and incubated with 125 nM Cell-ID Intercalator-Ir for 30 min at room temperature. 
After a further wash, tissue sections were dipped in Milli-Q water (Merck Millipore) 
for 1 min and dried for 20 min at room temperature. The acquisition was performed 
using a Hyperion imaging mass cytometer (Fluidigm) at a resolution of 1 µm, with 
settings aligned to company guidelines. The ablation frequency was 200 Hz, and 
the energy was 6 dB. Regions of interest were acquired at a size of 1 × 1 mm2. All 
data were stored as MCD files and txt files.
Data analysis
Data for single, live CD45+/dim cells gated from each sample individually using 
Cytobank as shown in Figure S1, were sample tagged and hyperbolic arcsinh 
transformed with a cofactor of 5 within Cytosplore+HSNE 17. The major immune 
lineages in Figure 1 were then identified by performing hierarchical stochastic 
neighbor embedding (HSNE) in Cytosplore+HSNE software 17. HSNE was carried 
out with default parameters (perplexity: 30; iterations: 1000). For the cluster 
identification, each cluster contains at least 100 cells. All HSNE plots were 
generated in Cytosplore 32. Cellular signatures of immune cells for each sample 
individually were generated in Cytosplore. Due to homogeneity and abundance 
of B cells in the fetal spleen, B cells from each spleen were downsampled to 
50,000 cells to deduce the cellular signatures. The similarity between two paired 
t-SNE maps was quantified by Jensen-Shannon (JS) divergence by measuring the 
similarity between corresponding probability density distribution after converting 
t-SNE maps to two-dimensional probability density functions in Matlab R2015b. 
Hierarchical clustering of the phenotype heatmap was created with Euclidean 
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correction and average linkage clustering while the cell frequency heatmap with 
Spearman correction and average linkage clustering in Matlab R2015b. Principal 
component analysis (PCA) was computed with the cluster frequencies of CD45+/
dim cells in the individual samples using “prcomp” function, and the result was 
visualized using “ggbiplot” function in R software. The cluster t-SNE map in 
Figure 5B was performed as our previous study 19. Briefly, the data matrix with 
cluster frequencies of CD45+/dim cells in the individual samples as input variance 
was normalized and computed to select the top ten highest variance principal 
components as input to the t-SNE analysis. Hence, the cluster with similar profiles 
clustered together in the t-SNE map. Images in Figure 6 and Figure S4 were 
generated using MCD Viewer software v1.0.560 (Fluidigm). 
Data availability
Mass cytometry data will be available via Flow Repository.
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Supplemental information
Figure S1 Gating strategy for single, live CD45+ cells across fetal tissues. Representative biaxial 
plots from a fetal intestine (top panel, N =7), a fetal spleen (middle panel, N =3) and a fetal liver (bottom 
panel, N=3) depicting the sequential gates for single, live CD45+ cells with percentages.
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Figure S2 
Analysis of 
the adaptive 
immune system 
across human 
fetal tissues 
using mass 
cytometry. (A) 
HSNE embedding 
of B cells (8.2 
x 105 cells) at 
the second 
level. Colors 
indicate cluster 
partitions. (B) 
t-SNE embedding 
of CD8+ T (6.9 
x 104 cells) and 
γδ T cells (3.6 x 
104 cells) at the 
single-cell level. 
Colors indicate 
cluster partitions. 
(C) Heatmap 
showing the 
median marker 
expression values 
of the 90 clusters 
identified in B, 
CD4+ T, CD8+ T 
and γδ T cells 
from seven 
fetal intestines, 
three spleens 
and three livers, 
and hierarchical 
clustering thereof. 
Tem = effector 
memory T cells, 
Tcm = central 
memory T cells 
and Temra 
= terminally 
differentiated T 
cells.
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Figure S3 
Analysis of the 
innate immune 
system across 
human fetal 
tissues using 
mass cytometry. 
(A) t-SNE 
embedding of 
ILCs (2.6 x 105 
cells), myeloid 
cells (6.4 x 
104 cells) and 
Lin- (8.7 x 104 
cells) at the 
single-cell level. 
Colors indicate 
cluster partitions. 
(B) Heatmap 
showing the 
median marker 
expression values 
of the 87 clusters 
identified in ILCs, 
myeloid cells and 
Lin- from seven 
fetal intestines, 
three spleens 
and three livers, 
and hierarchical 
clustering 
thereof. pDC = 
plasmacytoid 
dendritic cells. 
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Figure S4 Validation of the imaging mass cytometry antibody panel on human fetal intestine. 
Representative mass cytometry images of a human fetal intestine showing the expression of the indicated 
markers. Scale bar: 200 μm. Scale bars are identical in all the images.
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Table S1  CyTOF antibody panel 
Antigen Tag Clone Supplier Cat. Final  dilution
1 CD127 165Ho AO19D5 Flui 3165008B 1/800
2 CCR6 141Pr G034E3 Flui 3141003A 1/200
3 CD8a 146Nd RPA-T8 Flui 3146001B 1/200
4 CD11c 162Dy Bu15 Flui 3162005B 1/200
5 CD38 172Yb HIT2 Flui 3172007B 1/200
6 CD45 89Y HI30 Flui 3089003B 1/100
7 CD117 143Nd 104D2 Flui 3143001B 1/100
8 CD4 145Nd RPA-T4 Flui 3145001B 1/100
9 CD16 148Nd 3G8 Flui 3148004B 1/100
10 CD25 149Sm 2A3 Flui 3149010B 1/100
11 CD123 151Eu 6H6 Flui 3151001B 1/100
12 CD7 153Eu CD7-6B7 Flui 3153014B 1/100
13 CD163 154Sm GHI/61 Flui 3154007B 1/100
14 CCR7 159Tb G043H7 Flui 3159003A 1/100
15 CD14 160Gd M5E2 Flui 3160001B 1/100
16 CD161 164Dy HP-3G10 Flui 3164009B 1/100
17 CD27 167Er O323 Flui 3167002B 1/100
18 CD45RA 169Tm HI100 Flui 3169008B 1/100
19 CD3 170Er UCHT1 Flui 3170001B 1/100
20 PD-1 175Lu EH 12.2H7 Flui 3175008B 1/100
21 CD56 176Yb NCAM16.2 Flui 3176008B 1/100
22 CD11b 144Nd ICRF44 Flui 3144001B 1/100
23 TCRγδ 152Sm 11F2 Flui 3152008B 1/50
24 HLA-DR 168Er L243 BioL 307651 1/200
25 CD20 163Dy 2H7 BioL 302343 1/200
26 CD34 142Nd HIB19 BioL 343531 1/100
27 IgM 150Nd MHM88 BioL 314527 1/100
28 CD103 155Gd Ber-ACT8 BioL 350202 1/100
29 CRTH2 156Gd BM16 BioL 350102 1/100
30 CD28 171Yb CD28.2 BioL 302902 1/100
31 CD45RO 173Yb UCHL1 BioL 304239 1/100
32 CD122 158Gd TU27 BioL 339002 1/50
33 KLRG-1 161Dy REA261 MACS 120-014-229 1/50
34 CD8b 166Er SIDI8BEE ebio 14-5273 1/50
35 NKp46 174Yb 9E2 BioL 331902 1/40
Fluidigm (Flui), eBioscience (eBio) and Biolegend (BioL).
Table S1 Suspension mass cytometry antibody panel
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Table S2 Sample information
Table S3 Imaging mass cytometry antibody panel
 
Fetus ID Gestational age, wk Intestine Liver Spleen 
1 19 + - - 
2 16 + - - 
3 19 + - - 
4 19 + - - 
5 21 + + - 
6 21 + - - 
7 21 + - + 
8 21 - + + 
9 16 - + + 
 Antigen Tag Supplier Final dilution 
1 CD8a 146Nd Flui 1/50 
2 CD11c 162Dy Flui 1/50 
3 CD117 165Ho BioL 1/50 
4 CD38 172Yb Flui 1/50 
5 CD69 144Nd Flui 1/50 
6 CD45 89Y Flui 1/50 
7 CD4 145Nd Flui 1/50 
8 SMA 148Nd CST 1/200 
9 CD31 149Sm CST 1/100 
10 CD123 151Eu Flui 1/50 
11 CD7 153Eu Flui 1/100 
12 CD163 154Sm Flui 1/100 
13 CD161 164Dy Flui 1/50 
14 CD27 167Er Flui 1/50 
15 CD45RA 169Tm Flui 1/100 
16 CD3 170Er Flui 1/100 
17 Vimentin 175Lu CST 1/200 
18 CD56 176Yb Flui 1/100 
19 FOXp3 142Nd CST 1/100 
20 CD5 160Gd BioL 1/25 
21 HLA_DR 168Er BIoL 1/600 
22 E-cadherin 150Nd CST 1/50 
23 CD103 155Gd Abcam 1/50 
24 CD127 156Gd Beckman 1/50 
25 CD45 163Dy CST 1/100 
26 CD28 171Yb BioL 1/50 
27 CD45RO 173Yb BioL 1/50 
28 Ki-67 166Er CST 1/200 
29 CD57 174Yb Abcam 1/100 
30 Collagen1 147Sm Millipore 1/100 
31 D2-40 115In BioL 1/50 
Fluidigm (Flui) and Biolegend (BioL). 
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Abstract
Inflammatory intestinal diseases are characterized by abnormal immune 
responses and affect distinct locations of the gastrointestinal tract. Although the 
role of several immune subsets in driving intestinal pathology has been studied, 
a system-wide approach that simultaneously interrogates all major lineages on a 
single-cell basis is lacking. We used high-dimensional mass cytometry to generate 
a system-wide view of the human mucosal immune system in health and disease. 
We distinguished 142 immune subsets and through computational applications 
found distinct immune subsets in PBMCs and intestinal biopsies that distinguished 
patients from controls. In addition, mucosal lymphoid malignancies were readily 
detected as well as precursors from which these likely derived. These findings 
indicate that an integrated high-dimensional analysis of the entire immune 
system identifies immune subsets that are associated with the pathogenesis of 
complex intestinal disorders. This may have important implications for diagnostic 
procedures, immune-monitoring and treatment of intestinal diseases and mucosal 
malignancies.
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Introduction
The intestinal immune system protects us from bacterial, viral and parasitic 
infections. Disruption of intestinal homeostasis, however, can lead to a variety of 
autoinflammatory intestinal diseases, including celiac disease (CeD) and Crohn’s 
disease (CD), which together have a prevalence of 1,500 per 100,000 adults in the 
Western world 1, 2. Both diseases are multifactorial and encompass a broad spectrum 
of clinical phenotypes and ages of onset. CeD is a disease of the small intestine 
caused by pro-inflammatory CD4+ T cell responses specific for dietary gluten 
and concomitant destruction of the epithelium due to activation of intraepithelial 
CD8+ T cells. The introduction of a strict gluten-free diet constitutes a highly 
effective treatment for CeD but nevertheless 2-5% of patients develop refractory 
CeD type II (RCDII) with persistent inflammation. RCDII is characterized by a 
monoclonal outgrowth of aberrant intra-epithelial lymphocytes (IELs) from which 
an aggressive enteropathy-associated T cell lymphoma (EATL) evolves in 40% 
of patients 3. In contrast, CD affects the terminal ileum and/or colon and results 
from aberrant immune responses against the microbiota 4. CD is usually treated 
with the use of lifelong pharmacotherapy 5, including biologicals (e.g. anti-TNF) 
to reduce chronic inflammation and to accomplish sustained remission. Despite 
achieving states of remission, perianal fistulas occur in 25% of CD patients and 
this is accompanied by multiple relapses and a poor prognosis due to insufficient 
healing 6, 7. 
Although the role of several immune subsets in driving intestinal pathology 
has been studied in CeD 8, RCDII 9 and CD 10, a system-wide approach that 
simultaneously interrogates immune subsets across all major lineages on a single-
cell basis is currently lacking. High-dimensional mass cytometry (cytometry by 
time-of-flight; CyTOF) now offers the possibility to analyze many cellular markers 
simultaneously, providing an opportunity to analyze the mucosal immune system 
with unprecedented resolution 11. Novel computational tools have been developed 
to handle the high-dimensional single-cell datasets that originate from mass 
cytometry 12-14. In the current study we applied mass cytometry to analyze the 
composition of the immune compartment present in intestinal biopsies and paired 
peripheral blood mononuclear cell (PBMC) samples of patients with inflammatory 
intestinal diseases and controls. We identified 142 distinct immune cell subsets 
and through computational applications we found immune subsets in PBMCs and 
intestinal biopsies that distinguished patients with inflammatory diseases from 
controls. In addition, mucosal lymphoid malignancies were readily detected as 
well as the precursors from which these likely derived. Thus, mass cytometry 
unveiled previously unappreciated heterogeneity in the immune system and our 
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observations may help to develop improved diagnostic and therapeutic approaches 
for inflammatory bowel diseases.
Results
SPADE analysis identifies major immune lineages in peripheral blood and 
intestine
We designed a CyTOF panel of 32 metal isotope-tagged monoclonal antibodies, 
which was designed to obtain a global overview of the heterogeneity of the 
innate and adaptive immune system (Table S1). For this purpose, the panel 
contained lineage markers that distinguish the major adaptive and innate immune 
cell populations. In addition, markers were included to distinguish naïve from 
memory cells, resting from activated cells, and to identify homing properties and 
potential responsiveness to humoral factors. With this panel, we analyzed single-
cell suspensions from biological samples including duodenum biopsies (N=36), 
rectum biopsies (N=13), perianal fistulas (N=6) and peripheral blood mononuclear 
cells (PBMC) from control individuals (N=15) and from patients with inflammatory 
intestinal diseases (CeD, N=13; RCDII, N=5; EATLII, N=1 and CD, N=10) (Table 
S2). The large majority (N=28) of antibodies allowed clear discrimination of 
antibody-positive and -negative cells (Figure S1). To monitor the robustness of 
the measurements we included a standardized PBMC sample at regular intervals in 
the acquisition sessions during the entire 9-month study period. These consecutive 
control samples yielded highly similar results (Figure S2A-C), demonstrating the 
reproducibility of the data acquisition. We discriminated live, single CD45+ cells 
with DNA stains and event length. (Figure S2D). From the intestinal biopsies we 
acquired 27,500 duodenal, 17,500 rectal, and 76,500 perianal fistulous CD45+ 
cells on average (Figure 1A), and 76,500 CD45+ cells from the PBMC samples 
(data not shown). We visualized the global cellular heterogeneity by pooling 
all the acquired data on 5.2x106 cells and applying unsupervised hierarchical 
clustering with minimum spanning tree projection (SPADE), grouping the cells into 
a pre-defined number of nodes based on phenotypic similarity 15. A dendrogram 
displayed the corresponding higher-order relatedness between those nodes 
(Figure 1B). The major branches in this dendrogram corresponded to CD4+ T 
cells, CD8+ T cells, TCRγδ cells, B cells, innate lymphocytes (referred to as CD3-
CD7+ cells hereafter) and myeloid cells (Figure 1C). The cell frequencies of these 
major cell lineages obtained through SPADE were confirmed by traditional gating 
procedures using two-parameter dot plots (Table S3). 
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Figure 1. Collective SPADE analysis distinguishes major immune lineages in peripheral blood and 
intestine. (A) Live single CD45+ absolute cell number acquired for 55 intestinal biopsies. (B) A SPADE 
tree of a PBMC sample after analysis of the combined 102 sample dataset containing 5.2 x 106 cells. Size 
of the nodes is proportional to the respective number of clustered cells. Color bars represent ArcSinh5-
transformed values for CD3 marker expression. The identities of major immune lineages are annotated 
on the basis of lineage marker expression. (C) Color of the PBMC sample represents expression values 
for each marker as shown. (D) Representative SPADE trees showing an individual PBMC sample from a 
control and 3 patients with intestinal diseases. Color represents CD3 marker expression as described in 
panel B. (E) Comparisons of cellular frequencies for major immune lineages from 47 PBMC samples. (F) 
Representative SPADE trees showing an individual intestinal biopsy from a control and 5 patients with 
intestinal diseases. (G) Comparisons of cellular frequencies for major immune lineages from 55 intestinal 
biopsies. Data are plotted as single values (each data point represents an individual sample). *P <0.05; 
**P <0.01; ***P <0.001, using Mann-Whitney U test. Error bars show means ± s.e.m.
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In general, the subset distribution between PBMC samples from controls and 
patients was quite similar although a decrease in numbers of CD4+ T cells in 
patients with RCDII and some variability in the numbers of B cells and CD3-CD7+ 
cells was detected (Figures 1D and 1E). In contrast, substantial differences were 
evident between the PBMC and intestinal samples. For example, duodenal CD4+ T 
cell, CD8+ T cell, CD3-CD7+ cell and rectal myeloid cell subsets were distinct from 
those in peripheral blood (Figures 1D-1G). In addition, the SPADE dendrograms 
revealed disease-associated signatures (Figures 1D-1G) exemplified by the 
disappearance of CD3-CD7+ cells and an increase in TCRγδ cells in CeD relative to 
the control duodenal biopsies. Also, compared to controls and patients with CeD, an 
increase in CD3-CD7+ cells in the duodenum of patients with RCDII was observed. 
Of note is the dominant presence of a CD8+ T cell cluster in the duodenum of a 
patient with enteropathy-associated T cell lymphoma type II (EATLII). Finally, a 
highly diverse CD4+ T cell compartment was found in rectal biopsies of patients 
with CD and a dominant presence of myeloid cells in perianal fistulas. Thus, 
this global analysis indicated that there are immune-system-wide differences in 
subset composition between peripheral blood and intestinal samples, and between 
duodenal samples from patients and controls. 
t-SNE-ACCENCE analysis identifies 142 phenotypically distinct immune 
subsets 
While SPADE analysis provides an overview of the heterogeneity and the relatedness 
of subsets within the major immune lineages it does not allow analysis at the 
single-cell level and consequently rare cells are difficult to visualize. Therefore, 
we applied t-Distributed Stochastic Neighbor Embedding (t-SNE) analysis 16, 17 
which generates a two-dimensional map where cells with similar multidimensional 
phenotypes are placed close to each other, while maintaining single-cell resolution 
12. To ensure a similar impact of the cells from PBMC and intestinal samples on 
the t-SNE analysis the number of cells incorporated from those two compartments
Figure 2. t-SNE-ACCENSE analysis pipeline identifies tissue-specific CD4+ T cell subsets. (A) 
Collective t-SNE dimensionality reduced CD4+ T cell single-cell data (4.7x105 cells) derived from 102 
samples analyzed are plotted. Every dot represents a single cell and the color of the cells indicates 
ArcSinh5-transformed expression values for a given marker analyzed. (B) A density map depicting the 
local probability density of cells as embedded in panel A, computed using a kernel based transformation. 
Numbers in this map represents centers of phenotypic subsets and were identified using a peak detection 
algorithm. (C) A heatmap summary of median ArcSinh5-transformed expression values of T cell markers 
expressed by 16 CD4+ T cell subsets identified and hierarchical clustering of subsets with description 
of four categories. (D) A heatmap summary of average subset frequencies across tissues and disease 
states. Mean frequencies obtained from 102 samples analyzed. (E) A 3D heatmap as described in 
panel D. EM = effector memory and CM = central memory. A detailed heatmap showing 102 samples is 
described in Figure S4
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Figure 3. t-SNE-ACCENSE analysis delineates phenotypic distinct immune subsets in peripheral 
blood and intestine. (A) Identification of 142 cell subsets within the six major immune lineages through 
t-SNE-ACCENSE analysis. Cells from PBMCs were randomly sampled to match cell numbers with those 
from intestinal biopsies for each immune lineage individually. t-SNE plots are showing 4.7x105 CD4+ T cells, 
9.3x105 CD8+ T cells, 1.8x105 B cells, 1.8x105 TCRγδ cells, 1.9x105 CD3-CD7+ cells and 2.2x105 myeloid 
cells of the combined 102 sample dataset. (B) Heatmap showing characterization of 119 cell clusters (16 
CD4+ T cell subsets, 20 CD8+ T cell subsets, 16 B cell subsets, 28 TCRγδ cell subsets, 30 CD3-CD7+ cell 
subsets and 9 myeloid cell subsets). Shown are median ArcSinh5-transformed values of marker expression 
(black-to-yellow scale) and hierarchical clustering of markers and subsets within their major immune lineage 
were matched. We applied the t-SNE approach for every major lineage individually, 
here showing the CD4+ T cell compartment where over 440,000 cells were 
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incorporated in the analysis (Figure 2).
The t-SNE analysis revealed expected types of marker distributions on the CD4+ 
T cells, such as broadly expressed markers (CD7, IL-7Rα), markers that were 
expressed by subpopulations of the cells (CD56, PD1, CD25) and markers that 
were co-expressed (CD45RA and CCR7), but also unanticipated distributions were 
revealed, like largely mutually exclusive marker expression patterns (i.e. CD27 
and CD161) (Figure 2A). Next, we incorporated a kernel density-peak detection 
algorithm on the t-SNE map (ACCENSE) 14 which automatically identified 28 
CD4+ T cells subsets (Figure 2B) where each subset was defined by its marker 
expression profile (Figure 2C).
To reduce the complexity implied by the ACCENSE analysis we merged 
computationally-derived subsets with highly similar expression profiles, which 
resulted in 16 cell clusters that each express a distinct set of markers (Figure 
2D). They fell within four major CD4+ T cell categories: naïve (CD45RA+CCR7+), 
CD27+IL-7Rα- effector memory (EM; CD45RA-CCR7-), CD27-IL-7Rα+ EM and 
central memory (CM; CD45RA-CCR7+), and within those categories additional 
heterogeneity was present. For example, the highly similar CD161+CD27-IL-7Rα+ 
EM cell subsets 4 and 11 were distinguished from each other by the expression of 
CD56 (Figure 2D). We next analyzed the subset distribution of the CD4+ T cells 
in the various tissues included in the analysis by plotting the relative frequencies 
of the subsets for all samples analyzed (Figures 2E and 2F). In line with the 
SPADE analysis, the CD4+ T cell subsets of the duodenum, rectum and PBMC 
samples clustered to distinct locations in the cell frequency heatmap, also when 
examining the 102 samples individually (Figure S4). Thus, we could effectively 
delineate cell populations in a data-driven manner, and this approach revealed 
distinct signatures in the cellular composition of the CD4+ T cells in biopsy material 
and peripheral blood. 
By applying the t-SNE-ACCENSE analysis to all 6 major cell lineages individually 
we identified 142 subsets in the entire immune system (Figure 3A), 23 of 
which contained rare cells that did not fulfill lineage phenotypic criteria (data not 
shown). The distinct phenotypes of the remaining 119 subsets are summarized 
in a heatmap (Figure 3B) where the subsets are clustered according to their 
phenotypic hierarchy within their lineage and clustered based on marker 
expression. The analysis identifies relatively few subsets within the B cell and 
myeloid compartments, likely due to the composition of the antibody panel which 
was designed to capture the heterogeneity of the CD7+ lymphoid cells. In this 
context, our antibody panel identified many distinct subsets within the TCRγδ 
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and CD3-CD7+ immune lineages, a diversity that was even greater than that 
detected in the CD4+ and CD8+ T cell lineages despite the fact that the latter 
were generally more abundant in the samples included. Collectively, the combined 
t-SNE-ACCENSE approach on high-dimensional cytometry data can effectively 
identify phenotypic distinct subsets in an unbiased and data-driven manner, and 
the analysis indicates that the heterogeneity of the immune system is far greater 
than previously appreciated. 
Visualization of cellular ‘finger-print’ signatures across tissues and 
disease states
To visualize the distribution of immune cells based on tissue-origin and disease 
state we used the t-SNE maps to deduce cellular ‘finger-print-like’ signatures of 
immune cells in the 6 major immune lineages (Figure 4A). The ‘finger-print’ 
gives a visual representation of the position of a collection of cells from particular 
(tissue) samples in the t-SNE map of the collective dataset. As such it gives a 
unified overview of the distinctness of cells within the samples analyzed stratified 
for tissues and disease states. In all 6 immune lineages, the duodenum, rectum 
and PBMC samples displayed a distinct cellular signature (Figure 4A). Moreover, 
on the basis of these signature maps, we were able to identify phenotypically 
distinct cell clusters that were either specifically present or abundant in certain 
diseases (highlighted by red boxes and arrows in Figure 4A). For example, the 
lineage (Lin)- CD3-CD7+ cells that expanded monoclonally in patients with RCDII 
(purple arrow; Figure 4A) were distinguished by the expression of CD45RA in 6 
out of 7 patients (Figures 4B and 4C). Moreover, these aberrant Lin- CD3-CD7+ 
cells were also detectable in PBMC samples of 3 out of 6 patients (Figures 4A 
and 4D), indicating a systemic spread of the pre-malignant cells. Similarly, a 
massive expansion of CD56+CD161+ CD8+ T cells was observed in a patient with 
an established lymphoma of EATL-type 2 (green arrow; Figure 4A). Rare cells 
(0.1-0.2% of CD8+ T cells) displaying an identical phenotype were detected in 
25% of the other duodenum samples and these may therefore represent the 
precursor from which the lymphoma arose. In addition, two distinct IL-7Rα+ innate 
lymphoid cell type 3-like (ILC3-like) 18 cell clusters were identified that were either 
chemokine receptor CCR6+ or CCR6- (blue arrow; Figures 4A and 4B). While the 
CCR6+ ILC3-like cells represented 50% of the CD3-CD7+ cells in the rectum of CD 
patients, its CCR6- ILC3-like counterpart, which is associated with an inflammatory 
phenotype in CD 19, was more abundant in the fistulas (Figure 4C). Also, 94% of 
the myeloid cells within the inflammatory perianal fistulas (red arrow; Figure 4A) 
displayed a CD11b+CD11c+ dendritic cell-like phenotype (Figure 4B) and they 
comprised 50% of the accumulated immune infiltrate (Figure 4C).
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Figure 4. Stratified t-SNE plots identify distinct cellular ‘finger-print’ signatures across tissues 
and disease states. (A) Collective t-SNE dimensionality reduced single-cell data from all 102 samples 
analyzed are plotted showing six major immune lineages stratified for tissues and disease states. 
Red boxes and arrows indicate t-SNE location of phenotypically distinct disease-associated clusters 
of cells (B) Heatmap summary of median ArcSinh5-transformed expression values of cellular markers 
expressed by gated subsets and annotation for each subset. Arrows as in panel A. (C) Comparisons 
B C
0
20
40
60
80
100 ****
****
  (%
 o
f C
D
3-
C
D
7+
)
Ct
rl
Ce
D
RC
DI
I
EA
TL
II CD
Fis
tul
a
0
20
40
60
80
100
  (%
 o
f C
D
45
+ )
0
20
40
60
80
**
Ct
rl
Ce
D
RC
DI
I
EA
TL
II CD
Fis
tul
a
  (%
 o
f C
D
3-
C
D
7+
)
0  
0.1
0.2
0.3
0.4
  (%
 o
f C
D
45
+ )
0
1.0
2.0
3.0
4.0
5.0
90
100
Ct
rl
Ce
D
RC
DI
I
EA
TL
II CD
Fis
tul
a
  (%
 o
f C
D
8+
 T
 c
el
ls
)
0
0.2
0.4
0.6
0.8
1.0
90
100
  (%
 o
f C
D
45
+ )
D
0
20
40
60
80 ***
Ct
rl
Ce
D
RC
DI
I
EA
TL
II CD
Fis
tul
a
  (%
 o
f C
D
3-
C
D
7+
)
0
1
2
3
  (%
 o
f C
D
45
+ )
CCR6+ ILC3 CCR6- ILC3
CD45RA+Lin- CD56+CD161+
1.00
JS divergence
E
***
Ct
rl
Ce
D
RC
DI
I
EA
TL
II CD
Fis
tul
a
  (%
 o
f M
ye
lo
id
)
0
20
40
60
80
100
0
20
40
60
80
100
  (%
 o
f C
D
45
+ )
CD11b+CD11c+
0
10
20
30
  (%
 o
f C
D
3-
C
D
7+
)
0
1
2
3
4
5
  (%
 o
f C
D
45
+ )
CD45RA+Lin-
Ct
rl
Ce
D
RC
DI
I
CD
0 7.5
Marker counts
C
D
45
C
D
7
C
D
16
1
C
D
38
IL
-7
R
α
C
D
56
C
C
R
6
C
D
45
R
A
C
C
R
7
C
D
3
C
D
8a
C
D
8b
C
D
27
C
D
28
c-
K
IT
C
D
25
N
K
p4
6
C
D
11
c
C
D
11
b
C
D
12
2
C
D
14
C
D
19
CCR6-ILC3
CCR6+ILC3
CD56+CD161+CD8+ T cell
CD11b+CD11c+Myeloid
CD45RA+Lin-CD3-CD7+
P
D
-1
A
t-SNE2
t-S
N
E
1
Ctrl CeD RCDII CD Fistula
PBMC
Ctrl CeD
Duodenum Rectum
RCDII CDEATLII
CD4+
T cells
Ctrl
CeD
RCDII
CD
Fistula
Ctrl
CeD
RCDII
CD
D
uo
de
nu
m
P
B
M
C R
ec
tu
m
CD4+ 
T cells Ctrl
CeD
RCDII
CD
Fistula
Ctrl
CeD
RCDII
CD
B cells
Ctrl
CeD
RCDII
CD
Fistula
Ctrl
CeD
RCDII
CD
TCRγδ 
cells Ctrl
CeD
RCDII
CD
Fistula
Ctrl
CeD
RCDII
CD
CD3-CD7+ 
cells 
Ctrl
CeD
RCDII
CD
Fistula
Ctrl
CeD
RCDII
CD
CD8+ 
T cells
Ctrl
CeD
RCDII
CD
Fistula
Ctrl
CeD
RCDII
CD
Myeloid
CD3-
CD7+ 
cells 
CD8+
T cells
1.0
6.2
1.8
5.3
71.7  
0.5
0.0
0.0 
1.7
50.7
2.2
19.7
0.5
4.4
0.6
1.1 
9.8
0.1
0.8
3.7
0.2 0.1 0.2
99.6
0.0 0.0 0.0 0.0 0.0 0.0
B cells
Myeloid
cells
29.3 30.1 15.7 66.1 60.0 94.3 4.2 4.2 0.9 0.2
TCRγδ
T cells
D
uo
de
nu
m
P
B
M
C R
ec
tu
m
Chapter 5
136
of cellular frequencies for subsets from intestinal biopsies. (D) Comparisons of cellular frequencies for 
the CD45RA+Lin- CD3-CD7+ subset from PBMC samples. (E) Pairwise Jensen-Shannon (JS) divergence 
plots of the collective t-SNE maps from all 102 samples analyzed showing six major immune lineages. 
A higher JS divergence value indicates more dissimilarity between a pair of t-SNE maps as shown 
in panel A. White squares indicate invalid comparisons. Data are plotted as single values. Red lines 
indicate mean value as % of CD45+ cells. (each data point represents an individual sample). *P <0.05; 
**P <0.01; ***P <0.001; ****P <0.0001, using Mann-Whitney U test. Error bars show means ± s.e.m.
Figure 5. Immune system landscape visualizes subset composition. A 3-dimensional heatmap 
summary showing average frequencies of 119 immune subsets in the 102 biological samples 
combined with hierarchical clustering of samples and description of tissue type, disease state and 
biological assignment of the subsets. Color scale and z-axis indicate percentage of CD45+ cells. 
EM = effector memory, CM = central memory, TEMRA = terminally differentiated, Lin = lineage, 
cNK = conventional NK cells, ILC = innate lymphoid cells and pDC = plasmacytoid dendritic cells. 
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We next used the Jensen-Shannon (JS) divergence to quantify similarities and 
dissimilarities between pairs of t-SNE maps (Figure 4E). In these plots the JS 
divergences between samples from the intestine and peripheral blood were high for 
every major lineage (Figure 4E), indicative of dissimilarity of cellular signatures. In 
addition, the JS divergences reveal disease-associated cellular profiles exemplified by 
similarity of RCDII and CeD duodenal myeloid cells compared with those in duodenal 
controls, distinct CD8+ T cells in RCDII patient blood and distinct B cells, CD3-CD7+ 
cells and myeloid cells in CD patient blood compared with other blood samples.
Furthermore, we visualized the immune composition as an immune landscape 
where the distribution of the subsets in the various tissue and blood samples 
is shown (Figure 5). A 2-dimensional representation of the immune landscape 
along with the phenotypes of the associated immune subsets is shown in Figure 
S5, visualizing the distinct cellular phenotypes of the immune subsets and their 
occurrence in the various tissues. Together these findings illustrate that in most 
of the major immune lineages, cellular subsets could be identified that were 
exclusively present or enriched in defined tissue samples only. In peripheral blood, 
cells were mainly defined by expression of interleukin 7 receptor α (IL-7Rα), CCR7, 
CD27 and CD28 for CD4+ and CD8+ T cells, CCR6 for B cells, CD56 for CD3-CD7+ 
cells and CD14 for myeloid cells. Similarly, many mucosal cells were defined by 
expression of CD161 for CD4+ and CD8+ T cells, CD38 for TCRγδ cells and IL-7Rα 
for CD3-CD7+ cells
Together these analyses demonstrate that by deducing cellular ‘finger-print’ 
signatures of immune cells we were able to visualize and quantify the immune 
subset distribution in the samples analyzed. In addition, we were able to identify 
immune subsets that are associated with disease states. 
An integrated system-wide view of the immune system reveals disease-
associated networks of immune subsets
Finally, we investigated whether the identified immune-system-wide cellular 
patterns could be integrated collectively and used to characterize samples 
according to tissue location or disease state by visualizing them in relation to 
several clinical variables. For this purpose we visualized the immune composition 
of all identified subsets from all included biological samples in a single graph by 
applying the t-SNE algorithm on cell frequency values. As expected, the PBMC and 
intestinal biopsy samples formed two distinct clusters (Figure 6A). In addition, 
the rectum and peri-anal fistula biopsies separated from the duodenal biopsies 
(Figures 6A and 6B) and the duodenal biopsies from patients with CeD and 
RCDII clustered away from the duodenal control biopsies (Figures 6A and 6B).
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Figure 6. Integrated analysis of immune subset composition reveals tissue- and disease-
associated clustering of biological samples. Collective t-SNE dimensionality reduced cell percentage 
data (as % of CD45+ cells) of 142 subsets for 102 samples analyzed are plotted. Every dot represents 
a single sample and the color of the samples shows the corresponding clinical information: (A) tissue, 
(B) disease, (C) biopsy inflammation, (D) gender, (E) age in years, (F) samples from six patients that 
were sampled twice. The left dashed border represents the PBMC cluster and the right dashed border 
represents the intestinal cluster. (G) Deducing disease-specific signatures in the t-SNE map based on 
the clustering patterns of the samples. (H) Collective t-SNE dimensionality reduced cell percentage data 
(as % of CD45+ cells) of 142 subsets for 102 samples analyzed are plotted. Every dot represents a single 
immune subset. The closer the subsets are together the more similar the cell frequency values are across 
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Top five ranked subsets contributing to the disease-specific t-SNE sample signatures
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the samples. (I) Disease-specific subset signatures (average subset values per disease cluster in panel 
G, encoded with varying dot color and size). (J) Table showing top five ranked subsets contributing to 
the disease-specific t-SNE sample signatures (as shown in panel I) displaying both major lineage subset 
number and biological assignation. Lineage (Lin), conventional NK cell (cNK), effector memory (EM), 
central memory (CM) and innate lymphoid cells (ILC). Average cell frequency values are shown in Figure 
5.
Also, the duodenal biopsies of the four RCDII patients with the most severe 
inflammation (Table S2) mapped far from the other duodenum samples (Figures 
6B and 6C). Furthermore, three RCDII biopsies, two of which were from patients 
in remission, clustered with the other CeD biopsies, suggesting a persisting CeD 
immune profile. The inflammation state of the biopsies was reflected in the cluster 
structure of intestinal samples in general (Figure 6C), while this was not the case 
for gender (Figure 6D). Moreover, the age of the patients and controls from which 
the samples were derived is reflected in the clustering of the samples, particularly 
in peripheral blood (Figure 6E). The PBMC and intestinal samples from six 
patients that were biopsied twice, with a 3- to 6-months time interval, clustered 
tightly together (Figure 6F) highlighting the reproducibility and robustness of this 
unbiased approach. 
In order to reveal which cellular subsets were associated with the disease-
associated patterns (Figure 6G), we performed a second t-SNE analysis on the 
subsets of the same dataset (instead of the samples) visualizing networks of 
cellular subsets that determine disease-specificity (Figures 6H and 6I) and 
identified the top 5 ranked subsets contributing to these clustering patterns 
(Figure 6J). In this context, expected types of health- and disease-associated 
subsets were identified in the intestinal mucosa, such as CD45RA-Lin- CD3-CD7+ 
cells in control individuals, CD8a+ and CD8a- TCRγδ cells in CeD, CD45RA+Lin- 
CD3-CD7+ cells in RCDII, CCR6+ILC3 in CD and CD14-CD11b+ myeloid cells in 
fistulas. In addition, previously unidentified subset associations were revealed 
as well, such as CD45RA- cNK cells and CD56-CD27-EM CD4+ T cells in controls, 
CD27-EM CD8+ T cells in CeD, CRTH2+ myeloid cells in RCDII (ranked 6), CCR6-CM 
and PD-1+CD27+EM CD4+ T cells in CD, and CCR6-CCR7+ B cells in the fistulas. 
Thus, by integrating data-driven approaches highly specific disease-associated 
immune signatures across innate and adaptive major lineages in the intestine 
were readily identified. Figure S6 gives an overview of the developed integrated 
analysis pipeline developed in the current study. 
Discussion
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Mass cytometry offers the opportunity to simultaneously analyze dozens of single-
cell markers on complex cellular samples resulting in highly complex datasets. 
Conventional approaches for flow cytometry data analysis are not suitable for 
such datasets, suffer from individual user bias, and require prior knowledge of the 
cell type of interest. SPADE 13 was originally applied to handle mass cytometric 
data. More recently, an unbiased analysis pipeline has been developed combining 
t-SNE 12, 16 and ACCENSE 14 with mass cytometry to visualize and delineate 
phenotypically distinct subsets 20. In the current study we used a 32 antibody 
panel that was specifically designed to detect heterogeneity within the major 
adaptive and innate cell lineages. We applied this antibody panel to a variety of 
PBMC and intestinal biopsy samples and combined this with the newly available 
unbiased computational approaches to unravel the complexity of the human 
mucosal immune system. We used the Barnes-Hut implementation of t-SNE, a 
recently developed, computationally efficient t-SNE optimization algorithm 17 to 
accommodate the large datasets. In addition, we provide novel applications of the 
t-SNE-based analysis allowing the visualization of cellular ‘finger-print’ signatures 
of immune cells, and by clustering samples based on their immune composition 
while visualizing the cluster-contributing subsets in parallel to highlight tissue- 
and disease-associated patterns. 
Our results demonstrate that the mass cytometry-based analysis was robust 
and reproducible as identical control PBMC samples that were included during 
the entire 9 month study period provided highly similar results. Moreover, we 
obtained biopsy and PBMC specimens from a number of patients twice with a time 
interval between 3 to 6 months and in the final sample visualization analysis these 
specimens clustered close together, demonstrating a high degree of reproducibility. 
Also, we readily observed changes in the composition of the immune compartment 
that are known to correlate with disease such as the increase in TCRγδ cells in 
CeD 21. 
Both the SPADE and the combined t-SNE-ACCENSE analysis demonstrate that 
duodenal, rectal and PBMC samples grouped into different clusters, to a large 
extent due to substantial differences in the CD4+ and CD8+ T cell compartments. 
In total, 142 subsets in the immune system were defined of which 120 displayed 
distinct marker expression profiles on the basis of which these subsets were 
delineated. Compared to the CD4+ and CD8+ T cell lineages, a larger degree of 
heterogeneity was detected in the TCRγδ and CD3-CD7+ immune lineages. While 
we cannot exclude the possibility that by the use of another antibody panel 
additional heterogeneity within the CD4+ and CD8+ lineages may be revealed, 
the distinct marker expression profiles of the TCRγδ and CD3-CD7+ subsets may 
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correlate with distinct and potentially location-specific functional properties. This 
will be the subject of future investigations. Thus, based on 28 markers mass 
cytometry visualized system-wide cellular differences in subset composition in the 
samples obtained from the various anatomical locations. Further studies including 
control rectum samples are required to determine how these differences relate to 
the anatomical site and/or disease state.
Recent studies have described a crucial role for ILCs in CD 22. They reside mainly 
in mucosal tissues and are functionally specialized cells characterized by the 
expression of lineage-defining transcription factors. Even without these markers in 
our antibody panel we were able to distinguish ILC-like subsets on the basis of cell 
surface phenotype through machine-learning cell cluster detection approaches. 
We identified a CRTH2+ ILC2-like subset in PBMC samples and in line with previous 
reports such cells were not found in intestinal samples 22. Moreover, we detected 
an ILC3-like subset that was exclusively present in rectum biopsies of CD patients 
in remission. This subset corresponds with the IL-22-producing anti-inflammatory 
CD25-CD56+ ILC subset previously found in the intestine of CD patients 19, 22. 
Moreover, we observed that their CD56- ILC counterpart was enriched in fistulas, 
and these cells were previously shown to produce the inflammatory cytokine IL-
17A 19. The CD56--ILC3-like cells in fistulas unexpectedly showed expression of 
CD11c, a marker that has been used as ‘dump channel’ in the ILC field. Those 
cells may thus have been discarded from datasets of previous studies, highlighting 
the importance of unbiased data-driven approaches as used in the current 
study. In addition, the CD4+ T cell compartment in the CD biopsies was highly 
heterogeneous. Further studies are required to determine a possible relationship 
with the highly variable disease symptoms in CD. 
Mucosal lymphoid malignancies were readily detected in patients with RCDII and in 
a patient with an EATL-type 2 lymphoma, along with the distinct cellular phenotypes 
that distinguish these lymphoma’s. The latter information could be used to identify 
the potential precursor cells in the healthy mucosa from which these malignancies 
are likely to originate. In the case of RCDII these precursors are Lin-CD3-CD7+ 
cells, confirming previous results 23. Moreover, our current analysis indicates that 
these precursors can be distinguished from their malignant counterpart by the 
lack of expression of CD45RA. Conversion of this subset to a CD45RA positive 
phenotype may thus predict development of RCDII and could constitute a novel 
prognostic marker. Also, extremely low numbers of CD56+CD161+CD8a+CD8b+ T 
cells were found in mucosal biopsies of healthy individuals, a phenotype which 
matches that of the CD8+ T cell malignancy in a patient with EATLII. Thus, the 
t-SNE analysis is highly suitable for the identification of mucosal malignancies 
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and their likely precursors in healthy individuals, information that may be used to 
develop therapeutic approaches based on cellular characteristics.
Compared to control duodenal samples we observed the disappearance of CD3-
CD7+ cells and the increase in TCRγδ cells in CeD, both well-described disease 
hallmarks 21, 23. In the global analysis of the entire cell frequency dataset this 
resulted in the formation of clusters that distinguish duodenal biopsies derived 
from CeD patients from those of controls. By transposing the cell frequency 
dataset the disease cluster-associated subsets and their relative contribution 
to the clustering could be visualized and quantified. This tSNE application thus 
provided detailed information on the disease-associated networks of immune 
subsets. The identification of mucosal immune signatures that correlated with 
health and disease may potentially lead to the development of unbiased diagnostic 
procedures based on a single mass cytometric analysis. 
Perianal fistulas in CD remain a substantial clinical challenge, causing pain, 
discharge, and abscess formation 24. Achieving complete fistula healing is difficult 
and accompanied by multiple relapses, and despite the best available therapies 
durable remission rates of perianal fistulas remain disappointingly low 7. In this 
respect it will be important to unravel the function of the CD11b+CD11c+ myeloid 
cells that dominate in the fistula, where the immune composition is distinct from 
that in the adjacent rectum biopsies. This will be addressed in future studies.
In such follow-up studies our approach can be further refined as four antibodies 
included in the original 32 antibody panel (CD103, IL21-R, CD34 and TCRαβ) 
were not informative. In particular the inclusion of antibodies specific for lineage-
defining transcription factors and cytokines may provide further insight into the 
relationship between cell lineages and their function in the mucosal immune 
system. Moreover, the inclusion of an alternative metal reporter for the CD103-
specific antibody in future studies may allow discrimination between cells derived 
from the epithelium and the lamina propria. Also, with regard to CD and perianal 
fistula we could not draw definitive conclusions regarding disease-specific changes 
as we lacked healthy control rectum samples. It would thus be highly valuable 
to characterize mucosal biopsies obtained from various intestinal locations 
within the same patients and controls, allowing direct comparisons. Finally, by 
combining the analysis of the mucosal immune system with an analysis of the 
stromal cell compartment a more integrated view of disease-specific changes 
may be obtained, optimizing opportunities to develop more effective personalized 
treatment modalities.
In conclusion, the mass cytometric analysis of the mucosal immune system 
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revealed heterogeneity that was greater than previously appreciated. Also, our 
results indicate that disease-specific leukocytes reside mainly in the affected 
organ and are much less readily detectable in PBMC. The identification of disease-
associated changes in immune composition offers opportunities to determine 
cellular parameters that correlate with disease and predict response to treatment, 
an important step towards personalized and cost-effective treatment.
Experimental procedures 
Human Samples 
Samples were collected from patients who were undergoing routine diagnostic 
endoscopies, and the curettage material of perianal fistulas were obtained at 
surgical intervention. The clinical characteristics of the patients are shown in Table 
S2. All samples were obtained after informed consent, medical ethical commission 
approval, in accordance with the local ethical guidelines of the VU Medical Center 
in Amsterdam (adult duodenal biopsies) and the Leiden University Medical Center 
(pediatric duodenal biopsies, CD rectum biopsies, and perianal fistulas), and in 
accordance with the declaration of Helsinki. 
Isolation of cells from intestinal and PBMC samples
Cells from the epithelium were isolated from two or three intestinal biopsies 
by treatment with 10 mL of HBSS (Sigma-Aldrich, St. Louis, United States) 
containing 1 mM EDTA (Merck, Darmstadt, Germany) under rotation for 2 hr at 
37°C. To obtain cells from the lamina propria, the biopsies were washed with PBS 
containing 0.5% fetal calf serum (FCS) and incubated with 5 mL of a collagenase 
mix containing IMDM culture medium (Lonza, Basel, Switzerland) with 20% FCS, 
1,000 U/mL collagenase IV (Worthington, Lakewood, United States) and 10 mg/
mL DNAseI grade II (Roche Diagnostics, Basel, Switzerland) for 2 hr at 37°C. 
The cell suspension was then filtered through a 70 µm nylon cell strainer and 
centrifuged in 0.5% FCS/PBS. Curettage material of perianal fistulas obtained 
at surgical intervention were minced with fine scissors and incubated with 10 
mL of HBSS containing 1 mM EDTA under rotation for 2 hr at 37°C. Peripheral 
blood mononuclear cells (PBMC) were isolated from up to 5 mL of freshly drawn 
heparin anticoagulated blood using Ficoll-PaqueTM density-gradient centrifugation. 
PBMC samples from CD patients were cryopreserved and stained after thawing. 
Cell suspensions were washed with 0.5% FCS/PBS and kept at 4°C until antibody 
staining.
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Antibodies 
Antibodies, manufacturers, and concentrations are listed in Table S1. Primary 
antibody metal-conjugates were either purchased or conjugated using a total 
of 100 µg of carrier-free formulations of purified antibody combined with the 
MaxPar X8 antibody labeling kit (Fluidigm Sciences, Toronto, Canada) according 
to the manufacturer’s instruction. Following conjugation, antibodies were diluted 
to 200 µL in Candor PBS Antibody Stabilization Buffer (Candor Bioscience GmbH, 
Wangen, Germany) and stored at 4°C. 
Antibody staining and data acquisition
Procedures for mass cytometry antibody staining and data acquisition were carried 
out as previously described 13. Briefly, directly after biopsy processing cells were 
resuspended in cell staining buffer (CSM; 1x PBS with 0.5% bovine serum albumin 
and 0.02% sodium azide, Fluidigm Sciences) and incubated with 1 mL of 1:500 
diluted 500 µM rhodium DNA intercalator (Fluidigm Sciences) for 15 min to stain 
dead cells at room temperature (rT). Cells were washed with CSM and surface 
stained for 45 min at rT with a mixture of metal isotope-conjugated antibodies 
using predetermined concentrations (Table S1). Antibody staining reactions were 
performed in 100 µL final volume. After staining, cells were washed twice with CSM 
and then resuspended in 1 mL of 1:1000 diluted 125 µM iridium DNA intercalator 
(DVS Sciences) in Fix and Perm Buffer (PBS with 1.6% paraformaldehyde, Fluidigm 
Sciences) for 45 min at rT to discriminate single cells. Cells were stored overnight 
at 4°C. Finally, cells were washed twice in CSM and once in distilled water at rT. 
Prior to data acquisition, cell pellets were diluted in distilled water containing 1:10 
diluted EQ Four Element Calibration Beads (Fluidigm Sciences) to the concentration 
of 0.4x106 cells/mL to achieve an acquisition rate of 500 events/s on the CyTOF 2TM 
mass cytometer (Fluidigm Sciences) 25. CyTOF data were acquired and analyzed 
on-the-fly, using dual-count mode and noise-reduction on. All other settings were 
either default settings or optimized with tuning solution, as instructed by Fluidigm 
Sciences. After data acquisition, the mass bead signal was used to normalize the 
short term signal fluctuations with the reference EQ passport P13H2302 during 
the course of each experiment and the bead events were removed 26.
Data analysis
SPADE analyses were performed as described 15 with 500 target number of nodes 
and 10% of target down-sampled events using the implementation in Cytobank 
27. Data from exported FCS files of major immune lineages as delineated by 
SPADE (Figure 1) were transformed using hyperbolic arcsin with a cofactor of 
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5. Because the number of cell events varied greatly between PBMC and intestinal 
biopsies, the contribution of intestinal and PBMC cells were normalized to a 1:1 
ratio for each immune lineage and up to 10,000 events per sample was used. 
After down-sampling, the cumulative dataset per immune lineage was subjected 
to t-SNE dimensionality reduction. t-SNE was carried out using the Barnes-Hut 
implementation of t-SNE, a recent developed, computationally efficient t-SNE 
optimization algorithm (obtained from L.J.P. van der Maaten) 17 to accommodate 
the large volumes of our clinical data. t-SNE was run with a default perplexity 
of 30. Cellular ‘finger-print’ signatures of immune cells and marker expression 
color overlays of t-SNE maps were generated with Cyt 12. We used the Jensen-
Shannon (JS) divergence to quantify the similarity between t-SNE maps. After 
converting t-SNE maps into 2-dimensional probability density functions, the 
similarity between two maps is quantified as the JS divergence between their 
corresponding probability density functions. We used the base 2 logarithm in the 
JS divergence computation, which results in a continuous range of JS divergence 
values between 0 (for identical distributions) and 1 (for fully disjoint distributions). 
The density-peak detection algorithm to identify phenotypically distinct subsets 
was carried out with ACCENSE 14, using the two coordinates of the t-SNE map 
for each cell as input. The density-based clustering first searches for the optimal 
bandwidth, followed by estimating the kernel density that allows the detection 
of density peaks. The respective amount of subpopulations identified per major 
lineage was based on the calculated optimal kernel bandwidth. Two-dimensional 
gating analysis was done using Cytobank 27. Median intensity values of markers 
were calculated and visualized via plotting heatmaps. Hierarchical clustering 
dendrograms of heatmaps were produced using Pearson Correlation and average 
linkage clustering with MultiExperiment Viewer (www.tm4.org). Numbers of cells 
in different immune subsets were counted for each sample and percentages of 
each subset were calculated. t-SNE coordinates, ACCENSE subset number, and 
sample coding tags were added to FCS files as additional parameters to allow 
aggregate data analysis and visualization. The sample t-SNE map (Figure 6) was 
computed with the fractions of the total cell count per subtype (as % of CD45+ 
cells) as input variables. Standard t-SNE pre-processing was applied: the data 
matrix was normalized by centering each variable to zero mean, and scaling to 
unit vector length. In the sample map, a reprojection of the data on a reduced 
set of high-variance principal components (PCs) was performed. The component 
scores of the 10 highest variance PCs were used as input to the t-SNE. To reduce 
sensitivity to local optima, map construction was repeated 100 times with different 
randomly generated initial maps and the map with the minimal t-SNE error metric 
(Kullback Leibler divergence per data point) was selected. The subset t-SNE map 
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in Figures 6H and 6I was computed by transposing the normalized datamatrix. 
This switches the role of samples and variables, hence subsets with similar profiles 
across the population end up close together in the map. The t-SNE perplexity 
parameter was set to 10% of the number of data points in each map, i.e. 10 for 
the sample maps in Figures 6A-6F, and 15 for the subset map in Figure 6H and 
6I. Average subset values were computed per disease subgroup as identified in 
the sample t-SNE map in Figure 6G, and displayed per subgroup.
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Figure S1. Representative biaxial plots of antibody stainings used for the mass 
cytometry analysis 
To illustrate the functionality of each metal-conjugated antibody, representative 
biaxial plots showing typical staining profiles of the antibodies used. Cells gated as 
shown (annotated above plots) are represented as two-parameter density dot 
plots. 
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Figure S1. Representative biaxial plots of antibody stainings used for the mass 
cytometry analysis 
To illustrate the functionality of each metal-conjugated antibody, representative 
biaxial plots showing typical staining profiles of the antibodies used. Cells gated as 
shown (annotated above plots) are represented as two-parameter density dot 
plots. 
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Figure S2. SPADE and t-SNE analysis of the internal peripheral blood control. (A) Six PBMC samples 
from the same individual taken at different time points during the entire study period are shown after 
collective SPADE analysis of live single CD45+ cells. Size of the nodes is proportional to the respective 
number of clustered cells. Color bars represent ArcSinh5 transformed values for CD3 marker expression. 
The identities of major immune lineages are annotated on the basis of lineage marker expression (CD4+ = 
CD4+ T cells, CD8+ = CD8+ T cells and B = B cells) (for details SPADE analysis see Figure 1) (B) Collective 
t-SNE dimensionality reduced single-cell data containing live single CD45+ cells from 6 PBMC samples 
as described in panel a analyzed are plotted. Each sample was down-sampled to 50,000 events prior to 
the t-SNE analysis. (for details t-SNE analysis see Figures 2 and 4) (C) Pairwise Jensen-Shannon (JS) 
divergence plot of the collective t-SNE maps from the 6 PBMC samples analyzed. A lower JS divergence 
value indicates more similarity between a pair of t-SNE maps as shown in panel b. (D) Live, single CD45+ 
cells gating strategy. Representative mass cytometry plots of a duodenum biopsy showing sequential 
gates with percentages. Event length is a mass cytometric measurement for the amount of scans it took 
to acquire a given ion cloud.
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Figure S2. SPADE and t-SNE analysis of the internal peripheral blood control 
(A) Six PBMC samples from the same individual taken at different time points during the entire study period are shown after 
collective SPADE analysis of live single CD45+ cells. Size of the nodes is proportional to the respective number of clustered cells. 
Color bars represent ArcSinh5-transformed values for CD3 marker expression. The identities of major immune lineages are 
annotated on the basis of lineage marker expression (CD4+ = CD4+ T cells, CD8+ = CD8+ T cells and B = B cells) (for details SPADE 
analysis see Figure 1) (B) Collective t-SNE dimensionality reduced single-cell data containing live single CD45+ cells from 6 PBMC 
samples as described in panel a analyzed are plotted. Each sample was down-sampled to 50,000 events prior to the t-SNE 
analysis. (for details t-SNE analysis see Figures 2 and 4) (C) Pairwise Je sen-Shannon (JS) divergence plot of the collective t-SNE 
maps from the 6 PBMC samples analyzed. A lower JS divergence value indicates more similarity between a pair of t-SNE maps 
as shown in panel b. (D) Live, single CD45+ cells gating strategy. Representative mass cytometry plots of a duodenum biopsy 
showing seque tial gates with percenta es. Event length is a m ss cytometric measurement for the amount of scans it took to 
acquire a given ion cloud. 
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Figure S3. Traditional gating yields similar frequencies of major immune lineage cells as with 
SPADE analysis. (A) Representative samples are shown to demonstrate the gating strategy applied to 
identify the major immune lineages: CD4+ T cells, CD8+ T cells, B cells, TCRγδ cells, CD3-CD7+ cells and 
myeloid cells. Cells gated as shown (annotated above plots) are represented as two parameter density 
dot plots. (B) Correlation of cell frequencies obtained through traditional gating and with SPADE analysis 
are shown for the 102 samples as analyzed with linear regression. A dot represents a single sample.
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Figure S3.Traditional gating yields similar frequencies of major immune lineage cells as with SPADE analysis 
(A) Representative samples are shown to demonstrate the gating strategy applied to identify the major immune lineages: 
CD4+ T cells, CD8+ T cells, B cells, TCRγδ  cells, CD3-CD7+ cells and myeloid cells. Cells gated as shown (annotated above plots) 
are represented as two-parameter density dot plots. (B) Correlation of cell frequencies obtained through traditional gating 
and with SPADE analysis are shown for the 102 samples as analyzed with linear regression. A dot represents a single sample. 
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Figure S4. Tissue-specific composition of 
CD4+ T cell subsets. A heatmap summary 
of subset frequencies showing 102 samples 
and hierarchical clustering of samples with 
description of tissue type. EM = effector 
memory and CM = central memory
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Figure S4. Tissue-specific composition of CD4+ T cell subsets  
A heatmap summary of subset frequencies showing 102 
samples and hierarchical clustering of samples with 
description of tissue type. EM = effector memory and CM = 
central memory. 
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Figure S4. Tissue-specific composition of CD4+ T cell subsets  
A heatmap su mary of subset frequencies showing 102 
samples and hierarchical clustering of samples with 
description of tissue type. EM = ffector memory and CM = 
central memory. 
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Figure S5. Marker expression profiles and composition of immune subsets in peripheral blood 
and intestine. Heatmaps showing characterization of cell populations (median ArcSinh5-transformed 
values of marker expression; black-to-yellow scale), composition (average cell percentages; rainbow 
scale) and hierarchical clustering of markers and samples.
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Figure S5. Marker expression profiles and composition of immune subsets in peripheral blood and intestine 
Heatmaps showing (A) characterization of cell populations (median ArcSinh5-transformed values of marker expression; black-
to-yellow scale), (B) composition (average cell percent ges; rainbow scale) and hierarchical clus eri g of markers a d 
samples.  
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Figure S6. High-dimensional mass cytometry analysis pipeline. Samples containing single-cell data of 
cell populations of interest (e.g. based on SPADE analysis or gated subsets) are tagged with integer sample 
identification values, marker expression values are transformed using hyperbolic arcsin with a cofactor 
of 5, and cells events are downsampled to match sample cell number. Collective t-SNE dimensionality 
reduction was performed on the single-cell data derived from all the samples. A dot represents a single 
cell and color overlays illustrate marker expression values to deduce marker expression patterns. t-SNE 
maps are stratified for tissues and disease states to illustrate cellular ‘finger-print’ signatures. Pairwise 
Jensen-Shannon (JS) divergence analysis quantifies dissimilarity between a pair of t-SNE maps. On 
the basis of the map created by t-SNE, a machine-learning cell cluster detection approach (ACCENSE) 
delineates cell subsets. Heatmaps illustrate the phenotypic signature of the identified immune subsets 
and illustrate the composition of subsets within the samples. The cell frequency data of all the identified 
immune subsets are used to visualize samples in an integrated framework using the t-SNE algorithm, 
where a dot represents a single sample and the color overlay illustrates clinical information. Markers are 
indicated in letters, samples in roman letters and cell subsets in numbers.
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Figure S6. High-dimensional mass cytometry analysis pipeline  
Samples containing single-cell data of cell popula ons of interest (e.g. based on SPADE analysis or gated subsets) are 
tagged with integer sample iden fica on values, marker expression values are transformed using hyperbolic arcsin with a 
cofactor of 5, and cells events are downsampled to match sample cell number. Collec ve t-SNE dimensionality
performed on the single-cell data derived from all the samples. A dot represents a single cell and color overlays illustrate 
marker expression values to deduce marker expression pa erns. t-SNE maps are stra fied for sues and disease states to 
illustrate cellular ‘finger-print’ signatures. Pairwise Jensen-Shannon (JS) divergence analysis quan fies dissimilarity 
between a pair of t-SNE maps. On the basis of the map created by t-SNE, a machine-learning cell cluster detec on 
approach (ACCENSE) delineates cell subsets. Heatmaps illustrate the phenotypic signature of the iden fied immune 
subsets and illustrate the composi on of subsets within the samples. The cell frequency data of all the iden fied immune 
subsets are used to visualize samples in an integrated framework using the t-SNE algorithm, where a dot represents a 
single sample and the color overlay illustrates clinical informa on. Markers are indicated in le ers, samples in roman 
le ers and cell subsets in numbers. 
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Antigen Tag Clone Com. Cat# 
CD56 NCAM16.2 DVS 3176008B 
CD4 RPA-T4 DVS 3145001B 
CD8a RPA-T8 DVS 3146001B 
CD3 UCHT1 DVS 3170001B 
CD14 M5E2 DVS 3160001B 
CD19 HIB19 DVS 3142001B 
TCRgd 11F2 DVS 3152008B 
CD45 HI30 DVS 3154001B 
CD45RA HI100 DVS 3169008B 
CD27 O323 DVS 3167002B 
CD38 HIT2 DVS 3172007B 
CD127 AO19D5 DVS 3165008B 
CD11b ICRF44 DVS 3144001B 
CD7 CD7-6B7 DVS 3147006B 
CD34 581 DVS 3148001B 
C-Kit 104D2 DVS 3143001B 
CD161 HP-3G10 DVS 3164009B 
CD123 6H6 DVS 3151001B 
CCR6 G034E3 DVS 3141003A 
CD25 2A3 DVS 3149010B 
CCR7 G043H7 DVS 3159003A 
PD-1 EH 12.2H7 DVS 3175008B 
CD11c Bu15 DVS 3162005B 
CD8b SIDI8BEE eBio 14-5273 
CRTH2 BM16 BioL 350102 
TCRab 1P26 BioL 306702 
IL-21R 2G1-K12 BioL 347802 
IL-15Ra eBioJM7A4 eBio 14-7159-82 
CD103 Ber-ACT8 BioL 350202 
CD28 CD28.2 BioL 302902 
NKp46 9E2 BioL 331902 
CD122 TU27 BioL 339002 
176Yb 
145Nd 
146Nd 
170Er 
160Gd 
142Nd 
152Sm 
 154Sm 
169Tm 
167Er 
172Yb
165Ho 
144Nd 
147Sm 
148Nd
143Nd
164Dy 
151Eu
141Pr
149Sm
159Tb 
175Lu
162Dy 
166Er 
156Gd
150Nd 
153Eu
168Er
139La 
171Yb
174Yb
158Gd
Table S1. CyTOF antibody panel
 
 
 
 
 
 
 
 
 
 
 
Conc.
1:100
1:100
1:100
1:100
1:100
1:100
1:100
1:100
1:100
1:100
1:100
1:100
1:100
1:100
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1:100
1:100
1:100
1:100
1:100
1:100
1:100
1:50
1:50
1:50
1:50
1:50
1:100
1:100
1:100
1:200
DVS Sciences (DVS), eBioscience (eBio), and Biolegend (BioL).
The antibody panel was designed to obtain a global overview of the heterogeneity of the immune system. For this 
purpose, the panel included markers that distinguish the major immune cell lineages, i.e. CD4+ T cells, CD8+ T cells, TCRγδ  
cells, B cells, innate lymphocytes (CD3-CD7+) and myeloid cells. In addition, markers were included that allow the 
identification of phenotypically distinct subsets within those immune cell lineages, like naïve and memory cells, resting 
and activated cells. In addition, markers were included that provide information on additional differentiation stages of 
cells, homing properties of cells, and their potential responsiveness to humoral factors like cytokines and chemokines. 
Our choice in markers was biased towards phenotyping CD7-expressing lymphoid cells (T cells and CD3-CD7+ cells) rather 
than B cells and myeloid cells. 
The antibody panel was esigned to obtain a global overview of the heterogeneity of the immune system. 
For this purpose, the panel included markers that distinguish the major immune cell lineages, i.e. CD4+ T 
cells, CD8+ T cells, TCRγδ cells, B cells, innate lymphocytes (CD3-CD7+) and myeloid cells. In addition, 
markers were includ d that allow t  identification f phenotypically distinct subsets withi  those immune 
cell lineag s, like naïve and memory cells, resting and activated cells. In addition, markers were included 
that provide information on additional differentiation stages of cells, homing properties of cells, and their 
potential responsiveness to humoral factors like cytokines and chemokines. Our choice in markers was 
biased towards phenotyping CD7-expressing lymphoid cells (T cells and CD3-CD7+ cells) rather than B 
cells and myeloid cells.
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aTwo RCDII patients were biopsied twice at different time points.
bFour CD patients were rectally biopsied twice at different time points.
cAll 13 rectum biopsies of CD patients were non-inflamed, whereas all 6 fistula samples were inflamed.
dPBMC of CD patients were analyzed cryopreserved, whereas all other PBMC samples were analyzed 
fresh.
Celiac disease (CeD), refractory celiac disease type II (RCDII), enteropathy-associated T cell lymphoma 
type II (EATLII), Crohn’s Disease (CD), age at biopsy time point (AgeBiop), glutenfree diet (GFD), and 
peripheral blood mononuclear cells (PBMC)
  
Characteristics Ctrl  (N=15) 
CeD 
 (N=13) 
RCDIIa 
(N=5) 
EATLII 
(N=1) 
CDb 
(N=10) 
AgeBiop, (mean, ±SEM) 33.1±5.6 34.5±6.5 74.8±1.6 66 37.3±2.9 
Gender, N (%) 
 Male 5 (33.3) 6 (46.2) 5 (100.0) 0 (0.0) 3 (30.0) 
 Female 10 (66.6) 7 (53.8) 0 (0.0) 1(100.0) 7 (70.0) 
GFD, N (%) NA 
 No 13 (86.7) 5 (38.5) 0 (0.0) 0 (0.0) - 
 Yes 2 (13.3) 8 (61.5) 5 (100.0) 1 (100.0) - 
Type of Biopsy 
 Duodenum 15 13 7 1 - 
 Rectum - - - - 13 
 Fistula - - - - 6 
 PBMCd 14 13 6 - 14 
Inflamed gut biopsyc, N (%)
 No 14 (93.3) 6 (46.2) 2 (28.6)  0 (0.0) 12 (66.7) 
 Yes 1 (6.7) 7 (53.8) 5 (71.4) 1 (100.0) 6 (33.3) 
Marsh score biopsy N (%) NA NA 
 M0 14 (93.3) 6 (46.2) 2 (28.6) - - 
 M1 0 (0.0) 1 (7.7) 0 (0.0) - - 
 M2 0 (0.0) 0 (0.0) 0 (0.0) - - 
 M3a 1 (6.7) 1 (7.7) 2 (28.6) - - 
 M3b 0 (0.0) 4 (30.8) 1 (14.3) - - 
 M3c 0 (0.0) 1 (7.7) 2 (28.6) - - 
aTwo RCDII patients were biopsied twice at different time points. 
bFour CD patients were rectally biopsied twice at different time points. 
cAll 13 rectum biopsi s of CD patients wer  non-inflamed, whereas all 6 fistula samples were 
inflamed. 
dPBMC of CD patients were analyzed cryopreserved, whereas all other PBMC samples were 
analyzed fresh. 
Celiac disease (CeD), refractory celiac disease type II (RCDII), enteropathy-associated T cell 
lymphoma type II (EATLII), Crohn’s Disease (CD), age at biopsy time point (AgeBiop), gluten-
free di t (GFD), and peripheral bloo  mononuclear cells (PBMC). 
Table S2. Characteristics of control and patients with inflammatory intestinal diseases
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It has long been thought that the human fetal immune system develops in a 
sterile womb without exposure to foreign antigens. Therefore, the developing 
immune system is considered to be immature. However, due to the challenge to 
obtain fetal tissues, much of our understanding of the developing fetal immune 
system is based on studies performed with cord blood collected from preterm or 
term babies. Moreover, in recent years, several lines of evidence have challenged 
the dogmas about both the sterile environment in utero and the immature status 
of the developing fetal immune system. With the introduction of advanced single 
cell analysis methods, novel opportunities have become available to characterize 
the heterogeneity and composition of the immune system with unprecedented 
resolution. In this thesis, I have taken advantage of this opportunity to analyze 
the human fetal innate and adaptive immune compartments in the spleen, 
liver and intestine during the second trimester. The results demonstrate an 
early-life immune compartmentalization across the tissues before birth. By 
applying advanced computational and visualization tools I was able to identify 
putative differentiation trajectories in the developing intestine, results that were 
corroborated by functional analysis in vitro.
Diversity in the innate immune compartment and identification of a novel 
ILC subset
To explore the heterogeneity and development of the immune system in the 
human fetal intestine, we used mass cytometry with a 35-antibody panel that was 
designed to capture heterogeneity in both the innate and adaptive compartments. 
In chapter 2 we focused on the innate lymphoid cell (ILC) compartment. Here, 34 
phenotypically distinct innate lymphoid cell clusters were distinguished, including 
previously identified NK and CD127+ ILC subsets as well as several previously 
unrecognized clusters, providing evidence for extensive heterogeneity in the 
innate compartment. In particular, we identified a Lin-CD7+CD127-CD45RO+CD56+ 
subset that by unbiased hierarchical clustering was positioned in between the 
known NK cell and CD127+ ILC subsets, suggestive of potential developmental 
relationships with both the NK cells and CD127+ ILCs. 
The differentiation of ILCs has been well studied in mice whereas there are 
fewer studies on human ILC development1, 2. Also, a recent report demonstrated 
that human ILC development was distinct from the established murine model3, 
which highlights the need to conduct research directly on human samples. The 
differentiation of cells or transition from one subset to another usually exhibits 
stepwise changes in the transcriptional program and protein expression profiles. 
t-SNE is exceptionally well suited to integrate such gradual changes for many 
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markers simultaneously and in Cytosplore we were able to visualize the t-SNE 
computation over time. Therefore, we made use of this approach to probe potential 
cell differentiation trajectories in the fetal intestine (Chapter 2 and 3). This 
provides compelling evidence that in all 7 intestinal samples the int-ILCs clustered 
in between and connected to both the ILC2s, ILC3s and NK cells. By designing a 
minimal flow cytometry panel based on the mass cytometry data we were able 
to identify and isolate the int-ILC by conventional flow cytometry. Furthermore, 
in functional assays we validated that int-ILCs can generate both NK cells and 
ILC3s in vitro (Chapter 2). Consistent with our findings, Chen et al. identified 
an intermediate ILC subset in human tonsil that could give rise to NK cells and 
ILC3s3. Similar to our CD117+CD94- int-ILCs, this subset lacked the expression 
of CD34, CD127 and CD94, but expressed CD56 and CD117. Also, Chen et al. 
showed that the CD56- counterpart of this intermediate ILC could give rise to 
ILC2s. As ILC2s were prominent in the fetal intestine (about 5% of total ILCs) and 
were found to be connected with int-ILCs, we investigated whether the int-ILCs 
could differentiate into ILC2s as well. As we observed a sub-population of CD8a- 
int-ILCs expressing high level of GATA3, a masker transcriptional factor for ILC2 
function and differentiation, we flow purified these CD8a- int-ILCs and stimulated 
them with ILC2 stimuli (IL-7, SCF, IL-2, IL-4, IL-25 and IL-33) in an OP9-DL1 co-
culture system. However, under these conditions the cell surface phenotype of 
the int-ILCs remained unchanged. Further research is thus needed to clarify the 
putative relationship between int-ILC and ILC2.
ILC plasticity has been extensively addressed in both mouse and human, where 
certain ILC subsets will convert into other subsets after the appropriate cytokine 
stimuli4, 5, 6. As shown in chapter 2, all ILC subsets except ILC1s were identified 
in the human fetal intestine. Moreover, we observed a clear trajectory between 
ILC2s and ILC3s, suggesting that ILC2s may convert into ILC3s in utero as 
there is a virtual absence of ILC2s in the intestine after birth7. Furthermore, we 
noticed that the CD8a- int-ILCs-derived ILC3s and NK cells could partly revert 
their phenotype upon exposure to appropriate cytokine stimuli, suggesting that 
the int-ILCs may represent an intermediate subset between two plastic lineages. 
Importantly, the majority of the ILC subsets defined in the intestine including int-
ILCs were not found in the spleen and liver as shown in chapter 4, indicative of 
specific functions in the mucosa. The factors in the tissue microenvironment that 
promote the differentiation of int-ILC into NK cells and ILC3s need to be further 
investigated in the future. 
To extend the understanding of ILCs, the composition of ILCs in the fetal spleen 
and liver were determined in chapter 4 and additional heterogeneity was 
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observed in several NK clusters compared with the fetal intestine, likely reflecting 
distinct functions in each tissue microenvironment. Furthermore, several new 
clusters were identified with this unbiased data-driven analysis approach, such 
as the CD8a+ ILC3s. This raises the issue of the biological significance of these 
and other clusters identified by high-dimensional mass cytometry. Therefore, it 
is important to validate these clusters and distinguish them functionally from 
previously identified subsets in future studies. However, our systemic and detailed 
studies of ILCs in fetal tissues have already advanced the understanding of ILC 
biology in human.
Memory formation in the human fetal intestine
One of the main features of adaptive immunity is the formation of immunological 
memory, where T cells play a critical role. Naive T cells recirculate through 
lymph nodes where they encounter peptide epitopes presented by major 
histocompatibility complex (MHC) class molecules on professional APCs such as 
DCs. After recognition of a given peptide-MHC complex, naive T cells proliferate 
and differentiate into effector cells, which migrate to the infection site and clear 
the pathogen. Thereafter the majority of the effector cells die, however, a small 
proportion survive as memory cells, which mediate the anamnestic immune 
responses upon encounter with the same pathogen. In the current thesis, we 
dissected the CD4+ T cell compartment in the human fetal intestine using an 
array of advanced single cell technologies, which revealed the presence of three 
major populations: TN, TM and Tregs (Chapter 3). Furthermore, with an array of 
computational tools including diffusion map, principal component analysis (PCA), 
Vortex and developing t-SNE, a linear differentiation trajectory was revealed. In 
this trajectory TN cells clustered next to CD161-/low TCM and CD161-/low TEM cells, 
and the latter connected to CD161+ TEM cells in both single cell mass cytometry 
and single cell RNA-seq datasets, consistent with CD4+ T cell memory formation 
in the fetal intestine. Moreover, pseudotime analysis revealed an up-regulation of 
TCR signaling associated transcripts at the end of TN-TM trajectory, which further 
underpinned the formation of memory T cells in the fetal intestine. These results 
are in line with a previous study that revealed a similar linear differentiation 
model of memory formation in circulating CD4+ T cells based on genome-wide 
profiles of DNA methylation, histone modifications and DNA accessibility8. A linear 
differentiation model was also observed in the human CD8+ T cell compartment9, 
10. 
CD45RO is considered a marker for memory T cells, however, the majority of the 
CD4CD8 double-positive and 80% of the single-positive thymocytes are CD45RO+ 
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as well. Consequently, the occurrence of the isoform switching from CD45RO to 
CD45RA is considered one of the final steps in the maturation of T cells in the 
thymus11. This brings the possibility that the occurrence of CD45RO cells in the 
human fetal intestine might be due to thymic emigrants that have not switched 
from CD45RO to CD45RA. However, our mass cytometry analysis demonstrated 
that the TM cells in the fetal intestine expressed CD161 and CD127, while these 
markers were not expressed by single-positive thymocytes in the fetus (Data not 
shown). Together with the abundance of CD45RA+ TN cells in cord blood and the 
observation that the fetal intestinal TM cells readily produced cytokines, it is highly 
unlikely that the fetal intestinal TM cells are derived from CD45RO thymocytes. 
However, the possibility that (a proportion) of the intestinal memory CD4+ T cells 
originate from the mother still needs to be investigated through HLA typing or 
genotyping.
In the absence of foreign antigen exposure, the generation of memory-like T 
cells has been reported in mice. These antigen-inexperienced memory-like T cells 
harbored two main subsets: “innate memory” T cells and “virtual memory” T 
cells. The development of the former subset depends on IL-4 and thymic PLZF+ 
cells, whereas the latter need IL-15 and CD8a+ DCs12. However, these antigen-
inexperienced memory-like T cells were found predominantly in the CD8+ T cell 
compartment12 and only few studies reported the formation of such T cells in 
the CD4+ T compartment13, 14. While in man CD45RO+ memory-like T cells have 
been identified in the fetal spleen15, 16, these cells were able to proliferate upon 
stimulation with IL-2 but not after CD2 or CD3 cross-linking, indicative of an 
anergic state16. Therefore, these cells are distinct from the CD45RO+ memory-like 
cells that we identified in the human fetal intestine (Chapter 3 and 4), as these 
readily produced IL-2, IFN-γ, IL-4, granzyme B and large amounts of TNF after 
stimulation. 
Migratory DCs were found to be virtually absent before week 16 of gestation in 
the human fetus17. Consistent with this previous report17, our single-cell RNA-seq 
analysis of fetal intestinal cells identified a cluster of APCs, which displayed high 
expression levels of genes encoding HLA-DR, CD74 (HLA-class II invariant chain), 
CD80, CD86 and chemokine receptor CCR7. As CCR7 mediates DCs migration to 
lymph nodes in adults18, this would be compatible with priming of naive T cells in 
the mesenteric lymph nodes followed by homing of the resulting memory T cells to 
the lamina propria after week 16 of gestation. Also, we observed clonal expansion 
of intestinal TM cells. Together, our data in chapter 3 provide strong evidence for 
the formation of the bona fide memory CD4+ T cells in the developing human fetal 
intestine in utero.
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Nature of the antigens
The formation of memory T cells in the human fetal intestine (Chapter 3) suggests 
that this occurs due to exposure to (foreign) antigens. Strikingly, a marked clonal 
overlap in CDR3 amino acid repertoires was observed between memory CD4+ 
T cells isolated from different fetal intestinal samples, suggesting exposure to 
similar antigen(s). 
It is well established that maternal cells can cross the placental barrier and reside 
in the human fetal tissues from the second trimester onward during pregnancy, a 
phenomenon defined as “microchimerism” that can persist throughout adulthood19. 
In addition, it has been reported that non-inherited maternal antigens (NIMAs) 
promote the differentiation of human fetal CD4+ T cells19, presumably due to the 
direct contact between the fetal immune system and the semi-allogeneic maternal 
cells. Thus, some of the memory CD4+ T cell responses in the fetus may result 
from this. However, as the memory formation was most pronounced in the fetal 
intestine and not in the fetal spleen and liver, it is highly unlikely that this is solely 
due to exposure to NIMAs.
It is now well established that the microbiota plays an important role in the 
development and shaping of the function of the immune system. However, in 
fetal life the infant has been thought to be protected from exposure to foreign 
antigens20, a dogma that has been challenged by the detection of microbiota in 
the placenta21, amniotic fluid22 and meconium23. Although it is highly unlikely that 
there will be an abundance of viable microbes that pass the placental barrier, it is 
conceivable that microbial-derived antigens derived from the maternal intestinal 
microbiota will reach the amniotic fluid and as such reach the lumen of the fetal 
intestine where they could prime CD4+ T cell responses. In addition, it has been 
reported that infection with cytomegalovirus is one of the most common causes 
of congenital infection and that cytomegalovirus-specific T cell responses can be 
detected in early life24, 25, which might also lead to the priming of T cell responses 
in fetal life. In addition, allergen-specific T cells have been detected in cord blood26, 
27 and antigen-specific fetal T cells have also been detected in children whose 
mothers were infected with human immunodeficiency virus (HIV)28, hepatitis C 
virus (HCV)29 and malaria30. However, in our current studies, we used materials 
from fetuses obtained from mothers with a healthy pregnancy making it unlikely 
that the formation of memory T cells is driven by HIV, HCV or parasites. Rather 
we speculate that the memory CD4+ T cells in the fetal intestine are specific 
for microbial antigens derived from the mother. Therefore, we are currently 
investigating if intestinal T cell lines can be generated from fetal samples that are 
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specific for such microbial antigens. For this purpose, HLA-typed fetal intestinal 
cells are cultured with lysates of relevant intestinal bacterial strains and propagated 
with cytokines and repeated antigen stimulation in the presence of HLA-matched 
antigen presenting cells. The specificity of such primary cultures and T cell clones 
derived thereof will subsequently be determined in cell proliferation and cytokine 
secretion assays. It is tempting to speculate that the composition of the microbiota 
of the mother may determine the imprinting of the mucosal immune system in the 
fetus already at this early age and that this may have consequences later in life.
Although the frequency of Tregs identified in our studies (Chapter 3 and 4) is 
lower than expected, we did observe clear clonal expansions in the CD45RO+ Tregs 
compartment and a separate differentiation trajectory of the Tregs compared with 
TM cells in the intestine (Chapter 3). Thus, the relationship between these cell 
subsets and the nature of the antigens that drive the expansion of the CD45RO+ 
Tregs warrants further investigation. 
In this respect it is interesting that Glanville et al. developed an elegant algorithm 
termed GLIPH (group of lymphocyte interactions by paratope hotspots), which 
can cluster TCRs that have a high probability of sharing specificity, taking both 
conserved motifs and global similarity of complementarity-determining region 3 
(CDR3) sequences into account31. As fetal intestinal T cells will be exposed to a 
large repertoire of microbes upon birth, it will be of interest to apply this algorithm 
to our TCR-sequencing dataset as a means to identify commonalities in the TCR 
repertoire, which may point to the specific antigens that drive the formation of the 
TM and CD45RO+ Tregs. 
Immune compartmentalization across and within tissues
It is well established that the anatomical tissue location of T cells is of great 
importance for their T cell function in both mice and man32, 33. Recently, Farber et 
al. demonstrated early-life compartmentalization of human T cells with abundant 
naive T cells in the pediatric blood and almost all tissues and abundant effector 
memory T cells in pediatric lung and small intestinal tissue only34. Here, we 
utilized high-dimensional mass cytometry to profile the immune landscape in fetal 
intestine, spleen and liver (Chapter 4) with a 35-antibody panel. In line with the 
previous study, fetal intestines harbored memory-like T cells, whereas most T cells 
in fetal spleens and livers displayed a naive-like phenotype, indicative of T cell 
compartmentalization as early as the second trimester. Moreover, mass cytometry 
analysis of fetal DCs derived from spleen, thymus, lung and intestine revealed 
substantial heterogeneity between these tissues, suggestive of different tissue 
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imprinting17. Very recently, Yudanin et al. have reported that the tissue location 
differentially impacted the composition of ILCs in human as well35, supporting our 
finding of site-specific ILC signatures across fetal tissues. Our study in chapter 4 
was one of the first to show the existence of the early-life compartmentalization 
of the immune cells across tissues within almost each immune lineage in utero, 
which suggests different immune responses in situ and further highlights the 
importance of tissue environment on the development of immune cells. Moving 
on from the fetus to the adult, our study in chapter 5 also provides evidence 
for the regional specialization within the intestinal immune system in adults. 
Therefore, the integrated high-dimensional analysis provides a global and deeper 
understanding of the entire immune system and is in line with a local and tissue-
specific immune signature.
Functionality of the clusters
The number of phenotypically distinct immune clusters has increased significantly 
due to the introduction of high-dimensional single-cell techniques such as mass 
cytometry and RNA-sequencing. This raises the question to what extent such clusters 
represent functionally distinct entities. In this thesis, clusters were distinguished 
by differential expression of at least one protein or gene. In chapter 2 and 3, 34 
and 22 phenotypically distinct clusters were revealed in the intestinal ILC and CD4+ 
T cell compartment based on the marker expression profiles, respectively. To allow 
further functional studies with the identified clusters, a minimal marker gating 
strategy was designed to identify and isolate clusters of interest by conventional 
flow cytometry. By applying this approach, we demonstrated that the int-ILCs 
can differentiate into NK cells and ILC3s in vitro and the differentiation trajectory 
and cytokine production profiles supported the observation of the generation of 
intestinal memory T cells in the fetus. Therefore, this proved to be an useful 
approach where mass cytometry is used as an exploratory tool leading to novel 
hypotheses that can be further tested in functional assays (Figure 1). 
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that high school training will be difficult to 
achieve, the next starting point would be 
undergraduate programs at colleges and uni-
versities. Programs that specialize in molecular 
life sciences should at least integrate immunol-
ogy and bioinformatics. Learning some basics 
in big data science and programming would 
allow the next generation of scientists to use 
the wealth of data ahead much better than we 
can do it today (Box 2). These young scientists, 
who will already be digital natives concerning 
the use of the internet, should become natives 
of the interface between immunology and 
big data science and computational biology. 
As with any type of dual citizenship, speak-
ing both languages perfectly will be the key to 
success. Further specialization can follow after 
the bachelor’s degree. Depending on the edu-
cation system, this should be either integrated 
into master’s studies (as in Europe) or directly 
into graduate programs during the PhD phase 
(as in the US). One could envision a master’s 
program on molecular and systems immunol-
ogy covering classical aspects of immunology 
(innate immunology, adaptive immunology, 
infection immunology and tumor immunol-
ogy) but also integrating clinical immunol-
ogy, genomics and other omics technologies, 
bioinformatics, big data science and systems 
immunology.
During the PhD phase, an additional level 
of training in big data science, systems immu-
nology or computational biology should be 
offered to young immunologists. There are 
at least four levels of expertise to be reached. 
A minimum level of expertise would be to know 
about existing big data in the public domain, 
of omics technologies in human immunol-
ogy needs to be reflected in the curricula of 
our training programs. Moreover, our ability 
to measure genomic differences between indi-
viduals and species and to map microbiomes 
from different organs (all requiring big data 
generation and analysis) will lead to mandatory 
reporting of such omics data in animal mod-
els addressing human diseases. Particularly 
for those immune-related diseases for which 
genetic, epigenetic or microbiome informa-
tion can be obtained with a reasonable effort 
in humans, it can be foreseen that increasing 
requirements for reporting full genome and 
microbiome information in the respective ani-
mal models will shift research toward human 
immunology.
With such a setting in mind, the following 
scenario can be proposed. An integration of 
bioinformatics, genomics, big data science 
and systems biology into our undergraduate 
and graduate programs in immunology would 
be most favorable (Box 1). Currently, nobody 
would ask for a specialized master program in 
genetic mouse modeling. Yet an understand-
ing of at least the basics of genetic engineering 
in the mouse is a prerequisite for cutting-edge 
immunological research, and it is an integral 
part of study programs in immunology. Big 
data science and systems approaches now need 
to become equally integral components of our 
immunological study programs. For most insti-
tutions, this will require close collaborations in 
teaching with computer science, informatics, 
bioinformatics and mathematics departments.
Another issue is timing. When should we 
start to train young immunologists? Given 
autoantigen peptides to bind these receptors. 
Another example is the combination of tran-
scriptome data with extended bioinformatics 
to dissect activation of immune cells on a mul-
tidimensional scale13, along a time scale14 or 
both. Transcriptomes are an excellent starting 
point to determine transcriptional regulatory 
networks during immune cell activation. Such 
networks can be enriched for specific classes of 
genes (for example, transcription factors) that 
can be examined in subsequent experiments fol-
lowing a prioritization based on the hierarchy 
defined by unbiased computational modeling 
of transcriptome data. Another source of big 
data is the recently introduced single-cell RNA 
sequencing technologies that will revolutionize 
the way we will define immune cell subsets in 
the near future15,16.
Future training programs for immunology
To design future training programs in immu-
nological big data science, we need a clear 
vision and understanding about the role 
immunology should have in the future. There 
might be differences between centers or uni-
versities and from country to country, but big 
data will play a role in all settings. The advent 
of omics-based big data science will allow the 
assessment of human immune parameters in 
unprecedented detail and in an integrated fash-
ion using data from different high-throughput 
technologies. Moreover, it is becoming increas-
ingly clear that species-specific genetic, epigen-
etic and microbiome-mediated mechanisms 
are important modulators of immune-related 
mechanisms and diseases and are best stud-
ied in humans using omics-based technolo-
gies17–19. As stated by others, this will create 
new interest in human immunology in the 
decades to come20,21, and therefore the use 
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Figure 1  The circle of systems immunology. The 
big data–driven circle of systems immunology as a 
strategy to use big data to generate hypotheses in 
a data-driven fashion to use prioritized database 
hypotheses for further experimental validation 
by classical approaches using loss- and gain-of-
function experiments, in vivo modeling of disease, 
murine genetic models and other functional and 
observational approaches such as live cell imaging 
or flow cytometry. 
Box 1  Suggestions for future undergraduate immunology programs
Minimum requirements
Initiate interdisciplinary, interfaculty or interdepartmental study programs—at least the 
following departments or disciplines should be involved:
• Immunology
• Computational sciences
• Molecular medicine or biology
• Genetics or genomics
Integrate lectures, courses and seminars in bioinformatics and genomics into the study 
program:
• These lectures, courses and seminars should be mandatory (not elective)
• Team up with the computational science; make sure the courses are geared towards
computational approaches applicable to immunological research
• Practical courses should include experience in real data analysis
• Include lab rotations in computational science labs as part of the study program,
together with a lab rotation report
Further suggestions
Offer additional courses in big data sciences and systems immunology:
• These lectures could be elective
• Team up with systems biology big data science departments; make sure the courses
 are geared towards approaches applicable to immunological research
• Offer access to learning a programming language (elective)
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Figure 1 Big data–driven circle of systems 
immunology. Big dataset can be used to 
generate novel hypotheses in an unbiased 
data-driven fashion for further experimental 
validation using the classical approaches 
such as loss- and gain-of-function 
experiments, different murine models and 
other functional assays with flow cytometry. 
Adapted from Schultze (2015).
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Interestingly, the int-ILCs were a main contributor to the separation of non-affected 
inflammatory bowel disease (IBD) (control biopsies) and affected IBD biopsies 
that contained NK cells and ILC3s (Chapter 5). Thus, the int-ILC may give rise 
to NK cells and ILC3s in the intestine in the inflammatory context. Compared with 
the phenotype of intestinal ILCs in adult, fetal intestinal ILCs mainly expressed 
CD45RO, a marker expressed by memory T cells. As it has been reported that 
CD45RO+ ILC3s produced higher amounts of IL-17, IL-22, GM-CSF, TNF and 
IL-8 than the CD45RA+ ILC3s36, the function of these CD45RO+ ILCs need to be 
investigated in the future. Consistent with previously finding37, we did not find IL-
17A-producing CD4+ T cells in the fetal intestine, indicating that the generation of 
such cells takes place at a later time point and is associated with the post-natal 
exposure to the microbiota. Of note, a subgroup of the memory-like CD4+ T cells 
expressed CCR6 and CD117. As the former marker is associated with Th17 cell 
differentiation, these cells may be the precursor for the Th17 cells. Alternatively, 
the expression of CD117 may indicate that these cell represent a reservoir of 
memory cells that can rapidly expand when stem cell factor is released. Thus, 
the function of these cells warrants future investigation. In addition, the intestinal 
CD4+ T cells produced not only Th1- and Th2-type cell cytokines, but also IL-2, 
granzyme B and TNF. Recently, it has been shown that low numbers of TNF+CD4+ 
TEM cells promoted intestinal epithelial development, whereas high numbers 
impaired the epithelial development38, pointing to a non-immune function of these 
cells. However, these cells can also mediate an intestinal inflammatory response 
in preterm babies that may contribute to the necrotizing enterocolitis38. Thus, 
tight regulation of these memory CD4+ T cells is crucial already at a very early 
age, which may be reflected by the prominent Treg compartment in the developing 
fetal intestine. Together, these data illustrate that studies on the early-life immune 
system can potentially contribute to the understanding of derailed immune-
associated diseases later in life. With the identification of the 177 and 142 immune 
clusters in different fetal tissues and in the intestinal biopsy and PBMCs through 
the unbiased data-driven approach, respectively (Chapter 4 and 5), there is a 
clear need to further determine the functional significance of these clusters in 
future studies.
Spatial distribution of the immune subsets in tissue microenvironment 
Next to cell types, the cellular organization and cell-cell interactions play an 
important role in the maintenance of the appropriate tissue function. The tissue 
architecture and relationships between cells are lost when using mass and flow 
cytometry, however, imaging-mass cytometry breaks this limitation, as it can 
measure up to 40 markers in a single tissue section at 1 μm resolution, which thus 
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allows for an in-depth analysis of tissue structure39. We were one of the first to 
use imaging-mass cytometry in the Netherlands. Using this promising technique, 
the co-localization of the CD4+ T cells with HLA-DR+CD163+ APCs and CD127+ ILCs 
was revealed in the fetal intestine, which suggests functional interactions between 
these types of cells in the developing fetal immune system (Chapter 3 and 4). 
With the identification of a large number of phenotypically distinct cell clusters 
in both the innate and adaptive immune compartment within and across tissues, 
we were able to visualize the early-life immune compartmentalization in the fetal 
tissues in situ by using imaging-mass cytometry (Chapter 4 and Figure 2). 
Therefore, imaging-mass cytometry provides an unique opportunity to determine 
immune heterogeneity and cell-cell interactions in situ, providing another layer 
of understanding of the immune system. Furthermore, imaging-mass cytometry 
makes it possible to investigate issues that were raised in observations made in 
the current thesis. For example, we observed that int-ILCs can differentiate into NK 
cells and ILC3s during co-culture with stromal cells (OP9-DL1) in vitro (Chapter 
2). Consequently, better understanding of the neighborhood of int-ILCs may help 
to put this observation in the tissue context. Also, we expect that the determination 
of spatial location of the distinct CD4+ TM cell clusters and the interaction of these 
memory T cells with stromal cells and other innate or adaptive immune cells in 
the human fetal intestine will shed light on the cellular interactions underlying the 
generation of various CD4+ memory T cells populations in utero. In this respect, it 
will also be very interesting to study the development of fetal lymphoid structures 
like Peyer’s patches. Finally, the intestine has been considered as “the second 
brain” in our body and it has been reported that ILCs are adjacent to mucosal 
neurons40, 41, so application of the imaging-mass cytometry on the human fetal 
intestine can provide more insights into the development of the mucosal neuronal 
network and its interactions with the developing immune system. 
Imaging-mass cytometry data can be visualized by an overlay of individual makers 
as in traditional immune fluorescence staining. However, the limited number of 
markers that can be visualized simultaneously is not compatible with the complex 
multiplexed imaging-mass cytometry data. Up to recently, only few tools have 
been developed to analyze imaging-mass cytometry data, such as CellProfiles42 
and histoCAT43, which mainly work at the cellular level. Therefore, the analysis 
of imaging-mass cytometry data is still a big challenge in this field. Besides the 
development of the Imacyte toolkit (accepted), which facilitates the analysis 
of imaging-mass cytometry data at the cellular level, in collaboration with the 
bioinformaticians in the LUMC and TU Delft we have extended this analysis to the 
pixel level (Figure 2) using another in-house developed software tool (Cytosplore 
Imaging, unpublished), which allows an in-depth exploration of the data at the 
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Figure 2 Spatial distribution of the entire immune cells reveals the early immune 
compartmentalization across tissues in situ. (A) Pixels derived from PBMCs (1ROI), fetal intestine 
(4ROIs), fetal spleen (2ROIs) and fetal livers (2ROIs) based on the expression of E-cadherin, Vimentin, 
SMA, D2-40, collagen I and CD45 Cytosplore Imaging software (unpublished). This yielded distinct color-
coded clusters of pixels that were projected back onto the original images to obtain a global overview of the 
tissue architecture, reflecting the overall morphological differences between the tissues. Representative 
mass cytometry images of the PBMCs control, a fetal intestine, spleen and liver, showing the spatial 
distribution of the immune and stromal clusters. HSNE embedding of all the pixels derived from the 
PBMCs control, a fetal intestine, spleen and liver. Colors represent the different cell clusters. Scale bar: 
200 μm. (B) The similar analysis were performed on the CD45+ pixels based on the 26 immune makers. 
Representative mass cytometry images of the PBMCs control, a fetal intestine, spleen and liver, showing 
the spatial distribution of only the immune cell pixels. t-SNE embedding of the CD45+ pixels derived from 
the PBMCs control, a fetal intestine, spleen and liver. Colors indicate the XY-coordinates of the t-SNE 
plot. Scale bar: 200 μm. 
subcellular level. Currently, we are integrating the analysis at the pixel level with 
that at the cellular level in the tissue context. In the future, we would like to 
integrate the imaging-mass cytometry data with mass cytometry and RNA-seq 
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data. Eventually, a 3D image of the fetal tissues could also be reconstructed by 
using a series of tissue sections, in which the entire network between immune cells 
and surrounding stromal cells could be visualized in the tissue microenvironment.
Although there are many advantages to imaging-mass cytometry, a fundamental 
limitation is the speed of acquisition: 1 mm2 in 2 hours. This hampers the 
identification of rare cell populations such as the int-ILCs and CD117+ T cells 
in the tissue samples. To overcome this limitation, we are currently developing 
7-color Vectra antibody panels to detect int-ILCs in sections to allow preselection 
of regions of interest (ROIs) in a serial section for analysis with imaging-mass 
cytometry. Such an approach can also be applied to tissue samples from patients 
where there is substantial heterogeneity in the cell distribution patterns, such as in 
tumors or inflamed intestine. Finally, imaging-mass cytometry can also be used as 
an explorative tool to identify disease-specific clusters in the tissue context. This 
can form the basis for the development of a targeted Vectra or immunochemistry 
antibody panel to detect such disease-specific features for diagnostic and/or 
prognostic purposes. 
System immunology
System immunology is a new approach, where the immune system is investigated 
by integrating the results of a variety of approaches including single-cell mass 
cytometry, (single-cell) transcriptomics, TCR and BCR repertoire sequencing, 
metabolomics, proteomics, multiplexed imaging and epidemiology44. In chapter 
3, we used this approach by combining results obtained from single-cell mass 
cytometry, with single-cell RNA sequencing, TCR sequencing, flow cytometry 
and imaging-mass cytometry, to investigate the CD4+ T cell compartment in the 
human fetal intestine. Here, all techniques used reinforced the conclusion that 
memory-like CD4+ T cells are generated in the human fetal intestines in utero. 
Such a multidisciplinary systems immunology approach is particularly useful 
for studies on the human immune system as there are very limited possibilities 
for experiments to determine causal correlations in vivo. Importantly, for such 
a cooperative approach, a multi-disciplinary team of clinicians, technicians, 
bioinformaticians and immunologists is crucial to the success. Continuous 
integration of novel technologies will further enhance the power of this approach. 
For example, at the time we were conducting our studies, Cite-seq to quantify the 
expression of proteins and transcripts simultaneously at the single-cell level was 
not yet available so we had to rely on indirect approaches to distinguish between 
CD45RA+ and CD45RO+ T cells. Thus, with the development of more advanced 
techniques such as the third generation RNA sequencing, imaging-mass cytometry 
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and the scalable, interactive and user-friendly computational tools, the system-
immunology approach will provide us an unique opportunity to determine how the 
complex immune system operates in the tissue niche in health and disease.
A prenatal window of opportunity? 
The early postnatal period is considered a period in which environmental factors 
strongly affect the development of the immune system, which is likely linked 
to protection or susceptibility to a variety of immune-mediated diseases later in 
life45. In several studies, the impact of environmental factors on the fetal immune 
system have been investigated. Van de Pavert et al. reported that there was a 
significantly reduction of the lymph size and a decrease of the immune response 
efficiency in offspring that was fed a vitamin A-deficient diet46. Furthermore, an 
elegant study has shown that the maternal microbiome reprogramed the intestinal 
transcriptional expression profiles and shaped the immune composition of the 
offspring47. Also, allergen-specific T cell reactivity has been found in cord blood 
as early as week 23 of gestation26, 27 and, as mentioned above, antigen-specific T 
cells have been identified in fetuses whose mothers were suffering from human 
cytomegalovirus (HCMV)25, 48, 49, HIV28, hepatitis C virus29, malaria30, Cruzi50 and 
toxoplasmosis51 infection during pregnancy. Consistent with these findings, in the 
present study, tissue-resident memory-like CD4+ T cells have been identified in 
the fetal intestine whose mothers were with the normal pregnancy as early as 
the second trimester (Chapter 3). Moreover, DCs were identified in the human 
fetal intestine (Chapter 3 and 4), which may mediate T cell priming17. Also, 
intestinal NK cells readily produce granzyme B and perforin, suggesting functional 
maturation of NK cells in the developing fetus as well (Chapter 2). The formation 
of memory CD4+ T cell responses is accompanied by the appearance of Foxp3+ 
Tregs in several fetal tissues, the fetal intestine in particular (Chapter 3 and 4). 
In addition, it has been shown that fetal DCs strongly induced the production 
of Tregs17. Finally, several B cell clusters were CD20+CD27intCD38+, indicative of 
a regulatory B cell phenotype, in the fetal tissues. As such it is likely that the 
fetal immune system can be “trained” by the maternal-derived environmental 
factors before birth, which may provide an opportunity for the development of 
preventive strategies for the development of immune-mediated diseases such as 
celiac disease, inflammatory bowel diseases and allergy by influencing the balance 
between the development of memory CD4+ T cells and Foxp3+ Tregs in utero. 
Conclusions and future perspectives
Our studies provide a global, comprehensive and detailed description of the fetal 
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immune system during healthy pregnancy by integrating an array of advanced 
high-parameter single-cell techniques. We further determined the function of 
several identified cell clusters and identified a novel intestinal ILC subset that can 
give rise to NK cells and ILC3s in vitro (Figure 3), which adds another layer of 
understanding of ILC differentiation and plasticity. The full differentiation potential 
of this new subset needs to be explored in the future. What’s more, we revealed 
the generation of memory-like CD4+ T cells in the developing human fetal intestine 
(Figure 4), indicating the exposure to antigens in utero. Determination of the 
nature of the antigens, as well as the function of these memory-like T cells would 
be crucial for understanding the transition from the relatively “clean” womb to 
the relatively “dirty” external world. Additionally, the observation of site-specific 
immunity highlighted the importance to investigate the immune system in the 
tissue niche. The crosstalk between immune cells and surrounding stromal cells 
can now be determined using imaging-mass cytometry, which can be integrated 
with other omics data as well. Next to the immune landscape of the fetal spleen, 
liver and intestine that we have described, it will be relevant to investigate the 
composition of the developing immune system in other fetal lymphoid and non-
lymphoid tissues. In particular, comparisons of the fetal immune system at several 
time points in gestation and the neonatal period would be worthwhile as this will 
give a global picture of the development of human immune system and fill the 
gaps between prenatal and neonatal immunity. Overall, the results presented 
in the current thesis deepens our understanding of prenatal immunity and may 
ultimately be useful for the development of “early” intervention strategies to 
prevent the development of immune mediated diseases later in life. 
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Figure 3. Differentiation of int-ILCs. Monitoring t-SNE computation dynamics predicts the potential 
differential trajectories in silico (upper panel). Upon co-culturing with OP-DL1, the int-ILCs can give rise 
to NK cells (blue) and ILC3s (green) (bottom panel).
Figure 4. Memory generation of CD4+ T cells in the human fetal intestine. Phenotypically distinct 
naive (CD45RA+) and memory-like (CD45RO+) CD4+ T cells reside in the human fetal intestine at 
the second trimester during healthy pregnancy. The naive CD4+ T cells can produce TNF and IL-2, 
whereas memory-like T cells can produce not only TNF and IL-2, but also IFN-γ, IL-4 and granzyme 
B (GzmB), indicating functionality of the CD4+ T cell compartment. The identification of resident DCs 
and migratory DCs in the intestinal lamina propria and mesenteric lymph nodes (mLNs) by the second 
trimester prompted us to speculate their role in the generation of functional fetal memory-like CD4+ 
T cells. Although commensal microbe-derived antigens or NIMAs have been thought to be important 
in the memory generation of fetal intestinal T cells, the antigen specificity of these fetal memory-like 
CD4+ T cells remains unidentified. Adapted from Lim et al. (2019).
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regulatory responses7, a phenomenon that 
might contribute to the shaping of the ‘tone’ 
of the immune system after birth (that is, 
the balance of proinflammatory responses 
and regulatory responses), in particular 
at sites exposed to both nutrients and the 
microbiota. The intriguing observation that 
the majority of fetal intestinal T cells are 
capable of producing TNF also raises the 
possibility that these cells may contribute to 
protection against infection both before birth 
and after birth. How these cells are primed 
and the nature of the antigen responsible 
or even if exogenous antigens are required 
remain important questions to answer.
In their study, Li et al. utilize T cell antigen 
receptor–sequencing techniques to provide 
evidence of clonal T cell expansion among the 
fetal memory-like pool1; however, the nature 
of the antigens that drive this expansion, or 
whether this is indeed antigen driven, remains 
unclear. While the womb has until recently 
been considered a ‘sterile’ environment, 
this does not imply it is antigen free. 
Indeed, maternally derived cells have been 
identified within human fetal tissues from 
the second trimester of pregnancy onward, 
a phenomenon called ‘microchimerism’. 
These maternally derived cells persist 
in the offspring throughout adulthood7; 
perhaps fetal intestinal memory T cells, as a 
consequence of microchimerism, recognize 
genetically foreign non-inherited maternal 
antigens. Alternatively, while this remains 
controversial, a published study detected the 
presence of microbial communities within 
the placenta, amniotic fluid and meconium8, 
which suggests that the womb might not 
be an entirely sterile environment9. Perhaps 
exposure to trace microbes or microbe-
derived antigens present in the womb trigger 
the accumulation of fetal memory T cells.
If indeed fetal intestinal CD4+ T cells 
display reactivity to microbial or commensal 
antigens, understanding the stringency of this 
specificity would be essential. Poly-reactive 
commensal-specific IgA antibodies, using a 
germline-encoded specificity and produced 
by intestinal B cells, promote the anatomical 
segregation of the intestinal epithelium 
and the commensal microbiota10. Perhaps 
fetal memory CD4+ T cells exhibit similar 
T cell antigen receptor cross-reactivity to 
multiple antigens, as has been described 
for human immunodeficiency virus– and 
influenza virus–specific memory CD4+ T 
cells recirculating in adult human blood11. It 
would be of interest to explore the possibility 
that clonally expanded, broadly reactive 
fetal intestinal CD4+ T cells might provide a 
first line of immunity to a large repertoire of 
microbes, including the microbiota.
The generation of ‘virtual memory’ T cells 
in the absence of foreign-antigen experience 
has been reported in mouse studies. It 
was also shown that human fetal splenic 
CD45RO+ T cells were able to proliferate in 
response to exogenous IL-2 but remained 
unresponsive to stimulation with the invariant 
signaling protein CD312, which provided the 
first suggestion that ‘virtual memory’  
T cells could be found within the human 
fetus. The development of hybridoma-
screening and yeast-display systems and 
isolation of ex vivo T cell clones will be key 
to better understanding of the specificity and 
potential cross-reactivity of memory-like or 
memory T cells in the fetal intestine.
Going forward, an equally intriguing 
aspect of future studies would be to address 
how anatomical tissue localization influences 
T cell effector function in the fetal intestine. 
While this is technically challenging for 
human studies, approaches to distinguishing 
the intravascular or parenchymal localization 
of distinct subsets of fetal intestinal T cells 
may aid the understanding of fetal T cell 
effector function. This might include whether 
tissue entry imposes or hinders the ability of 
naive or memory-like fetal T cells to produce 
TNF and other effector cytokines, or whether 
naive CD4+ T cells within the intestine could 
be derived from blood contaminants or are 
located within developing tertiary lymphoid 
structures. Answering such questions might 
aid in the identification of tissue factors that 
control the effector function of fetal T cells. 
Finally, perhaps fetal intestinal memory-
like T cells are not all fetus derived. In line 
with the occurrence of pregnancy-induced 
microchimerism, perhaps some of the 
memory-like T cells that accumulate within 
the fetal intestine originate directly from the 
mother. HLA typing or genotyping from 
single-cell RNA-sequencing data may allow 
future studies to assign cells as being of 
maternal or fetal origin.
By leveraging recent technological 
advances, as demonstrated here by Li et al.1., 
researchers are increasingly able to perform 
sophisticated immunological studies to 
delineate the development of the human 
immune system. Deeper understanding of 
the accumulation and function of prenatal 
and neonatal human memory T cells, as well 
as definition of their antigen specificities 
mLN
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?
?
CD45RA+
T cells
CD45RO+
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TNF, IL-2, IFN-γ, IL-4, GzmB
Fig. 1 | Naive and memory-like CD4+ t cells accumulate within the fetal intestine. Heterogenous 
populations of phenotypically naive (CD45RA+) and memory-like (CD45RO+) CD4+ T cells accumulate 
in the fetal intestine by the second trimester of pregnancy. The majority of naive and memory-like CD4+ 
T cells can produce TNF and IL-2. In addition, memory-like T cells can also produce IFN-γ, IL-4 and 
granzyme B (GzmB) but not IL-17A. Both resident DCs and migratory DCs are already present withi  
the intestinal lamina propria and mesenteric lymph nodes (mLN) during gestation, but their ole in the 
accumulation and function of fetal emory-like CD4+ T cells remains to be addressed. The antig n 
p cificity of fetal memory-like T cells remains unknown, although commensal microbe–derived or 
genetically foreign non-inherited maternal antigens (NIMA) might serve a k y role in the activation and 
accu ulation of fetal i testinal T cells.
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English summary
Fetal immune system
The immune system provides protection against pathogens such as bacteria, 
viruses, parasites and fungi. It comprises a cellular and humoral compartment. The 
former is classically divided into the innate and adaptive immune compartment. 
Innate immunity provides a crucial first line of defense mediated by a swift, 
general and non-specific response to the invader. The innate compartment 
consists of various types of phagocytic granulocytes, myeloid cells and innate 
lymphoid cells (ILCs). Simultaneously, the adaptive immune system will mount a 
more tailored and specific response through antigen-specific receptors-expressing 
B and T lymphocytes, the latter including helper CD4+ T cells and cytotoxic CD8+ 
T cells. Ultimately, the combined innate and adaptive will lead to suppression or 
elimination of the invading pathogen and the generation of immunological memory 
that provides long-lasting immunity to the pathogen. 
The fetal immune system develops during pregnancy and it has to remain tolerant 
to the semi-allogeneic environment while being prepared for the immense exposure 
to foreign antigens directly upon birth. As the largest immune compartment in 
our body, the intestine is continuously exposed to antigens derived from both 
harmless dietary constituents and potential harmful (commensal) bacteria. For 
this, an elaborate intestinal immune system has evolved to distinguish the harmful 
from beneficial antigens. Although a few studies have reported the identification of 
several immune cell subsets in the fetal tissues such as memory T cells in spleen 
and intestine, due to the scarcity of the fetal tissues and technique limitations, 
most investigation of the fetal immune system are based on cord blood collected 
at birth. Therefore, a system-wide and detailed phenotypical characterization of 
the composition and development of the human fetal immune system, especially 
the intestine was lacking. In the current study, we have approached this issue by 
making use of recently introduced single cell technologies, including (imaging-) 
mass cytometry and single-cell RNA-sequencing.
(Imaging-) Mass cytometry
Mass cytometry is a new platform that couples flow cytometry with mass 
spectrometry. This technique uses rare earth metals as reporters instead of 
fluorophores, which removes the limitation on the number of antibodies that 
can simultaneously be used due to the spectral overlap of the fluorochromes, 
and eliminates the problem of autofluorescence. Through mass cytometry up 
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to 42 markers can now be used simultaneously at single-cell resolution with 
minimal overlap between channels. Therefore, mass cytometry now provides the 
opportunity to study the diversity and heterogeneity of the immune system with 
an unprecedent high resolution.
To gain spatial information in situ, imaging-mass cytometry has been developed 
recently as a new technology, which couples a laser ablation system with a mass 
cytometer. In this way, it enables the visualization of dozens of markers on the same 
tissue section simultaneously with a sub-cellular resolution of 1 μm. Therefore, 
imaging-mass cytometry further offers an opportunity to gain unprecedented 
insight into the organization of the immune system in situ. 
Single-cell RNA-sequencing
As a complementary approach to mass cytometry, single-cell RNA sequencing 
dissects the gene expression profiles on tens of thousands of individual cells 
at the single-cell level. As such, it provides an opportunity to determine the 
cell transcriptomic heterogeneity and the discovery of rare cell populations. 
Moreover, it facilitates the identification of potential cellular differentiation 
trajectories and regulatory networks among cells at the gene level.
Heterogeneity and differentiation of innate lymphoid cells 
In Chapter 2 we explored the heterogeneity and development of the innate 
lymphoid cell (ILC) compartment in the fetal intestine using mass cytometry with 
a 35-antibody panel. Here, 34 phenotypically distinct innate lymphoid cell clusters 
were distinguished, including previously identified NK and CD127+ ILC subsets as 
well as several previously unrecognized clusters, providing evidence for extensive 
heterogeneity in the innate compartment. Moreover, by visualizing the dynamics 
of the t-SNE computation, we identified smooth phenotypic transitions from cells 
within the Lin-CD7+CD127-CD45RO+CD56+ (int-ILCs) cluster to both NK cells and 
CD127+ ILCs, revealing potential differentiation trajectories. Finally, in functional 
assays, we validated that the int-ILCs can indeed give rise to both NK cells and 
ILC3s.
Memory formation in the human fetal intestine
In Chapter 3 we combined mass cytometry with single-cell RNA-sequencing, TCR-
sequencing, imaging-mass cytometry and flow cytometry to dissect the CD4+ T 
cell compartment in the human fetal intestine. Here, mass cytometry identified 22 
phenotypically distinct clusters, including naive-like, memory-like and regulatory-
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like subpopulations, which were confirmed and further characterized at the 
transcriptional level. Moreover, we observed that the memory-like CD4+ T cells 
readily produced the cytokines TNF, IFN-γ and IL-2. Furthermore, the integrated 
single-cell analysis revealed a robust memory differentiation trajectory. Finally, 
clonal expansion and co-localization of memory-like CD4+ T cells with APCs further 
supported the concept of the generation of memory-like CD4+ T cells in the human 
fetal intestine, suggesting exposure to foreign antigens in utero.
Site-specific immune signatures across and within tissues
To further extend the understanding of the fetal immune system, in Chapter 4 we 
applied mass cytometry to profile the innate and adaptive immune compartment in 
the fetal intestine, spleen and liver. Here, we identified 177 phenotypically distinct 
clusters including both previously identified and novel cell clusters. PCA analysis 
indicated substantial differences between the composition of the immune system 
in the different tissues. Moreover, imaging-mass cytometry further underpinned 
the distinctness of the immune system in the tissues in situ. Thus, our results 
provide evidence for early-life compartmentalization of the immune system in 
fetal spleen, liver and intestine.
In Chapter 5, we applied the mass cytometry to analyze the composition of the 
mucosal immune system of patients with inflammatory intestinal diseases and 
controls. Here, we revealed previously unrecognized heterogeneity in the mucosal 
immune system and tissue- and disease-specific immune subsets.
Conclusion 
Our studies provide a global, comprehensive and detailed description of the fetal 
immune system during healthy pregnancy by integrating an array of advanced 
high-parameter single-cell techniques. We further determined the function of 
several identified cell clusters and identified a novel intestinal ILC subset that can 
give rise to NK cells and ILC3s in vitro, which adds another layer of understanding 
of ILC differentiation and plasticity. Moreover, we revealed the generation of 
memory-like CD4+ T cells in the developing human fetal intestine, indicating the 
exposure to antigens in utero. Additionally, our results provided evidence for 
the early-life immune compartmentalization across tissues as early as second 
trimester, which highlights the importance to investigate the immune system in 
the tissue niche. Together, our studies deepens our understanding of prenatal 
immunity and may provide a prenatal window of opportunity for the development 
of preventive strategies for the immune-mediated diseases later in life.
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Nederlandse samenvatting
Het foetale afweersysteem
Het afweersysteem beschermt ons tegen pathogenen zoals bacteriën, virussen 
en schimmels. De cellulaire component van het afweersysteem bevat twee 
compartimenten, het innate en het adaptieve compartiment. Het innate 
afweersyteem bevat diverse phagocyterende cellen, antigeen presenterende 
cellen en lymphocyten die zorgen voor een snelle en aspecifieke reactie 
tegen binnendringende pathogenen. Tegelijkertijd reageert ook het adaptieve 
afweersysteem dat een veel specifiekere reactie opbouwt waarbij het gebruik maakt 
van antigeen-specifieke receptoren op B- en T-lymphocyten. Deze gecombineerde 
reactie zal uiteindelijk tot onderdrukking of eliminatie van het pathogeen leiden 
waarbij tegelijk geheugen wordt opgebouwd zodat hetzelfde pathogeen bij een 
volgende infectie sneller onschadelijk kan worden gemaakt.
Het foetale afweersysteem ontwikkelt zich tijdens de zwangerschap waarin het 
tolerant moet zijn  tegen de deels allogene omgeving waarin de foetus zich 
ontwikkelt terwijl het ook moet worden voorbereid op de ontwikkeling van de 
bacteriële microbiota in de darm direct na de geboorte. Het afweersysteem in 
de darm is het grootste in ons lichaam en is continue blootgesteld aan zowel 
onschuldige voedselcomponenten als potentieel schadelijke bacteriën die dit 
afweersysteem van elkaar moet kunnen onderscheiden. Hoewel enkele studies al 
hebben aangetoond dat het foetale afweersysteem diverse componenten bevat, 
is vanwege de beperkte beschikbaarheid van foetaal weefsel de meeste kennis 
over het foetale afweersysteem gebaseerd op studies met navelstrengbloed. Een 
gedegen en brede studie naar de compositie van het foetale afweersysteem, met 
name in de darm, ontbrak tot op heden. In het huidige proefschrift heb ik dit 
onderzocht waarbij ik gebruik gemaakt heb van de nieuwste ontwikkelingen op 
het gebied van cellulaire analyse, waaronder massa cytometrie en RNA-sequentie 
bepalingen.
Massa cytometrie
Massa cytometrie is een nieuwe methode waar flow cytometrie is gekoppeld 
aan massa spectrometrie. In massa cytometrie worden metalen als reporters 
gebruikt waardoor de beperkingen van het traditionele gebruik van fluorochomen 
opgeheven wordt en tot 42 markers gelijktijdig geanalyseerd kunnen worden. 
Door deze revolutionaire innovatie kan de diversiteit en compositie van het 
afweersysteem tot in detail worden bestudeerd. 
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Het is ook mogelijk om deze techniek op weefselcoupes toe te passen, imaging 
massa cytometrie genaamd, waarmee het mogelijk is om de diversiteit en 
organisatie van het afweersysteem in de context van het weefsel te bestuderen.
Bepalen van genexpressie op cel niveau
Complementair aan massa cytometrie kan de expressie van genen van tienduizenden 
cellen op single-cel niveau worden bepaald waarmee de heterogeniteit van cellen 
en de ontdekking van zeldzame celtypes mogelijk wordt. Ook kan deze aanpak 
leiden tot de identificatie van cel ontwikkelingstrajecten en regulatoire netwerken 
binnen het afweersysteem. 
Heterogeniteit en differentiatie van innate lymphocyten
In hoofdstuk 2 is de heterogeniteit en ontwikkeling van het innate lymphoide 
cel compartiment in de foetale darm bestudeerd m.b.v. massa cytometrie. Hierbij 
werden 34 fenotypisch verschillende  innate cel clusters gevonden, waaronder 
reeds eerder geïdentificeerde cel clusters zoals NK cellen en CD127+ ILC subsets, 
maar ook een aantal niet eerder beschreven cel clusters. Gebruikmakend van 
de eigenschappen van de computationele analyse methoden konden mogelijke 
ontwikkelingstrajecten binnen het innate lymphoide compartiment worden 
geïdentificeerd die erop duiden dat de NK cellen en ILC3 kunnen ontstaan uit 
Lin-CD7+CD127-CD45RO+CD56+ (int-ILCs) cellen. In functionele assays werd deze 
hypothese verder onderbouwd.
De opbouw van geheugen in de foetale darm
in hoofdstuk 3 Is massa cytometrie gecombineerd met single-cel RNA-sequencen, 
T cel receptor sequencen, imaging massa cytometrie en flow cytometrie om het 
CD4 positieve  T cel compartiment in de humane foetale darm te ontrafelen. 
Met massa cytometrie konden 22 CD4 T cel subsets worden onderscheiden 
waaronder naïeve, geheugen en regulatoire subsets. Middels RNA-sequencen 
werd dit verder onderbouwd. Opmerkelijk genoeg produceerden de geheugen 
cellen ontstekings mediatoren zoals TNF-alpha en Interferon-γ. Ook legde een 
gedetailleerde en geïntegreerde analyse van de data een differentiatie traject 
bloot dat de vorming van geheugen ondersteunde. Tenslotte wezen zowel de co-
lokalisatie van de geheugen T cellen met antigeen presenterende  cellen in het 
darmweefsel zelf, en aanwijzingen voor klonale cel expansie in de darm erop dat 
de geheugenvorming in de foetale darm het gevolg was van blootstelling van de 
foetus aan omgevingsfactoren in de baarmoeder. 
183
7
Appendices
Weefselspecifieke samenstelling van het afweersysteem
Om verder inzicht in het foetale afweersysteem te verkrijgen wordt in hoofdstuk 
4 beschreven hoe massa cytometrie is gebruikt om het innate and adaptieve 
afweersysteem in de foetale darm, milt en lever met elkaar te vergelijken. Deze 
analyse leidde tot de identificatie van 117 fenotypisch verschillende cel clusters 
waaronder zowel eerder beschreven alsmede nieuw ontdekte clusters. PCA analyse 
liet zien dat er grote verschillen zijn in de samenstelling van het afweersysteem 
in de drie geanalyseerde organen. Met imaging massa cytometrie werd deze 
weefsel-specifieke samenstelling bevestigd. Deze resultaten laten zien dat heel 
vroeg in het leven weefsel-specifieke compartimentalisatie van het afweersysteem 
ontstaat. 
In hoofdstuk 5 is massa cytometrie gebruikt om het afweersysteem  te analyseren 
in darmbiopten van patiënten die leiden aan chronische darmontsteking en dat 
te vergelijken met dat in gezonde controles. Deze analyse liet zien dat zowel 
weefsel- als ziekte-specifieke immuun subsets konden worden gedetecteerd.  
Conclusies
Het in dit proefschrift beschreven werk geeft een breed en gedetailleerd inzicht 
in de samenstelling van het foetale afweersysteem gedurende de zwangerschap. 
Hiervoor is gebruik gemaakt van een serie geavanceerde multiparameter 
technieken om cellen op single-cel niveau te bestuderen. Daarnaast is de functie 
van een aantal nieuw geïdentificeerde cel subsets bepaald. Hierbij is een nieuwe 
ILC subset gevonden die in vitro kan differentiëren tot zowel NK cellen als ILC3’s. 
Hiermee is nieuw inzicht verkregen in de plasticiteit van het ILC compartiment. 
Verder werd gevonden dat gedurende de zwangerschap geheugen cellen worden 
gevormd in de foetale darm, wat er op wijst dat de foetus in de baarmoeder is 
blootgesteld aan omgevingsfactoren. Tenslotte is gevonden dat reeds heel vroeg 
in het leven het afweersysteem in verschillende weefsels een eigen signatuur 
heeft en het afweersysteem zich dus aanpast aan het weefsel waarin het moet 
functioneren. Om de functie van het afweersysteem goed te doorgronden is het 
dus noodzakelijk om het afweersysteem in de weefselcontext te bestuderen. 
Al met al biedt dit werk nieuw inzicht in de samenstelling en functie van het 
foetale afweersysteem, kennis die mogelijk gebruikt kan gaan worden om de 
ontwikkeling van ziekten die door ontregelde reacties van het afweersysteem 
worden veroorzaakt te voorkomen. 
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